脳神経外科学レビュー

出版社： 総合医学社
著者：
発行日： 2019-08-05
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784883786794
電子書籍版： 2019-08-05 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

16,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

〈脳腫瘍〉〈脳血管障害〉〈小児脳神経外科〉〈画像診断〉など10のテーマを定め、レビューすべき59項目を取り上げ、直近1～2年に発表された国内外の論文を厳選。各論文の要旨と評価・意見なども掲載する。

目次

  • I．脳腫瘍
    　1．WHO2016脳腫瘍病理分類とcIMPACT-NOW update
    　2．Diffuse midline glioma
    　3．小児悪性脳腫瘍の分類と展望
    　4．グリオーマ遺伝子解析update
    　5．脊椎・脊髄update
    　6．良性脳腫瘍の遺伝子解析と治療
    　7．下垂体腫瘍のWHO2017新分類

    II．脳血管障害
    　8．脳血管障害と遺伝子
    　9．未破裂脳動脈瘤の自然歴と治療
    　10．血管奇形の治療
    　11．もやもや病の治療
    　12．硬膜動静脈瘻
    　13．脳梗塞急性期と慢性期の抗血小板療法
    　14．脳卒中の再発予防のための抗凝固療法
    　15．脳卒中の医療提供体制と地域，施設間連携
    　16．血管内再開通療法
    　17．脳動脈瘤塞栓術（Coil，WEB 他）
    　18．脳動脈瘤に対するフローダイバーター
    　19．頚動脈狭窄に対するCEA とCAS

    III．脳外傷
    　20．重症頭部外傷（最近の治療）
    　21．スポーツによる脳振盪（Sports Related Concussion：SRC）
    　22．児童虐待
    　23．外傷にともなう高次脳機能障害

    IV．定位・機能
    　24．てんかんの診断と治療
    　25．ニューロモデュレーション
    　26．パーキンソン病・不随意運動の治療
    　27．FUS治療の現状と将来
    　28．痙縮の治療
    　29．定位的放射線治療の現状と展望

    V．小　児
    　30．脊髄髄膜瘤（胎児手術を含めた最近の進歩）
    　31．脊髄脂肪腫
    　32．頭蓋縫合早期癒合症（新たな手術法）
    　33．頭蓋内嚢胞性病変

    VI．脊髄・脊椎・末梢神経
    　34．頚椎変性疾患（頚椎人工椎間板）
    　35．腰椎変性疾患（低侵襲腰椎椎間板ヘルニア手術）
    　36．脊柱変形；各種脊椎矯正フォーミュラーについて
    　37．脊髄血管障害：脊髄AVM の新しい分類と治療
    　38．最近の知見1　脊髄再生医療の現状と未来
    　39．最新の知見2　ロボティックスの脊椎手術への応用

    VII．水頭症
    　40．正常圧水頭症　診断と治療
    　41． 小児の水頭症（シャント術vs 内視鏡手術）

    VIII．神経科学
    　42．多能性幹細胞を用いた神経再生医療
    　43．脳卒中に対する細胞療法
    　44．グリオーマに対する新規分子標的薬としての変異IDH1阻害薬の動向
    　45．鏡視下手術の展望
    　46．脳機能解析
    　47．遺伝子治療

    IX．手術・手技
    　48．神経内視鏡
    　49．定位放射線治療
    　50．顕微鏡の進化（Exoscope 含む）
    　51．術中蛍光診断技術
    　52．ハイブリッド手術室と術中画像診断
    　53．術中ナビゲーション
    　54．術中モニタリング

    X．画像診断
    　55．画像診断と人工知能
    　56．MRIの最新情報
    　57．血流と髄液動態のMRI
    　58．核医学検査の最新情報
    　59．術前シミュレーション画像

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 脳腫瘍

P.2 掲載の参考文献
1) Louis DN et al;International Agency for Research on Cancer:"WHO classification of tumours of the central nervous system, ed Revised 4th edition". Lyon:International Agency For Research On Cancer, 2016
 
2) Louis DN, Perry A, Reifenberger G et al:The 2016 World Health Organization Classification of Tumors of the Central Nervous System:a summary. Acta Neuropathol 131(6):803-820, 2016
PubMed
P.3 掲載の参考文献
3) Louis DN, Aldape K, Brat DJ et al:Announcing cIMPACT-NOW:the Consortium to inform molecular and practical approaches to CNS tumor taxonomy. Acta Neuropathol 133(1):1-3, 2017
 
4) Louis DN, Aldape K, Brat DJ et al:cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy):a new initiative in advancing nervous system tumor classification. Brain Pathol 27(6):851-852, 2017
 
5) Louis DN, Wesseling P, Paulus W et al:cIMPACT-NOW update 1:Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC). Acta Neuropathol 135(3):481-484, 2018
PubMed
P.4 掲載の参考文献
6) Louis DN, Giannini C, Capper D et al:cIMPACT-NOW update 2:diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135(4):639-642, 2018
PubMed
P.5 掲載の参考文献
7) Brat DJ, Aldape K, Colman H et al:cIMPACT-NOW update 3:recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". Acta Neuropathol 136(5):805-810, 2018
PubMed
8) Stichel D, Ebrahimi A, Reuss D et al:Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol 136(5):793-803, 2018
PubMed
9) Wijnenga MMJ, Dubbink HJ, French PJ et al:Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas:assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification. Acta Neuropathol 134(6):957-959, 2017
PubMed
10) Aibaidula A, Chan AK, Shi Z et al:Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol 19(10):1327-1337, 2017
 
P.6 掲載の参考文献
11) Shirahata M, Ono T, Stichel D et al:Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136(1):153-166, 2018
PubMed
12) Pekmezci M, Rice T, Molinaro AM et al:Adult infiltrating gliomas with WHO 2016 integrated diagnosis:additional prognostic roles of ATRX and TERT. Acta Neuropathol 133(6):1001-1016, 2017
PubMed
P.7 掲載の参考文献
13) Qaddoumi I, Orisme W, Wen J et al:Genetic alterations in uncommon low-grade neuroepithelial tumors:BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131(6):833-845, 2016
PubMed
P.8 掲載の参考文献
14) Schwalbe EC, Lindsey JC, Nakjang S et al:Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma:a cohort study. Lancet Oncol 18(7):958-971, 2017
PubMed
15) Northcott PA, Buchhalter I, Morrissy AS et al:The whole-genome landscape of medulloblastoma subtypes. Nature 547(7663):311-317, 2017
PubMed
P.9 掲載の参考文献
16) Sahm F, Schrimpf D, Stichel D et al:DNA methylation-based classification and grading system for meningioma:a multicentre, retrospective analysis. Lancet Oncol 18(5):682-694, 2017
PubMed
P.10 掲載の参考文献
1) Louis DN, Ohgaki H, Wiestler OD et al:WHO classification of tumours of the central nervous system. International Agency for Reserch on Cancer, Revised 4th edn. Lyon, 2016
 
2) Cohen KJ, Jabado N, Grill J:Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol 19(8):1025-1034, 2017
 
3) 武笠晃丈:脳腫瘍におけるヒストン H3 K27M変異の意義. Neuro-Oncologyの進歩 24:7-17, 2017
 
P.11 掲載の参考文献
4) Gessi M, Capper D, Sahm F et al:Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132(4):635-637, 2016
PubMed
5) Pages M, Beccaria K, Boddaert N et al:Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol 28(1):103-111, 2018
 
6) Orillac C, Thomas C, Dastagirzada Y et al:Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun 4(1):84, 2016
PubMed
7) Pratt D, Natarajan SK, Banda A et al:Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas. Acta Neuropathol 135(2):299-301, 2018
PubMed
8) Louis DN, Giannini C, Capper D et al:cIMPACT-NOW update 2:diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135(4):639-642, 2018
PubMed
9) Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N et al:Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG):A collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol 36(19):1963-1972, 2018
 
P.12 掲載の参考文献
10) Karremann M, Gielen GH, Hoffmann M et al:Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol 20(1):123-131, 2018
PubMed
11) Wang L, Li Z, Zhang M et al:H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Hum Pathol 78:89-96, 2018
 
12) Yi S, Choi S, Shin DA et al:Impact of H3.3 K27M mutation on prognosis and survival of grade IV spinal cord glioma on the basis of new 2016 World Health Organization classification of the central nervous system. Neurosurgery 84(5):1072-1081, 2019 (Epub 2018 May 1)
 
13) Kieran MW, Goumnerova LC, Prados M et al:Biopsy for diffuse intrinsic pontine glioma:a reappraisal. J Neurosurg Pediatr 18(3):390-391, 2016
PubMed
14) Puget S, Beccaria K, Blauwblomme T et al:Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst 31(10):1773-1780, 2015
 
P.13 掲載の参考文献
15) Gupta N, Goumnerova LC, Manley P et al:Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol 20(11):1547-1555, 2018
PubMed
16) Huang TY, Piunti A, Lulla RR et al:Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5(1):28, 2017
PubMed
17) Panditharatna E, Kilburn LB, Aboian MS et al:Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res 24(23):5850-5859, 2018
PubMed
18) Pan C, Diplas BH, Chen X et al:Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathol 137(2):297-306, 2019
PubMed
P.14 掲載の参考文献
19) Drew L:The unexpected role of histones in childhood brain cancer. Nature 561(7724):S56-S58, 2018
PubMed
20) Hashizume R:Epigenetic targeted therapy for diffuse intrinsic pontine glioma. Neurol Med Chir (Tokyo) 57(7):331-342, 2017
PubMed
21) Chheda ZS, Kohanbash G, Okada K et al:Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med 215(1):141-157, 2018
PubMed
22) Mount CW, Majzner RG, Sundaresh S et al:Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+diffuse midline gliomas. Nat Med 24(5):572-579, 2018
 
23) Himes BT, Zhang L, Daniels DJ:Treatment strategies in diffuse midline gliomas with the H3K27M mutation:the role of convection-enhanced delivery in overcoming anatomic challenges. Front Oncol 9:31, 2019
PubMed
24) Janssens GO, Gandola L, Bolle S et al:Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression:A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer 73:38-47, 2017
 
P.15 掲載の参考文献
25) Mackay A, Burford A, Carvalho D et al:Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520-537.e5, 2017
 
P.16 掲載の参考文献
1) Lassaletta A, Zapotocky M, Mistry M et al:Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol 35(25):2934-2941, 2017
PubMed
P.17 掲載の参考文献
2) Banerjee A, Jakacki RI, Onar-Thomas A et al:A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma:a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol 19(8):1135-1144, 2017
PubMed
3) Fangusaro JR, Onar-Thomas A, Young-Poussaint T et al:A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG):A Pediatric Brain Tumor Consortium (PBTC) study. J Clin Oncol 35(15suppl):10504-10504, 2017
 
4) Mackay A, Burford A, Carvalho D et al:Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520-537.e5, 2017
 
P.18 掲載の参考文献
5) Carvalho D, Taylor KR, Olaciregui NG et al:ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Commun Biol 2:156, 2019
PubMed
6) Chheda ZS, Kohanbash G, Okada K et al:Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med 215(1):141-157, 2018
PubMed
7) Mount CW, Majzner RG, Sundaresh S et al:Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas. Nat Med 24(5):572-579, 2018
 
8) Cavalli FMG, Remke M, Rampasek L et al:Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31(6):737-754.e6, 2017
 
9) Schwalbe EC, Lindsey JC, Nakjang S et al:Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma:a cohort study. Lancet Oncol 18(7):958-971, 2017
PubMed
10) Northcott PA, Buchhalter I, Morrissy AS et al:The whole-genome landscape of medulloblastoma subtypes. Nature 547(7663):311-317, 2017
PubMed
P.19 掲載の参考文献
11) Sharma T, Schwalbe EC, Williamson D et al:Second-generation molecular subgrouping of medulloblastoma:an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol, 2019 (doi:10.1007/s00401-019-02020-0)
 
12) Robinson GW, Rudneva VA, Buchhalter I et al:Risk-adapted therapy for young children with medulloblastoma (SJYC07):therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol 19(6):768-784, 2018
 
13) Goschzik T, Schwalbe EC, Hicks D et al:Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma:a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Lancet Oncol 19(12):1602-1616, 2018
 
P.20 掲載の参考文献
14) Johann PD, Erkek S, Zapatka M et al:Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29(3):379-393, 2016
PubMed
15) Torchia J, Golbourn B, Feng S et al:Integrated (epi) -genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30(6):891-908, 2016
PubMed
16) Sturm D, Orr BA, Toprak UH et al:New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164(5):1060-1072, 2016
PubMed
P.21 掲載の参考文献
17) Merchant TE, Bendel AE, Sabin ND et al:Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, supratentorial ependymoma. J Clin Oncol 37(12):974-983, 2019
PubMed
18) Upadhyaya SA, Robinson GW, Onar-Thomas A et al:Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro Oncol, 2019 (doi:10.1093/neuonc/noz069)
 
19) Fukushima S, Yamashita S, Kobayashi H et al:Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol 133(3):445-462, 2017
PubMed
20) Calaminus G, Frappaz D, Kortmann RD et al:Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol 19(12):1661-1672, 2017
 
P.22 掲載の参考文献
1) Sottoriva A, Spiteri I, Piccirillo SG et al:Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110(10):4009-4014, 2013
PubMed
2) Johnson BE, Mazor T, Hong C et al:Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343(6167):189-193, 2014
PubMed
3) Suzuki H, Aoki K, Chiba K et al:Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47(5):458-468, 2015
PubMed
P.23 掲載の参考文献
4) Wang J, Cazzato E, Ladewig E et al:Clonal evolution of glioblastoma under therapy. Nat Genet 48(7):768-776, 2016
PubMed
5) Lee JK, Wang J, Sa JK et al:Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nat Genet 49(4):594-599, 2017
PubMed
6) Hu H, Mu Q, Bao Z et al:Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor. Cell 175(6):1665-1678.e18, 2018
 
7) Aihara K, Mukasa A, Nagae G et al:Genetic and epigenetic stability of oligodendrogliomas at recurrence. Acta Neuropathol Commun 5(1):18, 2017
PubMed
P.24 掲載の参考文献
8) Arita H, Narita Y, Fukushima S et al:Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126(2):267-276, 2013
PubMed
9) Eckel-Passow JE, Lachance DH, Molinaro AM et al:Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499-2508, 2015
PubMed
10) Arita H, Yamasaki K, Matsushita Y et al:A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4(1):79, 2016
PubMed
11) Nguyen HN, Lie A, Li T et al:Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro Oncol 19(3):394-404, 2017
 
12) Lee JH, Lee JE, Kahng JY et al:Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560(7717):243-247, 2018
PubMed
P.25 掲載の参考文献
13) Abou-El-Ardat K, Seifert M, Becker K et al:Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro Oncol 19(4):546-557, 2017
 
14) Zhang Z, Chan AK, Ding X et al:Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas. Neuro Oncol 19(7):1008-1010, 2017
 
15) Turner KM, Deshpande V, Beyter D et al:Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543(7643):122-125, 2017
PubMed
16) deCarvalho AC, Kim H, Poisson LM et al:Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. Nat Genet 50(5):708-717, 2018
PubMed
P.26 掲載の参考文献
17) Koga T, Li B, Figueroa JM et al:Mapping of genomic EGFRvIII deletions in glioblastoma:insight into rearrangement mechanisms and biomarker development. Neuro Oncol 20(10):1310-1320, 2018
PubMed
18) Patel AP, Tirosh I, Trombetta JJ et al:Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396-1401, 2014
PubMed
P.27 掲載の参考文献
19) Tirosh I, Venteicher AS, Hebert C et al:Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539(7628):309-313, 2016
PubMed
20) Venteicher AS, Tirosh I, Hebert C et al:Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355(6332), 2017 (doi:10.1126/science.aai8478)
 
21) Filbin MG, Tirosh I, Hovestadt V et al:Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360(6386):331-335, 2018
PubMed
P.29 掲載の参考文献
1) Yi S, Choi S, Shin DA et al:Impact of H3.3 K27M Mutation on prognosis and survival of grade IV spinal cord glioma on the basis of new 2016 World Health Organization classification of the central nervous system. Neurosurgery 84(5):1072-1081, 2019 (Epub 2018 May 1)
 
2) Wang L, Li Z, Zhang M et al:H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Hum Pathol 78:89-96, 2018
 
P.30 掲載の参考文献
3) Seki T, Hida K, Yano S et al:Clinical factors for prognosis and treatment guidance of spinal cord astrocytoma. Asian Spine J 10(4):748-754, 2016
PubMed
4) Inoue T, Endo T, Nakamura T et al:Expression of CD133 as a putative prognostic biomarker to predict intracranial dissemination of primary spinal cord astrocytoma. World Neurosurg 110:e715-e726, 2018
PubMed
5) Luksik AS, Garzon-Muvdi T, Yang W et al:Pediatric spinal cord astrocytomas:a retrospective study of 348 patients from the SEER database. J Neurosurg Pediatr 19(6):711-719, 2017
 
6) Konar SK, Bir SC, Maiti TK et al:A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord. J Neurosurg Pediatr 19(2):239-248, 2017
 
P.31 掲載の参考文献
7) Wostrack M, Ringel F, Eicker SO et al:Spinal ependymoma in adults:a multicenter investigation of surgical outcome and progression-free survival. J Neurosurg Spine 28(6):654-662, 2018
PubMed
8) Behmanesh B, Gessler F, Dutzmann S et al:Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment. J Neurooncol 135(1):93-98, 2017
PubMed
P.32 掲載の参考文献
9) Li J, Chen G, Gu S et al:Surgical outcomes of spinal cord intramedullary cavernous malformation:A retrospective study of 83 patients in a single center over a 12-year period. World Neurosurg 118:e105-e114, 2018
 
10) Imagama S, Ito Z, Ando K et al:Optimal timing of surgery for intramedullary cavernous hemangioma of the spinal cord in relation to preoperative motor paresis, disease duration, and tumor volume and location. Global Spine J 7(3):246-253, 2017
PubMed
11) Raco A, Pesce A, Toccaceli G et al:Factors leading to a poor functional outcome in spinal meningioma surgery:Remarks on 173 cases. Neurosurgery 80(4):602-609, 2017
PubMed
12) Gilard V, Goia A, Ferracci FX et al:Spinal meningioma and factors predictive of postoperative deterioration. J Neurooncol 140(1):49-54, 2018
PubMed
P.33 掲載の参考文献
13) Bridges KJ, Jaboin JJ, Kubicky CD et al:Stereotactic radiosurgery versus surgical resection for spinal hemangioblastoma:A systematic review. Clin Neurol Neurosurg 154:59-66, 2017
PubMed
14) Siller S, Szelenyi A, Herlitz L et al:Spinal cord hemangioblastomas:significance of intraoperative neurophysiological monitoring for resection and long-term outcome. J Neurosurg Spine 26(4):483-493, 2017
PubMed
P.35 掲載の参考文献
1) Brokinkel B, Hess K, Mawrin C:Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation:a systematic review. Neuro Oncol 19(10):1298-1307, 2017
 
2) Vaubel RA, Chen SG, Raleigh DR et al:Meningiomas with rhabdoid features lacking other histologic features of malignancy:A study of 44 cases and review of the literature. J Neuropathol Exp Neurol 75(1):44-52, 2016
PubMed
3) Yesiloz U, Kirches E, Hartmann C et al:Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Neuro Oncol 19(8):1088-1096, 2017
 
4) Boetto J, Bielle F, Sanson M et al:SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro Oncol 19(3):345-351, 2017
 
5) Strickland MR, Gill CM, Nayyar N et al:Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. J Neurosurg 127(2):438-444, 2017
PubMed
6) Abedalthagafi M, Bi WL, Aizer AA et al:Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 18(5):649-655, 2016
PubMed
P.36 掲載の参考文献
7) Clark VE, Harmanci AS, Bai H et al:Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet 48(10):1253-1259, 2016
PubMed
8) Bi WL, Greenwald NF, Abedalthagafi M et al:Genomic landscape of high-grade meningiomas. NPJ Genom Med 2:pii15, 2017
 
9) Tauziede-Espariat A, Parfait B, Besnard A et al:Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma:a comprehensive immunophenotypical and molecular analysis. Brain Pathol 28(4):466-474, 2018
PubMed
10) Shankar GM, Santagata S:BAP1 mutations in high-grade meningioma:implications for patient care. Neuro Oncol 19(11):1447-1456, 2017
 
11) Sahm F, Schrimpf D, Olar A et al:TERT promoter mutations and risk of recurrence in meningioma. J Natl Cancer Inst 108(5):djv377, 2016
 
12) Juratli TA, Thiede C, Koerner MVA et al:Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas. Oncotarget 8(65):109228-109237, 2017
PubMed
13) Harmanci AS, Youngblood MW, Clark VE et al:Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun 8:14433, 2017
PubMed
14) Collord G, Tarpey P, Kurbatova N et al:An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures. Sci Rep 8(1):13537, 2018
PubMed
P.37 掲載の参考文献
15) Agnihotri S, Suppiah S, Tonge PD et al:Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun 8(1):186, 2017
PubMed
16) Sahm F, Schrimpf D, Stichel D et al:DNA methylation-based classification and grading system for meningioma:a multicentre, retrospective analysis. Lancet Oncol 18(5):682-694, 2017
PubMed
P.38 掲載の参考文献
17) Holsken A, Sill M, Merkle J et al:Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun 4:20, 2016
PubMed
18) Brastianos PK, Shankar GM, Gill CM et al:Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst 108(2):djv310, 2016
 
19) Yue Q, Yu Y, Shi Z et al:Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features. J Neurosurg 129(1):27-34, 2018
PubMed
20) Hara T, Akutsu H, Takano S et al:Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation. J Neurosurg, 2018 (doi:10.3171/2018.3.JNS172528)
 
21) Omay SB, Chen YN, Almeida JP et al:Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg 128(5):1473-1478, 2018
PubMed
P.40 掲載の参考文献
1) Asa SL, Mete O:Immunohistochemical biomarkers in pituitary pathology. Endocr Pathol 29(2):130-136, 2018
PubMed
2) Inoshita N, Nishioka H:The 2017 WHO classification of pituitary adenoma:overview and comments. Brain Tumor Pathol 35(2):51-56, 2018
PubMed
3) Nishioka H, Inoshita N:New WHO classification of pituitary adenomas (4th edition):assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 35(2):57-61, 2018
PubMed
4) Sjostedt E, Bollerslev J, Mulder J et al:A specific antibody to detect transcription factor T-Pit:a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours. Acta Neuropathol 134(4):675-677, 2017
 
5) Mete O, Kefeli M, Caliskan S et al:GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32(4):484-489, 2019 (Epub 2018 Nov 2)
 
6) Mete O, Alshaikh OM, Cintosun A et al:Synchronous multiple pituitary neuroendocrine tumors of different cell lineages. Endocr Pathol 29(4):332-338, 2018
PubMed
7) Mete O, Cintosun A, Pressman I et al:Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 31(6):900-909, 2018
PubMed
8) Tordjman KM, Greenman Y, Ram Z et al:Plurihormonal pituitary tumor of Pit-1 and SF-1 lineages, with synchronous collision corticotroph tumor:a possible stem cell phenomenon. Endocr Pathol 30(1):74-80, 2019 (Epub 2019 Jan 4)
 
9) Drummond J, Roncaroli F, Grossman AB et al:Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab, 2018 (doi:10.1210/jc.2018-00688)
 
P.41 掲載の参考文献
10) Chinezu L, Vasiljevic A, Trouillas J et al:Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature. Eur J Endocrinol 176(2):195-201, 2017
 
11) Delgado-Lopez PD, Pi-Barrio J, Duenas-Polo MT et al:Recurrent non-functioning pituitary adenomas:a review on the new pathological classification, management guidelines and treatment options. Clin Transl Oncol 20(10):1233-1245, 2018
PubMed
12) Del Basso De Caro M, Solari D, Pagliuca F et al:Atypical pituitary adenomas:clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev 40(1):105-114, 2017
PubMed
13) Rutkowski MJ, Alward RM, Chen R et al:Atypical pituitary adenoma:a clinicopathologic case series. J Neurosurg 128(4):1058-1065, 2018
 
P.42 掲載の参考文献
14) Raverot G, Dantony E, Beauvy J et al:Risk of recurrence in pituitary neuroendocrine tumors:A prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368-3374, 2017
PubMed
15) Hasanov R, Aydogan BI, Kiremitci S et al:The prognostic roles of the Ki-67 proliferation index, P53 expression, mitotic index, and radiological tumor invasion in pituitary adenomas. Endocr Pathol 30(1):49-55, 2019 (Epub 2019 Jan 4)
 
16) Micko ASG, Wohrer A, Hoftberger R et al:MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas. Pituitary 20(6):643-653, 2017
PubMed
17) Alshaikh OM, Asa SL, Mete O et al:An institutional experience of tumor progression to pituitary carcinoma in a 15-year cohort of 1055 consecutive pituitary neuroendocrine tumors. Endocr Pathol, 2019 (doi:10.1007/s12022-019-9568-5)
 
18) Trouillas J, Burman P, McCormack A et al:Aggressive pituitary tumours and carcinomas:two sides of the same coin? Eur J Endocrinol 178(6):C7-C9, 2018
 
19) Asa SL, Casar-Borota O, Chanson P et al:From pituitary adenoma to pituitary neuroendocrine tumor (PitNET):an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24(4):C5-C8, 2017
 
20) Raverot G, Burman P, McCormack A et al:European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1-G24, 2018
 
P.43 掲載の参考文献
21) Kasuki L, Wildemberg LE, Gadelha MR:Management of endocrine disease:Personalized medicine in the treatment of acromegaly. Eur J Endocrinol 178(3):R89-R100, 2018
 
22) Shibuya M:Welcoming the new WHO classification of pituitary tumors 2017:revolution in TTF-1-positive posterior pituitary tumors. Brain Tumor Pathol 35(2):62-70, 2018
PubMed
23) Hagel C, Buslei R, Buchfelder M et al:Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells. Pituitary 20(2):211-217, 2017
PubMed

II. 脳血管障害

P.47 掲載の参考文献
1) Bang OY, Chung JW, Cha J et al:A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis. PLoS One 11(6):e0156607, 2016
 
2) Cao Y, Kobayashi H, Morimoto T et al:Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Environ Health Prev Med 21(5):387-390, 2016
PubMed
3) Shinya Y, Miyawaki S, Imai H et al:Genetic analysis of ring finger protein 213 (RNF213) c.14576G>A in intracranial atherosclerosis of the anterior and posterior circulations. J Stroke Cerebrovasc Dis 26(11):2638-2644, 2017
PubMed
4) Morimoto T, Mineharu Y, Ono K et al:Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease. PLoS One 12(4):e0175649, 2017
 
5) Chang SA, Song JS, Park TK et al:Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 p.Arg4810Lys regardless of cooccurrence of moyamoya disease. Chest 153(2):404-413, 2018
PubMed
6) Komiyama M:Cardio-cephalic neural crest syndrome:A novel hypothesis of vascular neurocristopathy. Interv Neuroradiol 23(6):572-576, 2017
PubMed
P.48 掲載の参考文献
7) Guey S, Kraemer M, Herve D et al:Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet 25(8):995-1003, 2017
 
8) Morimoto T, Enmi JI, Hattori Y et al:Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep 8(1):3607, 2018
PubMed
9) Nardella G, Visci G, Guarnieri V et al:A single-center study on 140 patients with cerebral cavernous malformations:28 new pathogenic variants and functional characterization of a PDCD10 large deletion. Hum Mutat 39(12):1885-1900, 2018
 
10) Spiegler S, Rath M, Hoffjan S et al:First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing. Neurogenetics 19(1):55-59, 2018
 
P.49 掲載の参考文献
11) Detter MR, Snellings DA, Marchuk DA:Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ Res 123(10):1143-1151, 2018
PubMed
12) Tang AT, Choi JP, Kotzin JJ et al:Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545(7654):305-310, 2017
PubMed
13) Shenkar R, Shi C, Austin C et al:RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke 48(1):187-194, 2017
PubMed
14) Shenkar R, Peiper A, Pardo H et al:Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10/Ccm3 disease. Stroke 50(3):738-744, 2019
PubMed
15) Shenkar R, Shi C, Austin C et al:RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke 48(1):187-194, 2017
PubMed
16) Choi JP, Wang R, Yang X et al:Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci Adv 4(11):eaau0731, 2018
 
17) Lopez-Ramirez MA, Fonseca G, Zeineddine HA et al:Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med 214(11):3331-3346, 2017
PubMed
P.50 掲載の参考文献
18) Wooderchak-Donahue WL, McDonald J, O'Fallon B et al:BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet 93(3):530-537, 2013
 
19) McDonald J, Wooderchak-Donahue WL, Henderson K et al:Tissue-specific mosaicism in hereditary hemorrhagic telangiectasia:Implications for genetic testing in families. Am J Med Genet A 176(7):1618-1621, 2018
PubMed
20) Goumans MJ, Zwijsen A, Ten Dijke P et al:Bone morphogenetic proteins in vascular homeostasis and disease. Cold Spring Harb Perspect Biol 10(2):, 2018
PubMed
21) Jin Y, Muhl L, Burmakin M et al:Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat Cell Biol 19(6):639-652, 2017
 
22) Thalgott JH, Dos-Santos-Luis D, Hosman AE et al:Decreased expression of vascular endothelial growth factor receptor 1 contributes to the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Circulation 138(23):2698-2712, 2018
 
23) Ola R, Kunzel SH, Zhang F et al:SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2. Circulation 138(21):2379-2394, 2018
PubMed
24) Kini SD, Yiu DW, Weisberg RA et al:Bevacizumab as treatment for epistaxis in hereditary hemorrhagic telangiectasia:A literature review. Ann Otol Rhinol Laryngol 128(5):467-471, 2019
PubMed
P.51 掲載の参考文献
25) Dupuis-Girod S, Ambrun A, Decullier E et al:Effect of bevacizumab nasal spray on epistaxis duration in hereditary hemorrhagic telangectasia:A randomized clinical trial. JAMA 316(9):934-942, 2016
PubMed
26) Zhu W, Chen W, Zou D et al:Thalidomide reduces hemorrhage of brain arteriovenous malformations in a mouse model. Stroke 49(5):1232-1240, 2018
 
27) Parambil JG, Woodard TD, Koc ON:Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 128(10):2234-2236, 2018
PubMed
28) Nikolaev SI, Vetiska S, Bonilla X et al:Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 378(3):250-261, 2018
PubMed
P.52 掲載の参考文献
1) Etminan N, Chang HS, Hackenberg K et al:Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population:A systematic review and meta-analysis. JAMA Neurol, 2019 (doi:10.1001/jamaneurol.2019.0006)
 
2) Korja M, Lehto H, Juvela S et al:Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology 87(11):1118-1123, 2016
PubMed
P.53 掲載の参考文献
3) Can A, Castro VM, Ozdemir YH et al:Association of intracranial aneurysm rupture with smoking duration, intensity, and cessation. Neurology 89(13):1408-1415, 2017
 
4) Can A, Castro VM, Ozdemir YH et al:Alcohol consumption and aneurysmal subarachnoid hemorrhage. Transl Stroke Res 9(1):13-19, 2018
 
5) Andreasen TH, Bartek J Jr, Andresen M et al:Modifiable risk factors for aneurysmal subarachnoid hemorrhage. Stroke 44(12):3607-3612, 2013
PubMed
6) Murayama Y, Takao H, Ishibashi T et al:Risk analysis of unruptured intracranial aneurysms:Prospective 10-year cohort study. Stroke 47(2):365-371, 2016
PubMed
P.54 掲載の参考文献
7) Greving JP, Wermer MJ, Brown RD Jr et al:Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms:a pooled analysis of six prospective cohort studies. Lancet Neurol 13(1):59-66, 2014
PubMed
8) Tominari S, Morita A, Ishibashi T et al:Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 77(6):1050-1059, 2015
PubMed
9) Geurts M, Timmers C, Greebe P et al:Patients with unruptured intracranial aneurysms at the waiting list for intervention:risk of rupture. J Neurol 261(3):575-578, 2014
PubMed
10) Backes D, Rinkel GJE, Greving JP et al:ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms. Neurology 88(17):1600-1606, 2017
PubMed
P.55 掲載の参考文献
11) Inoue T, Shimizu H, Fujimura M et al:Annual rupture risk of growing unruptured cerebral aneurysms detected by magnetic resonance angiography. J Neurosurg 117(1):20-25, 2012
PubMed
12) Etminan N, Brown RD Jr, Beseoglu K et al:The unruptured intracranial aneurysm treatment score:a multidisciplinary consensus. Neurology 85(10):881-889, 2015
 
13) Ji W, Liu A, Lv X et al:Risk score for neurological complications after endovascular treatment of unruptured intracranial aneurysms. Stroke 47(4):971-978, 2016
PubMed
14) McDonald JS, McDonald RJ, Fan J et al:Comparative effectiveness of unruptured cerebral aneurysm therapies:propensity score analysis of clipping versus coiling. Stroke 44(4):988-994, 2013
PubMed
P.56 掲載の参考文献
15) Darsaut TE, Findlay JM, Magro E et al:Surgical clipping or endovascular coiling for unruptured intracranial aneurysms:a pragmatic randomised trial. J Neurol Neurosurg Psychiatry 88(8):663-668, 2017
 
16) Algra AM, Lindgren A, Vergouwen MDI et al:Procedural clinical complications, case-fatality risks, and risk factors in endovascular and neurosurgical treatment of unruptured intracranial aneurysms:A systematic review and meta-analysis. JAMA Neurol, 2018 (doi:10.1001/jamaneurol.2018.4165)
 
P.57 掲載の参考文献
17) Sonobe M, Yamazaki T, Yonekura M et al:Small unruptured intracranial aneurysm verification study:SUAVe study, Japan. Stroke 41(9):1969-1977, 2010
PubMed
18) Guresir E, Vatter H, Schuss P et al:Natural history of small unruptured anterior circulation aneurysms:a prospective cohort study. Stroke 44(11):3027-3031, 2013
PubMed
19) Ikawa F, Morita A, Tominari S et al:Rupture risk of small unruptured cerebral aneurysms. J Neurosurg, 2019 (doi:10.3171/2018.9.JNS181736)
 
P.58 掲載の参考文献
20) Malhotra A, Wu X, Forman HP et al:Management of tiny unruptured intracranial aneurysms:A comparative effectiveness analysis. JAMA Neurol 75(1):27-34, 2018
PubMed
21) Hishikawa T, Date I, Tokunaga K et al:Risk of rupture of unruptured cerebral aneurysms in elderly patients. Neurology 85(21):1879-1885, 2015
PubMed
22) Mahaney KB, Brown RD Jr, Meissner I et al:Age-related differences in unruptured intracranial aneurysms:1-year outcomes. J Neurosurg 121(5):1024-1038, 2014
PubMed
23) Brinjikji W, Rabinstein AA, Lanzino G et al:Effect of age on outcomes of treatment of unruptured cerebral aneurysms:a study of the National Inpatient Sample 2001-2008. Stroke 42(5):1320-1324, 2011
PubMed
P.59 掲載の参考文献
24) Bekelis K, Gottlieb DJ, Su Y et al:Comparison of clipping and coiling in elderly patients with unruptured cerebral aneurysms. J Neurosurg 126(3):811-818, 2017
PubMed
25) Mori K, Wada K, Otani N et al:Validation of effectiveness of keyhole clipping in nonfrail elderly patients with unruptured intracranial aneurysms. J Neurosurg 127(6):1307-1314, 2017
PubMed
26) Matsukawa H, Kamiyama H, Tsuboi T et al:Is age a risk factor for poor outcome of surgical treatment of unruptured intracranial aneurysms? World Neurosurg 94:222-228, 2016
PubMed
P.60 掲載の参考文献
27) Hasan DM, Mahaney KB, Brown RD Jr et al:Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 42(11):3156-3162, 2011
PubMed
28) Hasan DM, Chalouhi N, Jabbour P et al:Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms:preliminary results. J Am Heart Assoc 2(1):e000019, 2013
 
29) Omodaka S, Endo H, Niizuma K et al:Circumferential wall enhancement on magnetic resonance imaging is useful to identify rupture site in patients with multiple cerebral aneurysms. Neurosurgery 82(5):638-644, 2018
PubMed
30) Thompson BG, Brown RD Jr, Amin-Hanjani S et al:Guidelines for the management of patients with unruptured intracranial aneurysms:A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46(8):2368-2400, 2015
PubMed
P.61 掲載の参考文献
1) Mohr JP, Parides MK, Stapf C et al:Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA):a multicentre, non-blinded, randomised trial. Lancet 383(9917):614-621, 2014
 
P.62 掲載の参考文献
2) Al-Shahi Salman R, White PM, Counsell CE et al:Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 311(16):1661-1669, 2014
PubMed
3) Magro E, Gentric JC, Darsaut TE et al:Responses to ARUBA:a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg 126(2):486-494, 2017
PubMed
4) Hong CS, Peterson EC, Ding D et al:Intervention for A randomized trial of unruptured brain arteriovenous malformations (ARUBA) - Eligible patients:An evidence-based review. Clin Neurol Neurosurg 150:133-138, 2016
PubMed
5) Potts MB, Lau D, Abla AA et al:Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg 122(4):912-920, 2015
PubMed
6) Cenzato M, Boccardi E, Beghi E et al:European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien) 159(6):1059-1064, 2017
PubMed
P.63 掲載の参考文献
7) Derdeyn CP, Zipfel GJ, Albuquerque FC et al:Management of brain arteriovenous malformations:A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(8):e200-e224, 2017
 
8) Patibandla MR, Ding D, Kano H et al:Stereotactic radiosurgery for Spetzler-Martin Grade IV and V arteriovenous malformations:an international multicenter study. J Neurosurg 129(2):498-507, 2018
PubMed
9) Ilyas A, Ding D, Robert Hixson H et al:Volume-staged stereotactic radiosurgery for large intracranial arteriovenous malformations. J Clin Neurosci 43:202-207, 2017
PubMed
10) Akers A, Al-Shahi Salman R, A Awad I et al:Synopsis of guidelines for the Clinical Management of Cerebral Cavernous Malformations:Consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 80(5):665-680, 2017
PubMed
P.65 掲載の参考文献
1) 冨永悌二, 鈴木則宏, 宮本享 他:もやもや病(ウイリス動脈輪閉塞症)診断・治療ガイドライン(改訂版). 脳卒中の外科 46:1-24, 2018
Medical*Online
2) Miyamoto S, Yoshimoto T, Hashimoto N et al:Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease:results of the Japan Adult Moyamoya Trial. Stroke 45(5):1415-1421, 2014
PubMed
P.66 掲載の参考文献
3) Takahashi JC, Funaki T, Houkin K et al:Significance of the hemorrhagic site for recurrent bleeding:Prespecified analysis in the Japan Adult Moyamoya Trial. Stroke 47(1):37-43, 2016
PubMed
4) Funaki T, Takahashi JC, Yoshida K et al:Periventricular anastomosis in moyamoya disease:detecting fragile collateral vessels with MR angiography. J Neurosurg 124(6):1766-1772, 2016
PubMed
5) Funaki T, Takahashi JC, Houkin K et al:Angiographic features of hemorrhagic moyamoya disease with high recurrence risk:a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128(3):777-784, 2018
 
6) Funaki T, Takahashi JC, Houkin K et al:High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease:analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg, 2018 (doi:10.3171/2017.9.JNS17576)
 
7) Fujimura M, Funaki T, Houkin K et al:Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease:case-control study of the Japan Adult Moyamoya Trial. J Neurosurg, 2018 (doi:10.3171/2017.11.JNS171990)
 
8) Wang QN, Bao XY, Zhang Y et al:Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease:long-term outcome of a consecutive series of 95 adult patients from a single center. J Neurosurg, 2018 (doi:10.3171/2017.12.JNS172246)
 
P.67 掲載の参考文献
9) Kim H, Jang DK, Han YM et al:Direct bypass versus indirect bypass in adult moyamoya angiopathy with symptoms or hemodynamic instability:A meta-analysis of comparative studies. World Neurosurg 94:273-284, 2016
PubMed
10) Jang DK, Lee KS, Rha HK et al:Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. J Neurosurg 127(3):492-502, 2017
PubMed
11) Funaki T, Takahashi JC, Miyamoto S:Late cerebrovascular events and social outcome after adolescence:Long-term outcome of pediatric moyamoya disease. Neurol Med Chir (Tokyo) 58(6):240-246, 2018
PubMed
P.68 掲載の参考文献
12) Nakamizo A, Amano T, Michiwaki Y et al:Long-term neurocognitive outcomes in patients with adult moyamoya disease. World Neurosurg 119:e441-e448, 2018
PubMed
P.69 掲載の参考文献
1) LaHue SC, Kim H, Pawlikowska L et al:Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula. J Neurosurg, 2018 (doi:10.3171/2017.10.JNS171987)
 
2) Polster SP, Zeineddine HA, Baron J et al:Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening. J Neurosurg 129(4):954-960, 2018
PubMed
P.70 掲載の参考文献
3) Kannath SK, Rajendran A, Thomas B et al:Volumetric T2-weighted MRI improves the diagnostic accuracy of spinal vascular malformations:comparative analysis with a conventional MR study. J Neurointerv Surg:neurintsurg-2018-014522, 2019
 
4) Zalewski NL, Rabinstein AA, Brinjikji W et al:Unique gadolinium enhancement pattern in spinal dural arteriovenous fistulas. JAMA Neurol 75(12):1542-1545, 2018
PubMed
5) Hodel J, Leclerc X, Kalsoum E et al:Intracranial arteriovenous shunting:detection with arterial spin-labeling and susceptibility-weighted imaging combined. AJNR Am J Neuroradiol 38(1):71-76, 2017
PubMed
P.71 掲載の参考文献
6) Amukotuwa SA, Marks MP, Zaharchuk G et al:Arterial spin-labeling improves detection of intracranial dural arteriovenous fistulas with MRI. AJNR Am J Neuroradiol 39(4):669-677, 2018
PubMed
7) Crockett MT, Chiu AHY, Singh TP et al:Transvenous coil embolization with intraoperative cone beam CT assistance in the treatment of hypoglossal canal dural arteriovenous fistulae. J Neurointerv Surg 11(2):179-183, 2019
PubMed
8) Diaz OM, Toledo MM, Roehm JOF et al:Unique percutaneous direct puncture technique for occlusion of a hypoglossal canal dural arteriovenous fistula. J Neurointerv Surg 10(12):1179-1182, 2018
PubMed
9) Ertl L, Bruckmann H, Kunz M et al:Endovascular therapy of low- and intermediate-grade intracranial lateral dural arteriovenous fistulas:a detailed analysis of primary success rates, complication rates, and long-term follow-up of different technical approaches. J Neurosurg 126(2):360-367, 2017
PubMed
P.72 掲載の参考文献
10) Clarencon F, Di Maria F, Gabrieli J et al:Double-lumen balloon for Onyx(R) embolization via extracranial arteries in transverse sigmoid dural arteriovenous fistulas:initial experience. Acta Neurochir (Wien) 158(10):1917-1923, 2016
 
11) Alturki AY, Enriquez-Marulanda A, Schmalz P et al:Transarterial Onyx embolization of bilateral transverse-sigmoid dural arteriovenous malformation with transvenous balloon assist-initial U.S. experience with Copernic RC venous remodeling balloon. World Neurosurg 109:398-402, 2018
PubMed
12) Kerolus MG, Chung J, Munich SA et al:An Onyx tunnel:reconstructive transvenous balloon-assisted Onyx embolization for dural arteriovenous fistula of the transverse-sigmoid sinus. J Neurosurg 129(4):922-927, 2018
PubMed
13) Guo F, Zhang Y, Liang S et al:The Procedure-related complications of transarterial Onyx embolization of dural arteriovenous fistula using transvenous balloon protection. World Neurosurg 116:e203-e210, 2018
 
P.73 掲載の参考文献
14) Mantilla D, Le Corre M, Cagnazzo F et al:Outcome of transarterial treatment of dural arteriovenous fistulas with direct or indirect cortical venous drainage. J Neurointerv Surg 10(10):958-963, 2018
PubMed
15) Ambekar S, Gaynor BG, Peterson EC et al:Long-term angiographic results of endovascularly "cured" intracranial dural arteriovenous fistulas. J Neurosurg 124(4):1123-1127, 2016
PubMed
16) Sadeh-Gonike U, Magand N, Armoiry X et al:Transarterial Onyx embolization of intracranial dural fistulas:A prospective cohort, systematic review, and meta-analysis. Neurosurgery 82(6):854-863, 2018
PubMed
17) Lamin S, Chew HS, Chavda S et al:Embolization of intracranial dural arteriovenous fistulas using PHIL liquid embolic agent in 26 patients:A multicenter study. AJNR Am J Neuroradiol 38(1):127-131, 2017
PubMed
P.74 掲載の参考文献
18) Flores BC, See AP, Weiner GM et al:Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas. J Neurosurg, 2018 (doi:10.3171/2017.9.JNS17397)
 
19) Howard BM, Grossberg JA, Prater A et al:Incompletely obliterated cranial arteriovenous fistulae are safely and effectively treated with adjuvant ε-aminocaproic acid. J Neurointerv Surg 10(7):698-703, 2018
 
P.75 掲載の参考文献
20) Starke RM, McCarthy DJ, Chen CJ et al:Evaluation of stereotactic radiosurgery for cerebral dural arteriovenous fistulas in a multicenter international consortium. J Neurosurg, 2019 (doi:10.3171/2018.8.JNS181467)
 
21) Tonetti DA, Gross BA, Jankowitz BT et al:Reconsidering an important subclass of high-risk dural arteriovenous fistulas for stereotactic radiosurgery. J Neurosurg, 2018 (doi:10.3171/2017.10.JNS171802)
 
P.77 掲載の参考文献
1) Rothwell PM, Algra A, Chen Z et al:Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke:time-course analysis of randomised trials. Lancet 388(10042):365-375, 2016
PubMed
2) Lee M, Saver JL, Hong KS et al:Antiplatelet regimen for patients with breakthrough strokes while on aspirin:A systematic review and meta-analysis. Stroke 48(9):2610-2613, 2017
 
3) Wang Y, Wang Y, Zhao X et al:Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369(1):11-19, 2013
PubMed
P.78 掲載の参考文献
4) Johnston SC, Easton JD, Farrant M et al:Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379(3):215-225, 2018
 
5) Jing J, Meng X, Zhao X et al:Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns:Subgroup analysis of the CHANCE randomized clinical trial. JAMA Neurol 75(6):711-719, 2018
PubMed
6) Zhou Y, Pan Y, Wu Y et al:Effect of estimated glomerular filtration rate decline on the efficacy and safety of clopidogrel with aspirin in minor stroke or transient ischemic attack:CHANCE substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Stroke 47(11):2791-2796, 2016
 
7) Lin Y, Wang A, Li J et al:Impact of glycemic control on efficacy of clopidogrel in transient ischemic attack or minor stroke patients with CYP2C19 genetic variants. Stroke 48(4):998-1004, 2017
PubMed
8) Hao Q, Tampi M, O'Donnell M et al:Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack:systematic review and meta-analysis. BMJ 363:k5108, 2018
PubMed
9) Ge F, Lin H, Liu Y et al:Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack:a systematic review and meta-analysis. Eur J Neurol 23(6):1051-1057, 2016
PubMed
P.79 掲載の参考文献
10) Bath PM, Woodhouse LJ, Appleton JP et al:Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS):a randomised, open-label, phase 3 superiority trial. Lancet 391(10123):850-859, 2018
 
11) Hong KS, Lee SH, Kim EG et al:Recurrent ischemic lesions after acute atherothrombotic stroke:Clopidogrel plus aspirin versus aspirin alone. Stroke 47(9):2323-2330, 2016
PubMed
12) Johnston SC, Amarenco P, Albers GW et al:Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 375(1):35-43, 2016
 
P.80 掲載の参考文献
13) Amarenco P, Albers GW, Denison H et al:Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin:a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol 16(4):301-310, 2017
 
14) Wang Y, Minematsu K, Wong KS et al:Ticagrelor in acute stroke or transient ischemic attack in Asian patients:From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). Stroke 48(1):167-173, 2017
 
15) Amarenco P, Albers GW, Denison H et al:Ticagrelor versus aspirin in acute embolic stroke of undetermined source. Stroke 48(9):2480-2487, 2017
PubMed
16) Ogawa A, Toyoda K, Kitagawa K et al:Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke:a phase 3, randomised, noninferiority trial (PRASTRO-I). Lancet Neurol 18(3):238-247, 2019
PubMed
17) Niu PP, Guo ZN, Jin H et al:Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke:an updated network meta-analysis. BMJ Open 6(3):e009013, 2016
 
P.81 掲載の参考文献
18) Toyoda K, Uchiyama S, Yamaguchi T et al:Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan:a multicentre, open-label, randomised controlled trial. Lancet Neurol 18(6):539-548, 2019
PubMed
19) Kim BJ, Lee EJ, Kwon SU et al:Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO):a multicentre, randomised controlled trial. Lancet Neurol 17(6):509-518, 2018
 
20) Hilkens NA, Algra A, Kappelle LJ et al:Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke. Neurology 90(8):e683-e689, 2018
PubMed
P.82 掲載の参考文献
21) Lau KK, Lovelock CE, Li L et al:Antiplatelet treatment after transient ischemic attack and ischemic stroke in patients with cerebral microbleeds in 2 large cohorts and an updated systematic review. Stroke 49(6):1434-1442, 2018
 
22) McNeil JJ, Woods RL, Nelson MR et al:Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med 379(16):1499-1508, 2018
PubMed
23) McNeil JJ, Wolfe R, Woods RL et al:Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med 379(16):1509-1518, 2018
PubMed
24) Gaziano JM, Brotons C, Coppolecchia R et al:Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE):a randomised, double-blind, placebo-controlled trial. Lancet 392(10152):1036-1046, 2018
 
25) Uchiyama S, Ishizuka N, Shimada K et al:Aspirin for stroke prevention in elderly patients with vascular risk factors:Japanese primary prevention project. Stroke 47(6):1605-1611, 2016
PubMed
P.84 掲載の参考文献
1) Nezu T, Hosomi N, Lip GY et al:Temporal trends in stroke severity and prior antithrombotic use among acute ischemic stroke patients in Japan. Circ J 80(9):2033-2036, 2016
PubMed
2) Yamashita Y, Hamatani Y, Esato M et al:Clinical characteristics and outcomes in extreme elderly (age >- 85 years) Japanese patients with atrial fibrillation:The Fushimi AF Registry. Chest 149(2):401-412, 2016
PubMed
3) Koga M, Yoshimura S, Hasegawa Y et al:Higher risk of ischemic events in secondary prevention for patients with persistent than those with paroxysmal atrial fibrillation. Stroke 47(10):2582-2588, 2016
PubMed
P.85 掲載の参考文献
4) Yasuda K, Fukuda S, Nakamura M et al:Predictors of cardioembolic stroke in Japanese patients with atrial fibrillation in the Fushimi AF Registry. Cerebrovasc Dis Extra 8(2):50-59, 2018
PubMed
5) Okumura Y, Yokoyama K, Matsumoto N et al:Three-year clinical outcomes associated with warfarin vs. direct oral anticoagulant use among Japanese patients with atrial fibrillation - Findings From the SAKURA AF Registry. Circ J 82(10):2500-2509, 2018
PubMed
6) Mentias A, Shantha G, Chaudhury P et al:Assessment of outcomes of treatment with oral anticoagulants in patients with atrial fibrillation and multiple chronic conditions:A comparative effectiveness analysis. JAMA Netw Open 1(5):e182870, 2018
 
7) Shpak M, Ramakrishnan A, Nadasdy Z et al:Higher incidence of ischemic stroke in patients taking novel oral anticoagulants. Stroke 49(12):2851-2856, 2018
PubMed
P.86 掲載の参考文献
8) Ogawa H, Hamatani Y, Doi K et al:Sex-related differences in the clinical events of patients with atrial fibrillation - The Fushimi AF Registry. Circ J 81(10):1403-1410, 2017
PubMed
9) Bower MM, Sweidan AJ, Shafie M et al:Contemporary reversal of oral anticoagulation in intracerebral hemorrhage. Stroke 50(2):529-536, 2019
PubMed
10) Wilson D, Seiffge DJ, Traenka C et al:Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology 88(18):1693-1700, 2017
PubMed
11) Connolly SJ, Crowther M, Eikelboom JW et al:Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380(14):1326-1335, 2019 (Epub 2019 Feb 7)
 
12) Ayoub K, Nairooz R, Almomani A et al:Perioperative heparin bridging in atrial fibrillation patients requiring temporary interruption of anticoagulation:Evidence from meta-analysis. J Stroke Cerebrovasc Dis 25(9):2215-2221, 2016
PubMed
P.87 掲載の参考文献
13) Nazha B, Pandya B, Cohen J et al:Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation. Circulation 138(14):1402-1411, 2018
PubMed
14) January CT, Wann LS, Calkins H et al:2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm:S1547-5271(19)30037-2, 2019
 
15) Patti G, Lucerna M, Pecen L et al:Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation:A sub-analysis from the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation). J Am Heart Assoc 6(7):e005657, 2017
 
P.88 掲載の参考文献
16) Giustozzi M, Vedovati MC, Verso M et al:Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants:A multicentre observational study. Int J Cardiol 281:56-61, 2019
 
17) Sakamoto Y, Nito C, Nishiyama Y et al:Safety of anticoagulant therapy including direct oral anticoagulants in patients with acute spontaneous intracerebral hemorrhage. Circ J 83(2):441-446, 2019
PubMed
18) Toyoda K, Yamagami H, Koga M:Consensus guides on stroke thrombolysis for anticoagulated patients from Japan:Application to other populations. J Stroke 20(3):321-331, 2018
PubMed
P.89 掲載の参考文献
19) Kodani E, Nagao T:Novel therapeutic target of anticoagulation therapy in patients with atrial fibrillation - Cognitive decline and dementia. Circ J 82(3):644-645, 2018
PubMed
20) Senoo K, Kondo Y, Kobayashi Y et al:Silent cerebral infarction in East Asian vs. non-Asian atrial fibrillation patients-Meta-analysis. Circ J 82(3):672-676, 2018
PubMed
21) Jacobs V, May HT, Bair TL et al:Long-term population-based cerebral ischemic event and cognitive outcomes of direct oral anticoagulants compared with warfarin among long-term anticoagulated patients for atrial fibrillation. Am J Cardiol 118(2):210-214, 2016
PubMed
22) Washida K, Kowa H, Hamaguchi H et al:Validation of the R2CHADS2 and CHADS2 Scores for predicting post-stroke cognitive impairment. Intern Med 56(20):2719-2725, 2017
PubMed
P.90 掲載の参考文献
1) Kobayashi A, Czlonkowska A, Ford GA et al:European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for prehospital management of stroke. Eur J Neurol 25(3):425-433, 2018
PubMed
P.91 掲載の参考文献
2) Menon BK, Sajobi TT, Zhang Y et al:Analysis of workflow and time to treatment on thrombectomy outcome in the endovascular treatment for small core and proximal occlusion ischemic stroke (ESCAPE)randomized, controlled trial. Circulation 133(23):2279-2286, 2016
PubMed
3) Simonsen CZ, Yoo AJ, Sorensen LH et al:Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke:A randomized clinical trial. JAMA Neurol 75(4):470-477, 2018
 
4) Alotaibi NM, Sarzetto F, Guha D et al:Impact of smartphone applications on timing of endovascular therapy for ischemic stroke:A preliminary study. World Neurosurg 107:678-683, 2017
PubMed
5) Aghaebrahim A, Streib C, Rangaraju S et al:Streamlining door to recanalization processes in endovascular stroke therapy. J Neurointerv Surg 9(4):340-345, 2017
PubMed
6) Koge J, Matsumoto S, Nakahara I et al:Improving treatment times for patients with in-hospital stroke using a standardized protocol. J Neurol Sci 381:68-73, 2017
PubMed
7) Schregel K, Behme D, Tsogkas I et al:Effects of Workflow Optimization in Endovascularly Treated Stroke Patients - A Pre-Post Effectiveness Study. PLoS One 11(12):e0169192, 2016
 
8) Janssen PM, Venema E, Dippel DWJ:Effect of workflow improvements in endovascular stroke treatment. Stroke 50(3):665-674, 2019
PubMed
P.92 掲載の参考文献
9) Mathur S, Walter S, Grunwald IQ et al:Improving prehospital stroke services in rural and underserved settings with mobile stroke units. Front Neurol 10:159, 2019
PubMed
10) McTaggart RA, Yaghi S, Cutting SM et al:Association of a primary stroke center protocol for suspected stroke by large-vessel occlusion with efficiency of care and patient outcomes. JAMA Neurol 74(7):793-800, 2017
PubMed
11) Morris S, Ramsay AIG, Boaden RJ et al:Impact and sustainability of centralising acute stroke services in English metropolitan areas:retrospective analysis of hospital episode statistics and stroke national audit data. BMJ 364:l1, 2019
 
P.93 掲載の参考文献
12) Hastrup S, Johnsen SP, Terkelsen T et al:Effects of centralizing acute stroke services:A prospective cohort study. Neurology 91(3):e236-e248, 2018
 
13) Stroke Unit Trialists' Collaboration.:Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2013(9):CD000197
PubMed
14) Lin E, Calderon V, Goins-Whitmore J et al:World's first 24/7 mobile stroke unit:Initial 6-month experience at Mercy Health in Toledo, Ohio. Front Neurol 9:283, 2018
PubMed
P.94 掲載の参考文献
15) Ebinger M, Kunz A, Wendt M et al:Effects of golden hour thrombolysis:a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol 72(1):25-30, 2015
PubMed
16) Yamal JM, Rajan SS, Parker SA et al:Benefits of stroke treatment delivered using a mobile stroke unit trial. Int J Stroke 13(3):321-327, 2018
PubMed
17) Wu TC, Parker SA, Jagolino A et al:Telemedicine can replace the neurologist on a mobile stroke Unit. Stroke 48(2):493-496, 2017
PubMed
18) Messe SR, Khatri P, Reeves MJ et al:Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry. Neurology 87(15):1565-1574, 2016
PubMed
19) Gonzales S, Mullen MT, Skolarus L et al:Progressive rural-urban disparity in acute stroke care. Neurology 88(5):441-448, 2017
PubMed
20) Gumbinger C, Reuter B, Hacke W et al:Restriction of therapy mainly explains lower thrombolysis rates in reduced stroke service levels. Neurology 86(21):1975-1983, 2016
PubMed
P.95 掲載の参考文献
21) Gerschenfeld G, Muresan IP, Blanc R et al:Two paradigms for endovascular thrombectomy after intravenous thrombolysis for acute ischemic stroke. JAMA Neurol 74(5):549-556, 2017
PubMed
22) Ismail M, Armoiry X, Tau N et al:Mothership versus drip and ship for thrombectomy in patients who had an acute stroke:a systematic review and meta-analysis. J Neurointerv Surg 11(1):14-19, 2019
PubMed
23) Wechsler LR, Demaerschalk BM, Schwamm LH et al:Telemedicine quality and outcomes in stroke:A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48(1):e3-e25, 2017
 
24) Dorsey ER, Glidden AM, Holloway MR et al:Teleneurology and mobile technologies:the future of neurological care. Nat Rev Neurol 14(5):285-297, 2018
PubMed
P.96 掲載の参考文献
25) Ali SF, Hubert GJ, Switzer JA et al:Validating the TeleStroke Mimic Score:A prediction rule for identifying stroke mimics evaluated over telestroke networks. Stroke 49(3):688-692, 2018
 
P.97 掲載の参考文献
1) Berkhemer OA, Fransen PS, Beumer D et al:A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372(1):11-20, 2015
PubMed
2) Goyal M, Demchuk AM, Menon BK et al:Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019-1030, 2015
PubMed
3) Campbell BC, Mitchell PJ, Kleinig TJ et al:Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009-1018, 2015
PubMed
4) Saver JL, Goyal M, Bonafe A et al:Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285-2295, 2015
PubMed
5) Jovin TG, Chamorro A, Cobo E et al:Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372(24):2296-2306, 2015
PubMed
P.98 掲載の参考文献
6) Goyal M, Menon BK, van Zwam WH et al:Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723-1731, 2016
PubMed
7) Bracard S, Ducrocq X, Mas JL et al:Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE):a randomised controlled trial. Lancet Neurol 15(11):1138-1147, 2016
PubMed
8) Muir KW, Ford GA, Messow CM et al:Endovascular therapy for acute ischaemic stroke:the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry 88(1):38-44, 2017
PubMed
9) Nogueira RG, Jadhav AP, Haussen DC et al:Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378(1):11-21, 2018
PubMed
10) Albers GW, Marks MP, Kemp S et al:Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378(8):708-718, 2018
PubMed
11) Powers WJ, Rabinstein AA, Ackerson T et al:2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke:A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46-e110, 2018
 
12) Lapergue B, Blanc R, Gory B et al:Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion:The ASTER Randomized Clinical Trial. JAMA 318(5):443-452, 2017
PubMed
13) Turk AS 3rd, Siddiqui A, Fifi JT et al:Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS):a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet 393(10175):998-1008, 2019
PubMed
P.99 掲載の参考文献
14) McTaggart RA, Tung EL, Yaghi S et al:Continuous aspiration prior to intracranial vascular embolectomy (CAPTIVE):a technique which improves outcomes. J Neurointerv Surg 9(12):1154-1159, 2017
PubMed
15) Goto S, Ohshima T, Ishikawa K et al:A stent-retrieving into an aspiration catheter with proximal balloon (ASAP) technique:A technique of mechanical thrombectomy. World Neurosurg 109:e468-e475, 2018
PubMed
16) Nogueira RG, Frei D, Kirmani JF et al:Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention:A randomized clinical trial. JAMA Neurol 75(3):304-311, 2018
PubMed
17) Saver JL, Goyal M, van der Lugt A et al:Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke:A meta-analysis. JAMA 316(12):1279-1288, 2016
PubMed
18) McTaggart RA, Ansari SA, Goyal M et al:Initial hospital management of patients with emergent large vessel occlusion (ELVO):report of the standards and guidelines committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg 9(3):316-323, 2017
 
19) Mueller-Kronast NH, Zaidat OO, Froehler MT et al:Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke:Primary results of the STRATIS Registry. Stroke 48(10):2760-2768, 2017
PubMed
P.100 掲載の参考文献
20) Froehler MT, Saver JL, Zaidat OO et al:Interhospital transfer before thrombectomy is associated with delayed treatment and worse outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke). Circulation 136(24):2311-2321, 2017
PubMed
21) Pride GL, Fraser JF, Gupta R et al:Prehospital care delivery and triage of stroke with emergent large vessel occlusion (ELVO):report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery. J Neurointerv Surg 9(8):802-812, 2017
 
22) Smith EE, Kent DM, Bulsara KR et al:Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke:A systematic review for the 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke 49(3):e111-e122, 2018
 
23) Schonenberger S, Uhlmann L, Hacke W et al:Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy:A randomized clinical trial. JAMA 316(19):1986-1996, 2016
 
24) Lowhagen Henden P, Rentzos A, Karlsson JE et al:General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke:The An-Stroke Trial (Anesthesia During Stroke). Stroke 48(6):1601-1607, 2017
PubMed
25) Simonsen CZ, Yoo AJ, Sorensen LH et al:Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke:A randomized clinical trial. JAMA Neurol 75(4):470-477, 2018
 
26) Campbell BCV, van Zwam WH, Goyal M et al:Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care:a meta-analysis of individual patient data. Lancet Neurol 17(1):47-53, 2018
 
P.101 掲載の参考文献
27) Roman LS, Menon BK, Blasco J et al:Imaging features and safety and efficacy of endovascular stroke treatment:a meta-analysis of individual patient-level data. Lancet Neurol 17(10):895-904, 2018
PubMed
28) Campbell BCV, Majoie CBLM, Albers GW et al:Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy:a meta-analysis of individual patient-level data. Lancet Neurol 18(1):46-55, 2019
PubMed
29) Campbell BCV, Mitchell PJ, Churilov L et al:Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 378(17):1573-1582, 2018
PubMed
P.102 掲載の参考文献
1) Pierot L, Costalat V, Moret J et al:Safety and efficacy of aneurysm treatment with WEB:results of the WEBCAST study. J Neurosurg 124(5):1250-1256, 2016
PubMed
2) Pierot L, Gubucz I, Buhk JH et al:Safety and efficacy of aneurysm treatment with the WEB:results of the WEBCAST 2 Study. AJNR Am J Neuroradiol 38(6):1151-1155, 2017
PubMed
3) Pierot L, Moret J, Turjman F et al:WEB treatment of intracranial aneurysms:clinical and anatomic results in the French Observatory. AJNR Am J Neuroradiol 37(4):655-659, 2016
PubMed
P.103 掲載の参考文献
4) Fiorella D, Molyneux A, Coon A et al:Demographic, procedural and 30-day safety results from the WEB Intra-saccular Therapy Study (WEB-IT). J Neurointerv Surg 9(12):1191-1196, 2017
PubMed
5) Arthur A, Hoit D, Coon A et al:Physician training protocol within the WEB Intrasaccular Therapy (WEB-IT) study. J Neurointerv Surg 10(5):500-504, 2018
PubMed
P.104 掲載の参考文献
6) Pierot L, Moret J, Barreau X et al:Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg 10(6):553-559, 2018
 
7) Piotin M, Biondi A, Sourour N et al:The LUNA aneurysm embolization system for intracranial aneurysm treatment:short-term, mid-term and long-term clinical and angiographic results. J Neurointerv Surg 10(12):e34, 2018
 
8) Aguilar Perez M, Bhogal P, Martinez Moreno R et al:The Medina Embolic Device:early clinical experience from a single center. J Neurointerv Surg 9(1):77-87, 2017
 
9) Haffaf I, Clarencon F, Shotar E et al:Medina embolization device for the treatment of intracranial aneurysms:18 months' angiographic results. J Neurointerv Surg 11(5):516-522, 2019 (Epub 2018 Nov 24)
 
P.105 掲載の参考文献
10) Iosif C, Piotin M, Saleme S et al:Safety and effectiveness of the Low Profile Visualized Intraluminal Support (LVIS and LVIS Jr) devices in the endovascular treatment of intracranial aneurysms:results of the TRAIL multicenter observational study. J Neurointerv Surg 10(7):675-681, 2018
PubMed
11) Grossberg JA, Hanel RA, Dabus G et al:Treatment of wide-necked aneurysms with the Low-profile Visualized Intraluminal Support (LVIS Jr) device:a multicenter experience. J Neurointerv Surg 9(11):1098-1102, 2017
PubMed
12) Zhang X, Zhong J, Gao H et al:Endovascular treatment of intracranial aneurysms with the LVIS device:a systematic review. J Neurointerv Surg 9(6):553-557, 2017
 
13) Cheung NK, Chiu AH, Cheung A et al:Long term follow-up of bifurcation aneurysms treated with braided stent assisted coiling and complex T- and Y- stent constructs. J Neurointerv Surg 10(6):560-565, 2018
PubMed
14) Petr O, Brinjikji W, Cloft H et al:Current trends and results of endovascular treatment of unruptured intracranial aneurysms at a single institution in the Flow-Diverter Era. AJNR Am J Neuroradiol 37(6):1106-1113, 2016
 
P.106 掲載の参考文献
15) Raymond J, Klink R, Chagnon M et al:Hydrogel versus bare platinum coils in patients with large or recurrent aneurysms prone to recurrence after endovascular treatment:A randomized controlled trial. AJNR Am J Neuroradiol 38(3):432-441, 2017
PubMed
P.107 掲載の参考文献
16) Xue T, Chen Z, Lin W et al:Hydrogel coils versus bare platinum coils for the endovascular treatment of intracranial aneurysms:a meta-analysis of randomized controlled trials. BMC Neurol 18(1):167, 2018
 
17) Yu LB, Yang XJ, Zhang Q et al:Management of recurrent intracranial aneurysms after coil embolization:a novel classification scheme based on angiography. J Neurosurg, 2018 (doi:10.3171/2018.6.JNS181046)
 
18) Bond KM, Brinjikji W, Murad MH et al:Diffusion-weighted imaging-detected ischemic lesions following endovascular treatment of cerebral aneurysms:A systematic review and meta-analysis. AJNR Am J Neuroradiol 38(2):304-309, 2017
PubMed
P.108 掲載の参考文献
19) Oh SW, Shin NY, Lee HJ et al:Delayed enhancing lesions after coil embolization of aneurysms:clinical experience and benchtop analyses. J Neurointerv Surg 9(12):1243-1247, 2017
PubMed
20) Kim KS, Fraser JF, Grupke S et al:Management of antiplatelet therapy in patients undergoing neuroendovascular procedures. J Neurosurg 129(4):890-905, 2018
PubMed
P.110 掲載の参考文献
1) Brinjikji W, Lanzino G, Cloft HJ et al:Risk factors for hemorrhagic complications following pipeline embolization device treatment of intracranial aneurysms:Results from the International Retrospective Study of the Pipeline Embolization Device. AJNR Am J Neuroradiol 36(12):2308-2313, 2015
PubMed
2) Brinjikji W, Lanzino G, Cloft HJ et al:Risk factors for ischemic complications following pipeline embolization device treatment of intracranial aneurysms:Results from the IntrePED Study. AJNR Am J Neuroradiol 37(9):1673-1678, 2016
PubMed
3) Kallmes DF, Brinjikji W, Boccardi E et al:Aneurysm Study of Pipeline in an Observational Registry (ASPIRe). Interv Neurol 5(1-2):89-99, 2016
 
P.111 掲載の参考文献
4) Becske T, Potts MB, Shapiro M et al:Pipeline for uncoilable or failed aneurysms:3-year follow-up results. J Neurosurg 127(1):81-88, 2017
 
5) Becske T, Brinjikji W, Potts MB et al:Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms:Five-year results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery 80(1):40-48, 2017
 
6) Raymond J, Gentric JC, Darsaut TE et al:Flow diversion in the treatment of aneurysms:a randomized care trial and registry. J Neurosurg 127(3):454-462, 2017
PubMed
7) Kiselev R, Orlov K, Dubovoy A et al:Flow diversion versus parent artery occlusion with bypass in the treatment of complex intracranial aneurysms:Immediate and short-term outcomes of the randomized trial. Clin Neurol Neurosurg 172:183-189, 2018
PubMed
P.112 掲載の参考文献
8) Park MS, Mazur MD, Moon K et al:An outcomes-based grading scale for the evaluation of cerebral aneurysms treated with flow diversion. J Neurointerv Surg 9(11):1060-1063, 2017
PubMed
9) Dodier P, Frischer JM, Wang WT et al:Immediate flow disruption as a prognostic factor after flow diverter treatment:Long-term experience with the pipeline embolization device. World Neurosurg 113:e568-e578, 2018
PubMed
10) Brown BL, Lopes D, Miller DA et al:The fate of cranial neuropathy after flow diversion for carotid aneurysms. J Neurosurg 124(4):1107-1113, 2016
PubMed
11) de Korte AM, Aquarius R, Meijer FJA et al:Intracranial aneurysm expansion might cause neurological deterioration after flow diverter treatment. World Neurosurg 120:e802-e810, 2018
PubMed
P.113 掲載の参考文献
12) White AC, Kumpe DA, Roark CD et al:Patterns, predictors, and outcomes of postprocedure delayed hemorrhage following flow diversion for intracranial aneurysm treatment. World Neurosurg 115:e97-e104, 2018
PubMed
13) Daou B, Starke RM, Chalouhi N et al:P2Y12 reaction units:Effect on hemorrhagic and thromboembolic complications in patients with cerebral aneurysms treated with the pipeline embolization device. Neurosurgery 78(1):27-33, 2016
PubMed
14) Nakae R, Nagaishi M, Kawamura Y et al:Microhemorrhagic transformation of ischemic lesions on T2*-weighted magnetic resonance imaging after Pipeline embolization device treatment. J Neurosurg, 2018 (doi:10.3171/2017.12.JNS172480)
 
15) Cagnazzo F, Lefevre PH, Mantilla D et al:Patency of the supraclinoid internal carotid artery branches after flow diversion treatment. A meta-analysis. J Neuroradiol 46(1):9-14, 2019
PubMed
16) Cagnazzo F, di Carlo DT, Cappucci M et al:Acutely ruptured intracranial aneurysms treated with flow-diverter stents:A systematic review and meta-analysis. AJNR Am J Neuroradiol 39(9):1669-1675, 2018
PubMed
17) Zhou G, Su M, Yin YL et al:Complications associated with the use of flow-diverting devices for cerebral aneurysms:a systematic review and meta-analysis. Neurosurg Focus 42(6):E17, 2017
 
18) Zhu D, Yan Y, Zhao P et al:Safety and efficacy of flow diverter treatment for blood blister-like aneurysm:A systematic review and meta-analysis. World Neurosurg 118:e79-e86, 2018
 
19) Kiyofuji S, Graffeo CS, Perry A et al:Meta-analysis of treatment outcomes of posterior circulation non-saccular aneurysms by flow diverters. J Neurointerv Surg 10(5):493-499, 2018
PubMed
P.114 掲載の参考文献
20) Hagen MW, Girdhar G, Wainwright J et al:Thrombogenicity of flow diverters in an ex vivo shunt model:effect of phosphorylcholine surface modification. J Neurointerv Surg 9(10):1006-1011, 2017
 
21) Marosfoi M, Clarencon F, Langan ET et al:Acute thrombus formation on phosphorilcholine surface modified flow diverters. J Neurointerv Surg 10(4):406-411, 2018
PubMed
22) Caroff J, Tamura T, King RM et al:Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia. J Neurointerv Surg 10(11):1097-1101, 2018
PubMed
23) Matsuda Y, Jang DK, Chung J et al:Preliminary outcomes of single antiplatelet therapy for surface-modified flow diverters in an animal model:analysis of neointimal development and thrombus formation using OCT. J Neurointerv Surg 11(1):74-79, 2019
 
24) Martinez-Galdamez M, Lamin SM, Lagios KG et al:Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms:preliminary results from a prospective clinical study. J Neurointerv Surg 9(8):772-776, 2017
PubMed
25) Martinez-Galdamez M, Lamin SM, Lagios KG et al:Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology:angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg 11(4):396-399, 2019
PubMed
26) Manning NW, Cheung A, Phillips TJ et al:Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage:multicentre experience. J Neurointerv Surg, neurintsurg-2018-014363, 2018
 
P.115 掲載の参考文献
1) Howard VJ, Meschia JF, Lal BK et al:Carotid revascularization and medical management for asymptomatic carotid stenosis:Protocol of the CREST-2 clinical trials. Int J Stroke 12(7):770-778, 2017
PubMed
P.116 掲載の参考文献
2) Bulbulia R, Halliday A:The Asymptomatic Carotid Surgery Trial-2 (ACST-2):an ongoing randomised controlled trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke. Health Technol Assess 21(57):1-40, 2017
PubMed
3) Eckstein HH, Reiff T, Ringleb P et al:SPACE-2:A missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg 51(6):761-765, 2016
PubMed
4) Paraskevas KI, Robertson V, Saratzis AN et al:Editor's Choice - An updated systematic review and meta-analysis of outcomes following eversion vs. conventional carotid endarterectomy in randomised controlled trials and observational studies. Eur J Vasc Endovasc Surg 55(4):465-473, 2018
 
5) Bosiers M, Deloose K, Torsello G et al:The CLEAR-ROAD study:evaluation of a new dual layer micromesh stent system for the carotid artery. EuroIntervention 12 (5):e671-e676, 2016
 
6) Bosiers M, Deloose K, Torsello G et al:Evaluation of a new dual-layer micromesh stent system for the carotid artery:12-month results from the CLEAR-ROAD study. EuroIntervention 14(10):1144-1146, 2018
PubMed
7) Stabile E, de Donato G, Musialek P et al:Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery:Results of a Patient-Based Meta-Analysis of 4 Clinical Studies. JACC Cardiovasc Interv 11(23):2405-2411, 2018
PubMed
P.117 掲載の参考文献
8) Omran J, Mahmud E, White CJ et al:Proximal balloon occlusion versus distal filter protection in carotid artery stenting:A meta-analysis and review of the literature. Catheter Cardiovasc Interv 89(5):923-931, 2017
PubMed
9) Kakumoto K, Harada K, Sankoda Y et al:Near-infrared spectroscopy cerebral oximetry as a predictor of neurological intolerance during carotid artery stenting with proximal protection. J Clin Neurosci 58:89-93, 2018
PubMed
10) Vasconcelos V, Cassola N, da Silva EM et al:Immediate versus delayed treatment for recently symptomatic carotid artery stenosis. Cochrane Database Syst Rev 9:CD011401, 2016
PubMed
11) Milgrom D, Hajibandeh S, Hajibandeh S et al:Editor's Choice - Systematic review and meta-analysis of very urgent carotid intervention for symptomatic carotid disease. Eur J Vasc Endovasc Surg 56(5):622-631, 2018
 
12) Powers WJ, Rabinstein AA, Ackerson T et al:2018 Guidelines for the early management of patients with acute ischemic stroke:A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46-e4e110, 2018
 
13) Wilson MP, Murad MH, Krings T et al:Management of tandem occlusions in acute ischemic stroke - intracranial versus extracranial first and extracranial stenting versus angioplasty alone:a systematic review and meta-analysis. J Neurointerv Surg 10(8):721-728, 2018
 
P.118 掲載の参考文献
14) Galyfos G, Sianou A, Filis K:Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting:A meta-analysis. J Neurol Sci 381:74-82, 2017
PubMed
15) Hussain MA, Alali AS, Mamdani M et al:Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy:a population-based study. J Neurosurg 129(6):1522-1529, 2018
PubMed
16) Huibers AE, Westerink J, de Vries EE et al:Editor's Choice - Cerebral hyperperfusion syndrome after carotid artery stenting:A systematic review and metaanalysis. Eur J Vasc Endovasc Surg 56(3):322-333, 2018
 
17) Hayakawa M, Matsumaru Y, Sakai N et al:Periprocedural evaluation and management against cerebral hyperperfusion syndrome after carotid artery stenting in Japan:A Nationwide Questionnaire Survey. JNET 11:341-350, 2017
 
18) Andereggen L, Amin-Hanjani S, El-Koussy M et al:Quantitative magnetic resonance angiography as a potential predictor for cerebral hyperperfusion syndrome:a preliminary study. J Neurosurg 128(4):1006-1014, 2018
PubMed
P.119 掲載の参考文献
19) Ichinose N, Hama S, Tsuji T et al:Predicting ischemic stroke after carotid artery stenting based on proximal calcification and the jellyfish sign. J Neurosurg 128(5):1280-1288, 2018
PubMed
20) Saito K, Yamagami H:【Carotid Artery Plaque Diagnosis】 Ultrasound diagnosis of carotid plaques. JNET 12:581-591, 2018
 
21) Hoshino M, Shimizu T, Ogura H et al:Intraplaque Microvascular Flow Signal in Superb microvascular imaging and magnetic resonance imaging carotid plaque imaging in patients with atheromatous carotid artery stenosis. J Stroke Cerebrovasc Dis 27(12):3529-3534, 2018
PubMed
22) Yamada K, Yoshimura S:【Carotid Artery Plaque Diagnosis】Magnetic resonance carotid plaque imaging. JNET 12:597-602, 2018
 
23) Sato Y, Ogasawara K, Narumi S et al:Optimal MR plaque imaging for cervical carotid artery stenosis in predicting the development of microembolic signals during exposure of carotid arteries in endarterectomy:comparison of 4 T1-weighted imaging techniques. AJNR Am J Neuroradiol 37(6):1146-1154, 2016
PubMed
24) Saba L, Yuan C, Hatsukami TS et al:Carotid artery wall imaging:Perspective and Guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol 39(2):E9-E31, 2018
 
P.120 掲載の参考文献
25) Oshida S, Mori F, Sasaki M et al:Wall shear stress and T1 contrast ratio are associated with embolic signals during carotid exposure in endarterectomy. Stroke 49(9):2061-2066, 2018
PubMed

III. 脳外傷

P.122 掲載の参考文献
1) Suehiro E, Fujiyama Y, Koizumi H et al:Directions for use of intracranial pressure monitoring in the treatment of severe traumatic brain injury using data from the Japan Neurotrauma Data Bank. J Neurotrauma 34:2230-2234, 2017
 
2) Ronning P, Helseth E, Skaga NO et al:The effect of ICP monitoring in severe traumatic brain injury:a propensity score-weighted and adjusted regression approach. J Neurosurg, 2018 (doi:10.3171/2018.7.JNS18270)
 
P.123 掲載の参考文献
3) Okonkwo DO, Shutter LA, Moore C et al:Brain oxygen optimization in severe traumatic brain injury phase-II:A phase II randomized trial. Crit Care Med 45(11):1907-1914, 2017
 
4) Wang JW, Li JP, Song YL et al:Decompressive craniectomy in neurocritical care. J Clin Neurosci 27:1-7, 2016
PubMed
5) Hutchinson PJ, Kolias AG, Timofeev IS et al:Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 375(12):1119-1130, 2016
PubMed
6) Carney N, Totten AM, O'Reilly C et al:Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 80(1):6-15, 2017
PubMed
7) Shackelford SA, Del Junco DJ, Reade MC et al:Association of time to craniectomy with survival in patients with severe combat-related brain injury. Neurosurg Focus 45(6):E2, 2018
 
P.124 掲載の参考文献
8) Kolias AG, Viaroli E, Rubiano AM et al:The current status of decompressive craniectomy in traumatic brain injury. Curr Trauma Rep 4(4):326-332, 2018
PubMed
9) Gopalakrishnan MS, Shanbhag NC, Shukla DP et al:Complications of decompressive craniectomy. Front Neurol 9:977, 2018
PubMed
10) Dietrich WD, Bramlett HM:Therapeutic hypothermia and targeted temperature management for traumatic brain injury:Experimental and clinical experience. Brain Circ 3(4):186-198, 2017
PubMed
11) Andrews PJ, Sinclair HL, Rodriguez A et al:Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury:the Eurotherm3235 RCT. Health Technol Assess 22(45):1-134, 2018
PubMed
12) Cooper DJ, Nichol AD, Bailey M et al:Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury:The POLAR Randomized Clinical Trial. JAMA 320(21):2211-2220, 2018
PubMed
P.125 掲載の参考文献
13) Hifumi T, Kuroda Y, Kawakita K et al:Fever control management is preferable to mild therapeutic hypothermia in traumatic brain injury patients with abbreviated injury scale 3-4:A multi-center, randomized controlled trial. J Neurotrauma 33(11):1047-1053, 2016
PubMed
14) Berger-Pelleiter E, Emond M, Lauzier F et al:Hypertonic saline in severe traumatic brain injury:a systematic review and meta-analysis of randomized controlled trials. CJEM 18(2):112-120, 2016
PubMed
15) Burgess S, Abu-Laban RB, Slavik RS et al:A systematic review of randomized controlled trials comparing hypertonic sodium solutions and mannitol for traumatic brain injury:Implications for emergency department management. Ann Pharmacother 50(4):291-300, 2016
PubMed
16) Alnemari AM, Krafcik BM, Mansour TR et al:A comparison of pharmacologic therapeutic agents used for the reduction of intracranial pressure after traumatic brain injury. World Neurosurg 106:509-528, 2017
PubMed
17) Maguigan KL, Dennis BM, Hamblin SE et al:Method of hypertonic saline administration:Effects on osmolality in traumatic brain injury patients. J Clin Neurosci 39:147-150, 2017
PubMed
18) Asehnoune K, Lasocki S, Seguin P et al:Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review. Crit Care 21(1):328, 2017
PubMed
P.126 掲載の参考文献
19) Jokar A, Ahmadi K, Salehi T et al:The effect of tranexamic acid in traumatic brain injury:A randomized controlled trial. Chin J Traumatol 20(1):49-51, 2017
PubMed
20) Fakharian E, Abedzadeh-Kalahroudi M, Atoof F:Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg 109:e748-e753, 2018
PubMed
21) Hermanides J, Plummer MP, Finnis M et al:Glycaemic control targets after traumatic brain injury:a systematic review and meta-analysis. Crit Care 22(1):11, 2018
PubMed
P.127 掲載の参考文献
22) Plummer MP, Notkina N, Timofeev I et al:Cerebral metabolic effects of strict versus conventional glycaemic targets following severe traumatic brain injury. Crit Care 22(1):16, 2018
PubMed
P.128 掲載の参考文献
1) McCrory P, Meeuwisse W, Dvorak J et al:Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med 51(11):838-847, 2017
PubMed
2) 荻野雅宏, 中山晴雄, 重森裕, 他:スポーツにおける脳振盪に関する共同声明-第5回スポーツ脳振盪会議(ベルリン, 2016)-解説と翻訳. 神経外傷 42 (in press)
 
3) Sport concussion assessment tool-5th edition. Br J Sports Med 51(11):851-858, 2017
PubMed
4) Echemendia RJ, Meeuwisse W, McCrory P et al:The Sport Concussion Assessment Tool 5th Edition (SCAT5):Background and rationale. Br J Sports Med 51(11):848-850, 2017
PubMed
P.129 掲載の参考文献
5) Sport concussion assessment tool for childrens ages 5 to 12 years. Br J Sports Med 51(11):862-869, 2017
PubMed
6) Davis GA, Purcell L, Schneider KJ et al:The Child Sport Concussion Assessment Tool 5th Edition (Child SCAT5):Background and rationale. Br J Sports Med 51(11):859-861, 2017
PubMed
7) Concussion recognition tool 5(C). Br J Sports Med 51(11):872, 2017
 
8) Echemendia RJ, Meeuwisse W, McCrory P et al:The Concussion Recognition Tool 5th Edition (CRT5):Background and rationale. Br J Sports Med 51(11):870-871, 2017
PubMed
9) McLeod TC, Lewis JH, Whelihan K et al:Rest and return to activity after sport-related concussion:A systematic review of the literature. J Athl Train 52(3):262-287, 2017
PubMed
P.131 掲載の参考文献
10) Leddy JJ, Haider MN, Ellis M et al:Exercise is medicine for concussion. Curr Sports Med Rep 17(8):262-270, 2018
PubMed
11) Schneider KJ, Leddy JJ, Guskiewicz KM et al:Rest and treatment/rehabilitation following sport-related concussion:a systematic review. Br J Sports Med 51(12):930-934, 2017
PubMed
12) Davis GA, Anderson V, Babl FE et al:What is the difference in concussion management in children as compared with adults? A systematic review. Br J Sports Med 51(12):949-957, 2017
PubMed
13) Emery CA, Black AM, Kolstad A et al:What strategies can be used to effectively reduce the risk of concussion in sport? A systematic review. Br J Sports Med 51(12):978-984, 2017
 
P.132 掲載の参考文献
14) Maroon JC, Winkelman R, Bost J et al:Chronic traumatic encephalopathy in contact sports:a systematic review of all reported pathological cases. PLoS One 10(2):e0117338, 2015
 
15) Mez J, Daneshvar DH, Kiernan PT et al:Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA 318(4):360-370, 2017
PubMed
16) McKee AC, Cairns NJ, Dickson DW et al:The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol 131(1):75-86, 2016
PubMed
17) Goswami R, Dufort P, Tartaglia MC et al:Frontotemporal correlates of impulsivity and machine learning in retired professional athletes with a history of multiple concussions. Brain Struct Funct 221(4):1911-1925, 2016
PubMed
18) Gardner RC, Hess CP, Brus-Ramer M et al:Cavum septum pellucidum in retired American pro-football players. J Neurotrauma 33(1):157-161, 2016
PubMed
19) Omalu B, Small GW, Bailes J et al:Postmortem autopsy-confirmation of antemortem [F-18] FDDNP-PET scans in a football player with chronic traumatic encephalopathy. Neurosurgery 82(2):237-246, 2018
 
20) Stern RA, Adler CH, Chen K et al:Tau positron-emission tomography in former national football league players. N Engl J Med 380(18):1716-1725, 2019
PubMed
P.133 掲載の参考文献
21) Shahim P, Tegner Y, Gustafsson B et al:Neurochemical aftermath of repetitive mild traumatic brain injury. JAMA Neurol 73(11):1308-1315, 2016
PubMed
22) Cherry JD, Stein TD, Tripodis Y et al:CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease. PLoS One 12(9):e0185541, 2017
PubMed
23) 日本臨床スポーツ医学会 学術委員会 脳神経外科部会:"頭部外傷10か条の提言(第2版)". 日本臨床スポーツ医学会, 2015
 
P.134 掲載の参考文献
1) Maguire SA, Kemp AM, Lumb RC et al:Estimating the probability of abusive head trauma:a pooled analysis. Pediatrics 128(3):e550-e564, 2011
 
2) Kelly P, John S, Vincent AL et al:Abusive head trauma and accidental head injury:a 20-year comparative study of referrals to a hospital child protection team. Arch Dis Child 100(12):1123-1130, 2015
 
P.135 掲載の参考文献
3) Choudhary AK, Jha B, Boal DK et al:Occipital sutures and its variations:the value of 3D-CT and how to differentiate it from fractures using 3D-CT? Surg Radiol Anat 32(9):807-816, 2010
PubMed
4) Magana JN, Kuppermann N:The PECARN TBI rules do not apply to abusive head trauma. Acad Emerg Med 24(3):382-384, 2017
 
5) Thamburaj K, Soni A, Frasier LD et al:Susceptibility-weighted imaging of retinal hemorrhages in abusive head trauma. Pediatr Radiol 49(2):210-216, 2019
PubMed
6) Zuccoli G, Khan AS, Panigrahy A et al:In Vivo Demonstration of Traumatic Rupture of the Bridging Veins in Abusive Head Trauma. Pediatr Neurol 72:31-35, 2017
PubMed
7) Bechtel K, Stoessel K, Leventhal JM et al:Characteristics that distinguish accidental from abusive injury in hospitalized young children with head trauma. Pediatrics 114(1):165-168, 2004
PubMed
8) Bradford R, Choudhary AK, Dias MS:Serial neuroimaging in infants with abusive head trauma:timing abusive injuries. J Neurosurg Pediatr 12(2):110-119, 2013
PubMed
9) Orru' E, Huisman TAGM, Izbudak I:Prevalence, patterns, and clinical relevance of hypoxic-ischemic injuries in children exposed to abusive head trauma. J Neuroimaging 28(6):608-614, 2018
PubMed
10) Choudhary AK, Bradford R, Dias MS et al:Venous injury in abusive head trauma. Pediatr Radiol 45(12):1803-1813, 2015
PubMed
11) Choudhary AK, Ishak R, Zacharia TT et al:Imaging of spinal injury in abusive head trauma:a retrospective study. Pediatr Radiol 44(9):1130-1140, 2014
PubMed
12) Kemp A, Cowley L, Maguire S:Spinal injuries in abusive head trauma:patterns and recommendations. Pediatr Radiol 44 Suppl 4:S604-S612, 2014
 
13) Choudhary AK, Bradford RK, Dias MS et al:Spinal subdural hemorrhage in abusive head trauma:a retrospective study. Radiology 262(1):216-223, 2012
PubMed
P.136 掲載の参考文献
14) Hansen JB, Frazier T, Moffatt M et al:Evaluations for abuse in young children with subdural hemorrhages:findings based on symptom severity and benign enlargement of the subarachnoid spaces. J Neurosurg Pediatr 21(1):31-37, 2018
PubMed
15) Towner D, Castro MA, Eby-Wilkens E et al:Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med 341(23):1709-1714, 1999
PubMed
16) Looney CB, Smith JK, Merck LH et al:Intracranial hemorrhage in asymptomatic neonates:prevalence on MR images and relationship to obstetric and neonatal risk factors. Radiology 242(2):535-541, 2007
PubMed
17) Rooks VJ, Eaton JP, Ruess L et al:Prevalence and evolution of intracranial hemorrhage in asymptomatic term infants. AJNR Am J Neuroradiol 29(6):1082-1089, 2008
PubMed
18) Foster KA, Recker MJ, Lee PS et al:Factors associated with hemispheric hypodensity after subdural hematoma following abusive head trauma in children. J Neurotrauma 31(19):1625-1631, 2014
 
19) Duhaime AC, Durham S:Traumatic brain injury in infants:the phenomenon of subdural hemorrhage with hemispheric hypodensity ("Big Black Brain"). Prog Brain Res 161:293-302, 2007
 
20) Costine-Bartell BA, McGuone D, Price G et al:Development of a model of hemispheric hypodensity ("Big Black Brain"). J Neurotrauma 36(5):815-833, 2019
 
21) Hasbani DM, Topjian AA, Friess SH et al:Nonconvulsive electrographic seizures are common in children with abusive head trauma*. Pediatr Crit Care Med 14(7):709-715, 2013
PubMed
22) Dingman AL, Stence NV, O'Neill BR et al:Seizure severity is correlated with severity of hypoxic-ischemic injury in abusive head trauma. Pediatr Neurol 82:29-35, 2018
PubMed
P.137 掲載の参考文献
23) Matlung SE, Bilo RA, Kubat B et al:Multicystic encephalomalacia as an end-stage finding in abusive head trauma. Forensic Sci Med Pathol 7(4):355-363, 2011
PubMed
24) Chevignard MP, Lind K:Long-term outcome of abusive head trauma. Pediatr Radiol 44 Suppl 4:S548-S558, 2014
 
25) Nuno M, Ugiliweneza B, Bardini RL et al:Age-related mortality in abusive head trauma. J Trauma Acute Care Surg, 2019 (doi:10.1097/TA.0000000000002255)
 
26) Risen SR, Suskauer SJ, Dematt EJ et al:Functional outcomes in children with abusive head trauma receiving inpatient rehabilitation compared with children with nonabusive head trauma. J Pediatr 164(3):613-619.e1-2, 2014
 
27) Lind K, Toure H, Brugel D et al:Extended follow-up of neurological, cognitive, behavioral and academic outcomes after severe abusive head trauma. Child Abuse Negl 51:358-367, 2016
PubMed
28) Miller Ferguson N, Sarnaik A, Miles D et al:Abusive head trauma and mortality-an analysis from an international comparative effectiveness study of children with severe traumatic brain injury. Crit Care Med 45(8):1398-1407, 2017
PubMed
P.138 掲載の参考文献
29) Castellani RJ, Schmidt CJ:Brain injury biomechanics and abusive head trauma. J Forensic Sci Med 4:91-100, 2018
 
30) Elinder G, Eriksson A, Hallberg B et al:Traumatic shaking:The role of the triad in medical investigations of suspected traumatic shaking. Acta Paediatr. 107 Suppl 472:3-23, 2018
 
31) Vinchon M, de Foort-Dhellemmes S, Desurmont M et al:Confessed abuse versus witnessed accidents in infants:comparison of clinical, radiological, and ophthalmological data in corroborated cases. Childs Nerv Syst 26(5):637-645, 2010
PubMed
32) Adamsbaum C, Grabar S, Mejean N et al:Abusive head trauma:judicial admissions highlight violent and repetitive shaking. Pediatrics 126(3):546-555, 2010
PubMed
33) Choudhary AK, Servaes S, Slovis TL et al:Consensus statement on abusive head trauma in infants and young children. Pediatr Radiol 48(8):1048-1065, 2018
PubMed
P.139 掲載の参考文献
34) 中村紀夫, 小林茂, 平川公義 他:小児の頭部外傷と頭蓋内血腫の特徴, 第II報. 脳と神経 17:785-794, 1965
 
35) Aoki N, Masuzawa H:Infantile acute subdural hematoma. Clinical analysis of 26 cases. J Neurosurg 61(2):273-280, 1984
 
36) 国立社会保障・人口問題研究所:日本の将来推計人口-平成28(2016)～77(2065)年-. 人口問題研究資料第336号平成29年7月31日
 
P.140 掲載の参考文献
1) Carroll LJ, Cassidy JD, Cancelliere C et al:Systematic review of the prognosis after mild traumatic brain injury in adults:cognitive, psychiatric, and mortality outcomes:results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch Phys Med Rehabil 95(3 Suppl):S152-S173, 2014
 
2) van der Naalt J, Timmerman ME, de Koning ME et al:Early predictors of outcome after mild traumatic brain injury (UPFRONT):an observational cohort study. Lancet Neurol 16(7):532-540, 2017
PubMed
P.141 掲載の参考文献
3) Lumba-Brown A, Yeates KO, Sarmiento K et al:Diagnosis and management of mild traumatic brain injury in children:A systematic review. JAMA Pediatr 172(11):e182847, 2018
 
4) Lumba-Brown A, Yeates KO, Sarmiento K et al:Centers for Disease Control and Prevention guideline on the diagnosis and management of mild traumatic brain injury among children. JAMA Pediatr 172(11):e182853, 2018
 
5) McCrory P, Meeuwisse W, Dvorak J et al:Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med 51(11):838-847, 2017
PubMed
P.142 掲載の参考文献
6) Asken BM, McCrea MA, Clugston JR et al:"Playing Through It":Delayed reporting and removal from athletic activity after concussion predicts prolonged recovery. J Athl Train 51(4):329-335, 2016
 
7) Mez J, Daneshvar DH, Kiernan PT et al:Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA 318(4):360-370, 2017
PubMed
8) Kovacs GG, Ferrer I, Grinberg LT et al:Aging-related tau astrogliopathy (ARTAG):harmonized evaluation strategy. Acta Neuropathol 131(1):87-8102, 2016
PubMed
9) Papa L:Potential blood-based biomarkers for concussion. Sports Med Arthrosc Rev 24(3):108-115, 2016
PubMed
10) Asken BM, Bauer RM, DeKosky ST et al:Concussion BASICS III:Serum biomarker changes following sport-related concussion. Neurology 91(23):e2133-e2143, 2018
 
11) Guty E, Arnett P:Post-concussion symptom factors and neuropsychological outcomes in collegiate athletes. J Int Neuropsychol Soc 24(7):684-692, 2018
PubMed
P.143 掲載の参考文献
12) Abbassi E, Sirmon-Taylor B:Recovery progression and symptom resolution in sport-related mild traumatic brain injury. Brain Inj 31(12):1667-1673, 2017
PubMed
13) Winter L, Moriarty HJ, Short TH:Beyond anger:emotion regulation and social connectedness in veterans with traumatic brain injury. Brain Inj 32(5):593-599, 2018
PubMed
14) Moran LM, Babikian T, Del Piero L et al:The UCLA study of predictors of cognitive functioning following moderate/severe pediatric traumatic brain injury. J Int Neuropsychol Soc 22(5):512-519, 2016
PubMed
P.144 掲載の参考文献
15) Shishido H, Kishimoto Y, Kawai N et al:Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease. Neurosci Lett 629:62-67, 2016
 
16) Li W, Risacher SL, McAllister TW et al:Traumatic brain injury and age at onset of cognitive impairment in older adults. J Neurol 263(7):1280-1285, 2016
PubMed
17) Sigurdardottir S, Andelic N, Wehling E et al:Return to work after severe traumatic brain injury:a national study with a oneyear follow-up of neurocognitive and behavioural outcomes. Neuropsychol Rehabil, 2018 (doi:10.1080/09602011.2018.1462719)
 
18) Konigs M, Engenhorst PJ, Oosterlaan J:Intelligence after traumatic brain injury:meta-analysis of outcomes and prognosis. Eur J Neurol 23(1):21-29, 2016
PubMed
P.145 掲載の参考文献
19) Azouvi P, Arnould A, Dromer E et al:Neuropsychology of traumatic brain injury:An expert overview. Rev Neurol (Paris) 173(7-8):461-472, 2017
 

IV. 定位・機能

P.148 掲載の参考文献
1) Krumholz A, Shinnar S, French J et al:Evidence-based guideline:Management of an unprovoked first seizure in adults:Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 85(17):1526-1527, 2015
 
2) 日本神経学会 監:CQ1-1 てんかんとはなにか. "てんかん診療ガイドライン2018". 医学書院, pp2-3, 2018
 
P.149 掲載の参考文献
3) Fisher RS, Cross JH, French JA et al:Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):522-530, 2017
PubMed
4) Scheffer IE, Berkovic S, Capovilla G et al:ILAE classification of the epilepsies:Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512-521, 2017
PubMed
5) Glauser T, Ben-Menachem E, Bourgeois B et al:Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54(3):551-563, 2013
PubMed
6) Shih JJ, Whitlock JB, Chimato N et al:Epilepsy treatment in adults and adolescents:Expert opinion, 2016. Epilepsy Behav 69:186-222, 2017
PubMed
7) Chen Z, Lusicic A, O'Brien TJ et al:Psychotic disorders induced by antiepileptic drugs in people with epilepsy. Brain 139(Pt 10):2668-2678, 2016
 
8) Stephen LJ, Wishart A, Brodie MJ:Psychiatric side effects and antiepileptic drugs:Observations from prospective audits. Epilepsy Behav 71(Pt A):73-78, 2017
 
P.150 掲載の参考文献
9) Tanaka T, Ihara M:Post-stroke epilepsy. Neurochem Int 107:219-228, 2017
PubMed
10) Haapaniemi E, Strbian D, Rossi C et al:The CAVE score for predicting late seizures after intracerebral hemorrhage. Stroke 45(7):1971-1976, 2014
PubMed
11) Winstein CJ, Stein J, Arena R et al:Guidelines for adult stroke rehabilitation and recovery:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 47(6):e98-e169, 2016
 
12) Powers WJ, Rabinstein AA, Ackerson T et al:2018 Guidelines for the early management of patients with acute ischemic stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 49(3):e46-e110, 2018
 
13) Galovic M, Dohler N, Erdelyi-Canavese B et al:Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score):a multivariable prediction model development and validation study. Lancet Neurol 17(2):143-152, 2018
 
14) Sayegh ET, Fakurnejad S, Oh T et al:Anticonvulsant prophylaxis for brain tumor surgery:determining the current best available evidence. J Neurosurg 121(5):1139-1147, 2014
PubMed
15) Chassoux F, Landre E:Prevention and management of postoperative seizures in neuro-oncology. Neurochirurgie 63(3):197-203, 2017
PubMed
P.151 掲載の参考文献
16) Englot DJ, Magill ST, Han SJ et al:Seizures in supratentorial meningioma:a systematic review and meta-analysis. J Neurosurg 124(6):1552-1561, 2016
PubMed
17) Koekkoek JA, Dirven L, Taphoorn MJ:The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma. Expert Rev Neurother 17(2):193-202, 2017
PubMed
18) Motika PV, Spencer DC:Treatment of epilepsy in the elderly. Curr Neurol Neurosci Rep 16(11):96, 2016
PubMed
P.152 掲載の参考文献
19) Tomson T, Battino D, Bonizzoni E et al:Comparative risk of major congenital malformations with eight different antiepileptic drugs:a prospective cohort study of the EURAP registry. Lancet Neurol 17(6):530-538, 2018
PubMed
20) Meador KJ, Loring DW:Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology 86(3):297-306, 2016
PubMed
21) Mullin JP, Shriver M, Alomar S et al:Is SEEG safe? A systematic review and meta-analysis of stereo-electroencephalography-related complications. Epilepsia 57(3):386-401, 2016
 
22) Mullin JP, Sexton D, Al-Omar S et al:Outcomes of subdural grid electrode monitoring in the stereoelectroencephalography era. World Neurosurg 89:255-258, 2016
PubMed
P.153 掲載の参考文献
23) Youngerman BE, Oh JY, Anbarasan D et al:Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography. Epilepsia 59(3):595-606, 2018
PubMed
24) Li MCH, Cook MJ:Deep brain stimulation for drug-resistant epilepsy. Epilepsia 59(2):273-290, 2018
PubMed
P.154 掲載の参考文献
1) Kawai K, Tanaka T, Baba H et al:Outcome of vagus nerve stimulation for drug-resistant epilepsy:the first three years of a prospective Japanese registry. Epileptic Disord 19(3):327-338, 2017
 
2) Garcia-Pallero MA, Garcia-Navarrete E, Torres CV et al:Effectiveness of vagal nerve stimulation in medication-resistant epilepsy. Comparison between patients with and without medication changes. Acta Neurochir (Wien) 159(1):131-136, 2017
PubMed
P.155 掲載の参考文献
3) Hamilton P, Soryal I, Dhahri P et al:Clinical outcomes of VNS therapy with AspireSR(R) (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre. Seizure 58:120-126, 2018
 
4) Ryvlin P, So EL, Gordon CM et al:Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy. Epilepsia 59(3):562-572, 2018
PubMed
5) Heck CN, King-Stephens D, Massey AD et al:Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation:final results of the RNS System Pivotal trial. Epilepsia 55(3):432-441, 2014
PubMed
6) Geller EB, Skarpaas TL, Gross RE et al:Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia 58(6):994-1004, 2017
PubMed
7) Jobst BC, Kapur R, Barkley GL et al:Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia 58(6):1005-1014, 2017
PubMed
P.156 掲載の参考文献
8) King-Stephens D, Mirro E, Weber PB et al:Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography. Epilepsia 56(6):959-967, 2015
PubMed
9) Salanova V, Witt T, Worth R et al:Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology 84(10):1017-1025, 2015
PubMed
10) Troster AI, Meador KJ, Irwin CP et al:Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy. Seizure 45:133-141, 2017
PubMed
11) Cukiert A, Cukiert CM, Burattini JA et al:Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy:A prospective, controlled, randomized, doubleblind study. Epilepsia 58(10):1728-1733, 2017
PubMed
P.157 掲載の参考文献
12) Bergfeld IO, Mantione M, Hoogendoorn ML et al:Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression:A randomized clinical trial. JAMA Psychiatry 73(5):456-464, 2016
PubMed
13) Holtzheimer PE, Husain MM, Lisanby SH et al:Subcallosal cingulate deep brain stimulation for treatment-resistant depression:a multisite, randomised, sham-controlled trial. Lancet Psychiatry 4(11):839-849, 2017
PubMed
14) Zhou C, Zhang H, Qin Y et al:A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 82:224-232, 2018
 
15) Rao VR, Sellers KK, Wallace DL et al:Direct electrical stimulation of lateral orbitofrontal cortex acutely improves mood in individuals with symptoms of depression. Curr Biol 28(24):3893-3902.e4, 2018
 
P.158 掲載の参考文献
16) Alonso P, Cuadras D, Gabriels L et al:Deep brain stimulation for obsessive-compulsive disorder:A meta-analysis of treatment outcome and predictors of response. PLoS One 10(7):e0133591, 2015
 
17) Cohn JF, Okun MS, Jeni LA et al:Automated affect detection in deep brain stimulation for obsessive-compulsive disorder:A pilot study. Proc ACM Int Conf Multimodal Interact 2018:40-44, 2018
PubMed
P.159 掲載の参考文献
18) Vansteensel MJ, Pels EGM, Bleichner MG et al:Fully implanted brain-computer interface in a locked-in patient with ALS. N Engl J Med 375(21):2060-2066, 2016
 
19) Minev IR, Musienko P, Hirsch A et al:Biomaterials. Electronic dura mater for long-term multimodal neural interfaces. Science 347(6218):159-163, 2015
PubMed
20) Aflalo T, Kellis S, Klaes C et al:Neurophysiology. Decoding motor imagery from the posterior parietal cortex of a tetraplegic human. Science 348(6237):906-910, 2015
PubMed
21) Flesher SN, Collinger JL, Foldes ST et al:Intracortical microstimulation of human somatosensory cortex. Sci Transl Med 8(361):361ra141, 2016
PubMed
22) Donati AR, Shokur S, Morya E et al:Long-term training with a brain-machine interface-based gait protocol induces partial neurological recovery in paraplegic patients. Sci Rep 6:30383, 2016
PubMed
P.160 掲載の参考文献
1) Blomstedt P, Stenmark Persson R, Hariz GM et al:Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease:a randomised blinded evaluation. J Neurol Neurosurg Psychiatry 89(7):710-716, 2018
PubMed
P.161 掲載の参考文献
2) Bot M, Schuurman PR, Odekerken VJJ et al:Deep brain stimulation for Parkinson's disease:defining the optimal location within the subthalamic nucleus. J Neurol Neurosurg Psychiatry 89(5):493-498, 2018
PubMed
3) Horisawa S, Nanke M, Kawamata T et al:Pallidothalamic tractotomy for Parkinson disease with 1-year follow-up:A case report. World Neurosurg 121:193-195, 2019
 
4) Bond AE, Shah BB, Huss DS et al:Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease:A randomized clinical trial. JAMA Neurol 74(12):1412-1418, 2017
PubMed
5) Martinez-Fernandez R, Rodriguez-Rojas R, Del Alamo M et al:Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease:a pilot study. Lancet Neurol 17(1):54-63, 2018
PubMed
P.162 掲載の参考文献
6) Samotus O, Parrent A, Jog M:Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson's disease patients. Mov Disord 33(5):783-792, 2018
PubMed
7) Pinto de Souza C, Hamani C, Oliveira Souza C et al:Spinal cord stimulation improves gait in patients with Parkinson's disease previously treated with deep brain stimulation. Mov Disord 32(2):278-282, 2017
PubMed
P.163 掲載の参考文献
8) Meng Y, Solomon B, Boutet A et al:Magnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor:A 2-year outcome study. Mov Disord 33(10):1647-1650, 2018
PubMed
9) Park YS, Jung NY, Na YC et al:Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord, 2019 (doi:10.1002/mds.27637)
 
10) Barbe MT, Reker P, Hamacher S et al:DBS of the PSA and the VIM in essential tremor:A randomized, double-blind, crossover trial. Neurology 91(6):e543-e550, 2018
 
11) Degeneffe A, Kuijf ML, Ackermans L et al:Comparing deep brain stimulation in the ventral intermediate nucleus versus the posterior subthalamic area in essential tremor patients. Surg Neurol Int 9:244, 2018
PubMed
P.164 掲載の参考文献
12) Ostrem JL, San Luciano M, Dodenhoff KA et al:Subthalamic nucleus deep brain stimulation in isolated dystonia:A 3-year follow-up study. Neurology 88(1):25-35, 2017
PubMed
13) Lin S, Wu Y, Li H et al:Deep brain stimulation of the globus pallidus internus versus the subthalamic nucleus in isolated dystonia. J Neurosurg, 2019 (doi:10.3171/2018.12.JNS181927)
 
14) Horisawa S, Ochiai T, Goto S et al:Safety and long-term efficacy of ventro-oral thalamotomy for focal hand dystonia:A retrospective study of 171 patients. Neurology 92(4):e371-e377, 2019
 
15) Horisawa S, Yamaguchi T, Abe K et al:A single case of MRI-guided focused ultrasound ventro-oral thalamotomy for musician's dystonia. J Neurosurg, 2018 (doi:10.3171/2018.5.JNS173125)
 
P.165 掲載の参考文献
1) 阿部圭市, 平孝臣:経頭蓋集束超音波:MRガイド下集束超音波治療. 脳神経外科46(7):633-644, 2018
 
P.166 掲載の参考文献
2) Elias WJ, Lipsman N, Ondo WG et al:A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med 375(8):730-739, 2016
PubMed
3) Chang JW, Park CK, Lipsman N et al:A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor:Results at the 2-year follow-up. Ann Neurol 83(1):107-114, 2018
PubMed
4) Meng Y, Solomon B, Boutet A et al:Magnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor:A 2-year outcome study. Mov Disord 33(10):1647-1650, 2018
PubMed
5) Park YS, Jung NY, Na YC et al:Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord, 2019 (doi:10.1002/mds.27637)
 
P.167 掲載の参考文献
6) Magara A, Buhler R, Moser D et al:First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease. J Ther Ultrasound 2:11, 2014
PubMed
7) Jung NY, Park CK, Kim M et al:The efficacy and limits of magnetic resonance-guided focused ultrasound pallidotomy for Parkinson's disease:a Phase I clinical trial. J Neurosurg, 2018 (doi:10.3171/2018.2.JNS172514)
 
8) Bond AE, Shah BB, Huss DS et al:Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant parkinson disease:A randomized clinical trial. JAMA Neurol 74(12):1412-1418, 2017
PubMed
9) Martinez-Fernandez R, Rodriguez-Rojas R, Del Alamo M et al:Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease:a pilot study. Lancet Neurol 17(1):54-63, 2018
PubMed
P.168 掲載の参考文献
10) Meng Y, Volpini M, Black S et al:Focused ultrasound as a novel strategy for Alzheimer disease therapeutics. Ann Neurol 81(5):611-617, 2017
PubMed
11) Burgess A, Dubey S, Yeung S et al:Alzheimer disease in a mouse model:MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology 273(3):736-745, 2014
 
12) Lipsman N, Meng Y, Bethune AJ et al:Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound. Nat Commun 9(1):2336, 2018
PubMed
P.169 掲載の参考文献
13) Kim SJ, Roh D, Jung HH et al:A study of novel bilateral thermal capsulotomy with focused ultrasound for treatment-refractory obsessive-compulsive disorder:2-year follow-up. J Psychiatry Neurosci 43(5):327-337, 2018
PubMed
14) Horisawa S, Yamaguchi T, Abe K et al:A single case of MRI-guided focused ultrasound ventro-oral thalamotomy for musician's dystonia. J Neurosurg, 2018 (doi:10.3171/2018.5.JNS173125)
 
P.170 掲載の参考文献
15) Krishna V, Sammartino F, Rezai A:A review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology:Advances in diagnosis and treatment. JAMA Neurol 75(2):246-254, 2018
 
P.171 掲載の参考文献
1) Hara T, Abo M, Hara H et al:Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients. Int J Neurosci 128(5):412-420, 2018
PubMed
P.172 掲載の参考文献
2) LaVallee J, Royer R, Smith G:Prevalence of bleeding complications following ultrasound-guided botulinum toxin injections in patients on anticoagulation or antiplatelet Therapy. PM R 9(12):1217-1224, 2017
PubMed
3) Rosales RL, Efendy F, Teleg ES et al:Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion:A meta-analysis. J Neurol Sci 371:6-14, 2016
PubMed
4) Devier D, Harnar J, Lopez L et al:Rehabilitation plus OnabotulinumtoxinA improves motor function over OnabotulinumtoxinA alone in post-stroke upper limb spasticity:A single-blind, randomized trial. Toxins (Basel) 9(7):E216, 2017
 
5) Prazeres A, Lira M, Aguiar P et al:Efficacy of physical therapy associated with botulinum toxin type A on functional performance in post-stroke spasticity:A randomized, double-blinded, placebo-controlled trial. Neurol Int 10(2):7385, 2018
PubMed
P.173 掲載の参考文献
6) Lee SY, Jeon YT, Kim BR et al:Combined treatment of botulinumtoxin and robot-assisted rehabilitation therapy on poststroke, upper limb spasticity:A case report. Medicine (Baltimore) 96(51):e9468, 2017
 
7) Erbil D, Tugba G, Murat TH et al:Effects of robot-assisted gait training in chronic stroke patients treated by botulinum toxin-a:A pivotal study. Physiother Res Int 23(3):e1718, 2018
 
8) Picelli A, Bacciga M, Melotti C et al:Combined effects of robot-assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke:a pilot, single blind, randomized controlled trial. Eur J Phys Rehabil Med 52(6):759-766, 2016
PubMed
9) Saulino M, Ivanhoe CB, McGuire JR et al:Best practices for intrathecal baclofen therapy:Patient selection. Neuromodulation 19(6):607-615, 2016
 
10) Boster AL, Bennett SE, Bilsky GS et al:Best practices for intrathecal baclofen therapy:Screening test. Neuromodulation 19(6):616-622, 2016
 
11) Boster AL, Adair RL, Gooch JL et al:Best practices for intrathecal baclofen therapy:Dosing and long-term management. Neuromodulation 19(6):623-631, 2016
 
12) Saulino M, Anderson DJ, Doble J et al:Best practices for intrathecal baclofen therapy:Troubleshooting. Neuromodulation 19(6):632-641, 2016
 
13) 山口広貴, 加耒美紀, 鶴屋英里他:ギャバロン(R)髄注(バクロフェン) シンクロメッド(R)ポンプシステム 使用成績調査-最終報告-. 臨床医薬 32:419-466, 2016
Medical*Online
14) 山口広貴, 加耒美紀, 鶴屋英里他:ギャバロン(R)髄注(バクロフェン) シンクロメッド(R)ポンプシステム 特定使用成績調査-最終報告-. 臨床医薬 32:469-509, 2016
Medical*Online
P.174 掲載の参考文献
15) 山口広貴, 鶴屋英里 佐川慶 他:脳卒中由来の痙縮に対するバクロフェン髄中療法の有用性の検討-使用成績調査の層別解析結果-. 臨床医薬 34:421-444, 2018
 
16) Creamer M, Cloud G, Kossmehl P et al:Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity:results from a multicentre, randomised, controlled, open-label trial (SISTERS). J Neurol Neurosurg Psychiatry 89(6):642-650, 2018
PubMed
17) Creamer M, Cloud G, Kossmehl P et al:Effect of intrathecal baclofen on pain and quality of life in poststroke spasticity. Stroke 49(9):2129-2137, 2018
PubMed
P.175 掲載の参考文献
1) Mahajan A, Ahmed S, McAleer MF et al:Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases:a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040-1048, 2017
PubMed
2) Brown PD, Ballman KV, Cerhan JH et al:Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC・3):a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049-1060, 2017
 
P.176 掲載の参考文献
3) Kayama T, Sato S, Sakurada K et al:Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504):A phase III, noninferiority, randomized controlled trial. J Clin Oncol 36(33):3282-3289, 2018
 
4) Brown PD, Jaeckle K, Ballman KV et al:Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases:A randomized clinical trial. JAMA 316(4):401-409, 2016
PubMed
5) Yamamoto M, Serizawa T, Shuto T et al:Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi-institutional prospective observational study. Lancet Oncol 15(4):387-395, 2014
 
6) Kroeze SG, Fritz C, Hoyer M et al:Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy:A systematic review. Cancer Treat Rev 53:25-37, 2017
PubMed
P.177 掲載の参考文献
7) El Rassy E, Botticella A, Kattan J et al:Non-small cell lung cancer brain metastases and the immune system:From brain metastases development to treatment. Cancer Treat Rev 68:69-79, 2018
PubMed
8) Lubgan D, Rutzner S, Lambrecht U et al:Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma. J Neurooncol 134(2):407-416, 2017
PubMed
9) Shah JL, Li G, Shaffer JL et al:Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma. Neurosurgery 82(1):24-34, 2018
PubMed
P.178 掲載の参考文献
10) Levy S, Chapet S, Scher N et al:Reirradiation of gliomas under stereotactic conditions:Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France). Cancer Radiother 21(8):759-765, 2017
PubMed
11) Murovic J, Ding V, Han SS et al:Impact of CyberKnife radiosurgery on overall survival and various parameters of patients with 1-3 versus >- 4 brain metastases. Cureus 9(10):e1798, 2017
 
12) Nakamura M, Nishimura H, Mayahara H et al:Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion:'symptomatic control'. J Radiat Res 58(6):834-839, 2017
PubMed
P.179 掲載の参考文献
13) Repka MC, Lei S, Campbell L et al:Long-term outcomes following conventionally fractionated stereotactic boost for high-grade gliomas in close proximity to critical organs at risk. Front Oncol 8:373, 2018
PubMed
14) Rashid A, Karam SD, Rashid B et al:Multisession radiosurgery for hearing preservation. Semin Radiat Oncol 26(2):105-111, 2016
PubMed
15) Manabe Y, Murai T, Ogino H et al:CyberKnife stereotactic radiosurgery and hypofractionated stereotactic radiotherapy as first-line treatments for imaging-diagnosed intracranial meningiomas. Neurol Med Chir (Tokyo) 57(12):627-633, 2017
PubMed
16) Kalani MA, Choudhri O, Gibbs IC et al:Stereotactic radiosurgery for intramedullary spinal arteriovenous malformations. J Clin Neurosci 29:162-167, 2016
PubMed
P.180 掲載の参考文献
17) Minniti G, Scaringi C, Paolini S et al:Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (> 2 cm) brain metastases:A comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95(4):1142-1148, 2016
 
18) Lehrer EJ, Peterson JL, Zaorsky NG et al:Single versus multifraction stereotactic radiosurgery for large brain metastases:An international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103(3):618-630, 2019
PubMed
19) Loganadane G, Dhermain F, Louvel G et al:Brain radiation necrosis:Current management with a focus on non-small cell lung cancer patients. Front Oncol 8:336, 2018
PubMed
20) Furuse M, Nonoguchi N, Kuroiwa T et al:A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis †. Neurooncol Pract 3(4):272-280, 2016
 

V. 小児

P.185 掲載の参考文献
1) Baumgarten HD, Flake AW:Fetal surgery. Pediatr Clin North Am 66(2):295-308, 2019
PubMed
2) McLone DG, Knepper PA:The cause of Chiari II malformation:a unified theory. Pediatr Neurosci 15(1):1-12, 1989
PubMed
3) Heffez DS, Aryanpur J, Hutchins GM et al:The paralysis associated with myelomeningocele:clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26(6):987-992, 1990
PubMed
P.186 掲載の参考文献
4) Adzick NS, Thom EA, Spong CY et al:A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364(11):993-1004, 2011
PubMed
5) Tulipan N, Wellons JC 3rd, Thom EA et al:Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 16(6):613-620, 2015
PubMed
P.187 掲載の参考文献
6) Elbabaa SK, Gildehaus AM, Pierson MJ et al:First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era:hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt). Childs Nerv Syst 33(7):1157-1168, 2017
 
7) Brock JW 3rd, Carr MC, Adzick NS et al:Bladder function after fetal surgery for myelomeningocele. Pediatrics 136(4):e906-e913, 2015
 
P.188 掲載の参考文献
8) Macedo A Jr, Ottoni SL, Garrone G et al:In utero myelomeningocoele repair and urological outcomes:the first 100 cases of a prospective analysis. Is there an improvement in bladder function? BJU Int 123(4):676-681, 2019
PubMed
9) Horst M, Mazzone L, Schraner T et al:Prenatal myelomeningocele repair:Do bladders better? Neurourol Urodyn 36(6):1651-1658, 2017
PubMed
10) Pastuszka A, Bohosiewicz J, Koszutski T:Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. Neurourol Urodyn 37(8):2792-2798, 2018
PubMed
P.189 掲載の参考文献
11) Hilton SA, Hodges MM, Dewberry LC et al:MOMS Plus:Single-institution review of outcomes for extended BMI criteria for open fetal repair of myelomeningocele. Fetal Diagn Ther, 2019 (doi:10.1159/000499484)
 
12) Kabagambe SK, Jensen GW, Chen YJ et al:Fetal surgery for myelomeningocele:A systematic review and meta-analysis of outcomes in fetoscopic versus open repair. Fetal Diagn Ther 43(3):161-174, 2018
PubMed
P.190 掲載の参考文献
13) Kohl T:Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part I:surgical technique and perioperative outcome. Ultrasound Obstet Gynecol 44(5):515-524, 2014
PubMed
14) Pedreira DA, Zanon N, Nishikuni K et al:Endoscopic surgery for the antenatal treatment of myelomeningocele:the CECAM trial. Am J Obstet Gynecol 214(1):111.e1-111.e11, 2016
 
15) Belfort MA, Whitehead WE, Shamshirsaz AA et al:Fetoscopic open neural tube defect repair:Development and refinement of a two-port, carbon dioxide insufflation technique. Obstet Gynecol 129(4):734-743, 2017
PubMed
16) Guilbaud L, Roux N, Friszer S et al:Two-port fetoscopic repair of myelomeningocele in fetal lambs. Fetal Diagn Ther 45(1):36-41, 2019
PubMed
17) Shieh HF, Tracy SA, Hong CR et al:Transamniotic stem cell therapy (TRASCET) in a rabbit model of spina bifida. J Pediatr Surg 54(2):293-296, 2019
 
P.191 掲載の参考文献
18) Vanover M, Pivetti C, Lankford L et al:High density placental mesenchymal stromal cells provide neuronal preservation and improve motor function following in utero treatment of ovine myelomeningocele. J Pediatr Surg 54(1):75-79, 2019
PubMed
P.192 掲載の参考文献
19) Kondo A, Akada S, Akiyama K et al:Real prevalence of neural tube defects in Japan:How many of such pregnancies have been terminated? Congenit Anom (Kyoto), 2019 (doi:10.1111/cga.12333)
 
20) https://www.mhlw.go.jp/houdou/2006/02/dl/h0201-3a3-03c.pdf
 
21) Milunsky A, Jick H, Jick SS et al:Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262(20):2847-2852, 1989
PubMed
22) 遠藤誠之, 和田誠司, 荻原英樹 他:フィラデルフィア小児病院での脊髄髄膜瘤胎内手術の実際. 小児の脳神経 42:247-260, 2017
Medical*Online
P.194 掲載の参考文献
1) Kim KH, Chong S, Lee JY et al:A method of untethering by skipping the area of positive responses on electrical stimulation during surgery of lumbosacral lipomatous malformation:'hopping on a stepping stone'. World Neurosurg:S1878-8750(18)32960-7, 2019
 
2) Xiong Y, Yang L, Zhen W et al:Conservative and surgical treatment of pediatric asymptomatic lumbosacral lipoma:a metaanalysis. Neurosurg Rev 41(3):737-743, 2018
 
P.195 掲載の参考文献
3) Wagner KM, Raskin JS, Hansen D et al:Surgical management of lipomyelomeningocele in children:Challenges and considerations. Surg Neurol Int 8:63, 2017
PubMed
4) da Rosa SP, Scavarda D, Choux M:Results of the prophylactic surgery of lumbosacral lipomas 20 years of experience in the Paediatric Neurosurgery Department La Timone Enfants Hospital, Marseille, France. Childs Nerv Syst 32(11):2205-2209, 2016
PubMed
P.196 掲載の参考文献
5) Roujeau T, James S, Forin V et al:Results of the prophylactic surgery of lumbosacral lipomas:the pendulum of management? Childs Nerv Syst 33(4):561-562, 2017
PubMed
6) Tu A, Hengel R, Cochrane DD:The natural history and management of patients with congenital deficits associated with lumbosacral lipomas. Childs Nerv Syst 32(4):667-673, 2016
PubMed
P.197 掲載の参考文献
7) Tu A, Hengel AR, Cochrane DD:Radiographic predictors of deterioration in patients with lumbosacral lipomas. J Neurosurg Pediatr 18(2):171-176, 2016
PubMed
8) Bai SC, Tao BZ, Wang LK et al:Aggressive resection of congenital lumbosacral lipomas in adults:Indications, techniques, and outcomes in 122 patients. World Neurosurg 112:e331-e341, 2018
PubMed
P.198 掲載の参考文献
9) Lee JY, Kim SW, Kim SP et al:A rat model of chronic syringomyelia induced by epidural compression of the lumbar spinal cord. J Neurosurg Spine 27(4):458-467, 2017
PubMed
10) Morota N, Ihara S, Ogiwara H:New classification of spinal lipomas based on embryonic stage. J Neurosurg Pediatr 19(4):428-439, 2017
 
P.199 掲載の参考文献
11) Tamura G, Morota N, Ihara S:Impact of magnetic resonance imaging and urodynamic studies on the management of sacrococcygeal dimples. J Neurosurg Pediatr 20(3):289-297, 2017
PubMed
P.200 掲載の参考文献
12) Stamates MM, Frim DM, Yang CW et al:Magnetic resonance imaging in the prone position and the diagnosis of tethered spinal cord. J Neurosurg Pediatr 21(1):4-10, 2018
PubMed
13) O'Neill BR, Gallegos D, Herron A et al:Use of magnetic resonance imaging to detect occult spinal dysraphism in infants. J Neurosurg Pediatr 19(2):217-226, 2017
 
14) Antherieu P, Levy R, De Saint Denis T et al:Diffusion tensor imaging (DTI) and Tractography of the spinal cord in pediatric population with spinal lipomas:preliminary study. Childs Nerv Syst 35(1):129-137, 2019
PubMed
P.201 掲載の参考文献
15) Usami K, Lallemant P, Roujeau T et al:Spinal lipoma of the filum terminale:review of 174 consecutive patients. Childs Nerv Syst 32(7):1265-1272, 2016
PubMed
16) Jones V, Wykes V, Cohen N et al:The pathology of lumbosacral lipomas:macroscopic and microscopic disparity have implications for embryogenesis and mode of clinical deterioration. Histopathology 72(7):1136-1144, 2018
PubMed
P.202 掲載の参考文献
17) Yerkes EB, Halline C, Yoshiba G et al:Lipomyelomeningocele for the urologist:Should we view it the same as myelomeningocele? J Pediatr Urol 13(4):371.e1-371.e8, 2017
 
18) Cha S, Wang KC, Park K et al:Predictive value of intraoperative bulbocavernosus reflex during untethering surgery for post-operative voiding function. Clin Neurophysiol 129(12):2594-2601, 2018
PubMed
P.203 掲載の参考文献
19) Morota N:Intraoperative neurophysiological monitoring of the bulbocavernosus reflex during surgery for conus spinal lipoma:what are the warning criteria? J Neurosurg Pediatr, 2019 (doi:10.3171/2018.12.PEDS18535)
 
20) Quinsey CS, Krause K, Baird LC et al:Incidence of symptomatic tethered spinal cord in pediatric patients presenting with neurofibromatosis types 1 and 2. J Neurosurg Pediatr 21(5):456-459, 2018
PubMed
P.205 掲載の参考文献
1) Derderian CA, Wink JD, McGrath JL et al:Volumetric changes in cranial vault expansion:comparison of fronto-orbital advancement and posterior cranial vault distraction osteogenesis. Plast Reconstr Surg 135(6):1665-1672, 2015
PubMed
2) Komuro Y, Shimizu A, Shimoji K et al:Posterior cranial vault distraction osteogenesis with barrel stave osteotomy in the treatment of craniosynostosis. Neurol Med Chir (Tokyo) 55(8):617-623, 2015
PubMed
3) Mundinger GS, Rehim SA, Johnson O 3rd et al:Distraction osteogenesis for surgical treatment of craniosynostosis:A systematic review. Plast Reconstr Surg 138(3):657-669, 2016
PubMed
P.206 掲載の参考文献
4) Jeong WS, Choi JW, Oh TS et al:Long-term follow-up of one-piece fronto-orbital advancement with distraction but without a bandeau for coronal craniosynostosis:Review of 26 consecutive cases. J Craniomaxillofac Surg 44(9):1252-1258, 2016
 
5) Elbanoby T:Craniofacial distraction in the management of anterior plagiocephaly:A novel idea and a systematic review of the literature. Pediatr Neurosurg 53(3):193-199, 2018
 
6) Johns D, Anstadt E, Donato D et al:Early posterior vault distraction osteogenesis for the treatment of syndromic craniosynostosis. Craniomaxillofac Trauma Reconstr 9(3):219-223, 2016
PubMed
7) McMillan K, Lloyd M, Evans M et al:Experiences in performing posterior calvarial distraction. J Craniofac Surg 28(3):664-669, 2017
PubMed
8) Ter Maaten NS, Mazzaferro DM, Wes AM et al:Craniometric analysis of frontal cranial morphology following posterior vault distraction. J Craniofac Surg 29(5):1169-1173, 2018
PubMed
9) Chong S, Wang KC, Phi JH et al:Minimally invasive suturectomy and postoperative helmet therapy:Advantages and limitations. J Korean Neurosurg Soc 59(3):227-232, 2016
 
P.207 掲載の参考文献
10) Nguyen DC, Farber SJ, Skolnick GB et al:One hundred consecutive endoscopic repairs of sagittal craniosynostosis:an evolution in care. J Neurosurg Pediatr 20(5):410-418, 2017
 
11) Wood BC, Ahn ES, Wang JY et al:Less is more:does the addition of barrel staves improve results in endoscopic strip craniectomy for sagittal craniosynostosis? J Neurosurg Pediatr 20(1):86-90, 2017
PubMed
12) Dalle Ore CL, Dilip M, Brandel MG et al:Endoscopic surgery for nonsyndromic craniosynostosis:a 16-year single-center experience. J Neurosurg Pediatr 22(4):335-343, 2018
PubMed
13) Rottgers SA, Lohani S, Proctor MR:Outcomes of endoscopic suturectomy with postoperative helmet therapy in bilateral coronal craniosynostosis. J Neurosurg Pediatr 18(3):281-286, 2016
PubMed
P.208 掲載の参考文献
14) Goyal A, Lu VM, Yolcu YU et al:Endoscopic versus open approach in craniosynostosis repair:a systematic review and meta-analysis of perioperative outcomes. Childs Nerv Syst 34(9):1627-1637, 2018
PubMed
15) Yan H, Abel TJ, Alotaibi NM et al:A systematic review and meta-analysis of endoscopic versus open treatment of craniosynostosis. Part 1:the sagittal suture. J Neurosurg Pediatr 22(4):352-360, 2018
PubMed
16) Yan H, Abel TJ, Alotaibi NM et al:A systematic review of endoscopic versus open treatment of craniosynostosis. Part 2:the nonsagittal single sutures. J Neurosurg Pediatr 22(4):361-368, 2018
PubMed
P.209 掲載の参考文献
1) Fujio S, Bunyamin J, Hirano H et al:A novel bilateral approach for suprasellar arachnoid cysts:A case report. Pediatr Neurosurg 51(1):30-34, 2016
PubMed
2) Gui S, Bai J, Wang X et al:Assessment of endoscopic treatment for quadrigeminal cistern arachnoid cysts:A 7-year experience with 28 cases. Childs Nerv Syst 32(4):647-654, 2016
 
P.210 掲載の参考文献
3) Knie B, Morota N, Ihara S et al:Pediatric intraventricular arachnoid cysts in the body of lateral ventricle:surgical outcome and its embryologic background. Childs Nerv Syst 32(11):2197-2204, 2016
PubMed
4) Chen Y, Fang HJ, Li ZF et al:Treatment of middle cranial fossa arachnoid cysts:A systematic review and meta-analysis. World Neurosurg 92:480-490.e2, 2016
 
5) Azab WA, Almanabri M, Yosef W:Endoscopic treatment of middle fossa arachnoid cysts. Acta Neurochir (Wien) 159(12):2313-2317, 2017
PubMed
P.213 掲載の参考文献
6) Mankotia DS, Sardana H, Sinha S et al:Pediatric interhemispheric arachnoid cyst:An institutional experience. J Pediatr Neurosci 11(1):29-34, 2016
PubMed
P.214 掲載の参考文献
7) Hanrahan J, Frantzias J, Lavrador JP et al:Posterior fossa arachnoid cyst causing torticollis and gastro-oesophageal reflux in an infant. Childs Nerv Syst 34(12):2519-2523, 2018
 
8) Feletti A, Alicandri-Ciufelli M, Pavesi G:Transaqueductal trans-Magendie fenestration of arachnoid cyst in the posterior fossa. Acta Neurochir (Wien) 158(4):655-662, 2016
PubMed
P.215 掲載の参考文献
9) Aljohani H, Romano A, Iaccarino C et al:Pure endoscopic management of fourth ventricle arachnoid cyst:Case report and literature review. Asian J Neurosurg 13(1):184-187, 2018
PubMed
10) El Damaty A, Marx S, Fleck S et al:Neuroendoscopic Approach to Intracranial Ependymal Cysts. World Neurosurg 97:383-389, 2017
PubMed
P.216 掲載の参考文献
11) El-Ghandour NMF:Endoscopic treatment of intraventricular ependymal cysts in children:personal experience and review of literature. Childs Nerv Syst 34(12):2441-2448, 2018
PubMed

VI. 脊髄・脊椎・末梢神経

P.218 掲載の参考文献
1) Chang CC, Huang WC, Wu JC et al:The option of motion preservation in cervical spondylosis:Cervical disc arthroplasty update. Neurospine 15(4):296-305, 2018
PubMed
2) Nunley PD, Coric D, Frank KA et al:Cervical disc arthroplasty:Current evidence and real-world application. Neurosurgery 83(6):1087-1106, 2018
PubMed
3) Pham M, Phan K, Teng I et al:Comparative study between M6-C and Mobi-C cervical artificial disc replacement:Biomechanical outcomes and comparison with normative data. Orthop Surg 10(2):84-88, 2018
 
4) Staudt MD, Das K, Duggal N:Does design matter? Cervical disc replacements under review. Neurosurg Rev 41(2):399-407, 2018
PubMed
5) Yang W, Si M, Hou Y et al:Superiority of 2-level total disk replacement using a cervical disk prosthesis versus anterior cervical diskectomy and fusion. Orthopedics 41(6):344-350, 2018
PubMed
P.219 掲載の参考文献
6) Xu S, Liang Y, Zhu Z et al:Adjacent segment degeneration or disease after cervical total disc replacement:a meta-analysis of randomized controlled trials. J Orthop Surg Res 13(1):244, 2018
 
7) Chang SW, Bohl MA, Kelly BP et al:The segmental distribution of cervical range of motion:A comparison of ACDF versus TDR-C. J Clin Neurosci 57:185-193, 2018
 
8) MacDowall A, Skeppholm M, Lindhagen L et al:Artificial disc replacement versus fusion in patients with cervical degenerative disc disease with radiculopathy:5-year outcomes from the National Swedish Spine Register. J Neurosurg Spine 30(2):159-167, 2018
 
9) Vleggeert-Lankamp CLA, Janssen TMH, van Zwet E et al:The NECK trial:Effectiveness of anterior cervical discectomy with or without interbody fusion and arthroplasty in the treatment of cervical disc herniation;a double-blinded randomized controlled trial. Spine J:S1529-9430(18)31322-6, 2018
PubMed
10) 頚椎人工椎間板置換術 適正使用基準 (第4版). 脊髄外科 32(2):223-227, 2018
 
11) Chen WM, Jin J, Park T et al:Strain behavior of malaligned cervical spine implanted with metal-on-polyethylene, metal-on-metal, and elastomeric artificial disc prostheses-A finite element analysis. Clin Biomech (Bristol, Avon) 59:19-26, 2018
 
12) Yuan W, Zhang H, Zhou X et al:The influence of artificial cervical disc prosthesis height on the cervical biomechanics:A finite element study. World Neurosurg 113:e490-e498, 2018
 
P.220 掲載の参考文献
13) Li Y, Fogel GR, Liao Z et al:Finite element model predicts the biomechanical performance of cervical disc replacement and fusion hybrid surgery with various geometry of ball-and-socket artificial disc. Int J Comput Assist Radiol Surg 12(8):1399-1409, 2017
PubMed
14) Li Y, Fogel GR, Liao Z et al:Prosthesis and hybrid strategy consideration for treating two-level cervical disc degeneration in hybrid surgery. Spine (Phila Pa 1976) 43(6):379-387, 2018
PubMed
15) Tian W, Yan K, Han X et al:Comparison of the clinical and radiographic results between cervical artificial disk replacement and anterior cervical fusion:A 6-year prospective nonrandomized comparative study. Clin Spine Surg 30(5):E578-E586, 2017
 
16) Zou S, Gao J, Xu B et al:Anterior cervical discectomy and fusion (ACDF) versus cervical disc arthroplasty (CDA) for two contiguous levels cervical disc degenerative disease:a meta-analysis of randomized controlled trials. Eur Spine J 26(4):985-997, 2017
PubMed
17) Shangguan L, Ning GZ, Tang Y et al:Discover cervical disc arthroplasty versus anterior cervical discectomy and fusion in symptomatic cervical disc diseases:A meta-analysis. PLoS One 12(3):e0174822, 2017
 
18) Findlay C, Ayis S, Demetriades AK:Total disc replacement versus anterior cervical discectomy and fusion:a systematic review with meta-analysis of data from a total of 3160 patients across 14 randomized controlled trials with both short- and medium- to long-term outcomes. Bone Joint J 100-B(8):991-1001, 2018
 
P.221 掲載の参考文献
19) Vaccaro A, Beutler W, Peppelman W et al:Long-term clinical experience with selectively constrained SECURE-C cervical artificial disc for 1-level cervical disc disease:Results from seven-year follow-up of a prospective, randomized, controlled investigational device exemption clinical trial. Int J Spine Surg 12(3):377-387, 2018
PubMed
20) Tu TH, Chang CC, Wu JC et al:Resection of uncovertebral joints and posterior longitudinal ligament for cervical disc arthroplasty. Neurosurg Focus 42(Video-Suppl1):V2, 2017
 
21) Lee DH, Cho JH, Baik JM et al:Does additional uncinate resection increase pseudarthrosis following anterior cervical discectomy and fusion? Spine (Phila Pa 1976) 43(2):97-104, 2018
PubMed
22) Voronov LI, Havey RM, Tsitsopoulos PP et al:Does resection of the posterior longitudinal ligament affect the stability of cervical disc arthroplasty? Int J Spine Surg 12(2):285-294, 2018
PubMed
23) Kieser DC, Cawley DT, Fujishiro T et al:Anterior bone loss in cervical disc arthroplasty. Asian Spine J 13(1):13-21, 2019
PubMed
24) Kieser DC, Cawley DT, Fujishiro T et al:Risk factors for anterior bone loss in cervical disc arthroplasty. J Neurosurg Spine 29(2):123-129, 2018
PubMed
P.222 掲載の参考文献
25) Brophy CM, Hoh DJ:Compressive cervical pannus formation in a patient after 2-level disc arthroplasty:a rare complication treated with posterior instrumented fusion. J Neurosurg Spine 29(2):130-134, 2018
 
26) Gornet MF, Singh V, Schranck FW et al:Serum metal concentrations in patients with titanium ceramic composite cervical disc replacements. Spine (Phila Pa 1976) 42(6):366-371, 2017
PubMed
27) Singh V, Skipor AK, Selim AA et al:Chromium and nickel concentrations in subjects with a stainless steel metal-on-metal cervical disc arthroplasty:Results from a prospective longitudinal study with 7 years follow-up. Int J Spine Surg 12(4):460-468, 2018
PubMed
P.223 掲載の参考文献
1) Alvi MA, Kerezoudis P, Wahood W et al:Operative approaches for lumbar disc herniation:A systematic review and multiple treatment meta-analysis of conventional and minimally invasive surgeries. World Neurosurg 114:391-407.e2, 2018
 
2) Phan K, Xu J, Schultz K et al:Full-endoscopic versus micro-endoscopic and open discectomy:A systematic review and meta-analysis of outcomes and complications. Clin Neurol Neurosurg 154:1-12, 2017
PubMed
P.224 掲載の参考文献
3) Song HP, Sheng HF, Xu WX:A case-control study on the treatment of protrusion of lumbar intervertebral disc through PELD and MED. Exp Ther Med 14(4):3708-3712, 2017
PubMed
4) Gibson JNA, Subramanian AS, Scott CEH:A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy. Eur Spine J 26(3):847-856, 2017
PubMed
5) Qin R, Liu B, Hao J et al:Percutaneous endoscopic lumbar discectomy versus posterior open lumbar microdiscectomy for the treatment of symptomatic lumbar disc herniation:A systemic review and meta-analysis. World Neurosurg 120:352-362, 2018
PubMed
6) Kapetanakis S, Gkantsinikoudis N, Chaniotakis C et al:Percutaneous transforaminal endoscopic discectomy for the treatment of lumbar disc herniation in obese patients:Health-related quality of life assessment in a 2-year follow-up. World Neurosurg 113:e638-e649, 2018
 
7) Kim JH, Kim HS, Kapoor A et al:Feasibility of full endoscopic spine surgery in patients over the age of 70 years with degenerative lumbar spine disease. Neurospine 15(2):131-137, 2018
PubMed
P.225 掲載の参考文献
8) Wu JJ, Chen HZ, Zheng C:Transforaminal percutaneous endoscopic discectomy and foraminoplasty after lumbar spinal fusion surgery. Pain Physician 20(5):E647-E651, 2017
 
9) Wu J, Zhang C, Zheng W et al:Analysis of the characteristics and clinical outcomes of percutaneous endoscopic lumbar discectomy for upper lumbar disc herniation. World Neurosurg 92:142-147, 2016
PubMed
10) Kondo M, Oshima Y, Inoue H et al:Significance and pitfalls of percutaneous endoscopic lumbar discectomy for large central lumbar disc herniation. J Spine Surg 4(1):79-85, 2018
PubMed
11) Yao Y, Liu H, Zhang H et al:Risk factors for recurrent herniation after percutaneous endoscopic lumbar discectomy. World Neurosurg 100:1-6, 2017
 
12) Yin S, Du H, Yang W et al:Prevalence of recurrent herniation following percutaneous endoscopic lumbar discectomy:A meta-analysis. Pain Physician 21(4):337-350, 2018
PubMed
P.226 掲載の参考文献
13) Yao Y, Zhang H, Wu J et al:Comparison of three minimally invasive spine surgery methods for revision surgery for recurrent herniation after percutaneous endoscopic lumbar discectomy. World Neurosurg 100:641-647.e1, 2017
 
14) Nie H, Zeng J, Song Y et al:Percutaneous endoscopic lumbar discectomy for L5-S1 disc herniation via an interlaminar approach versus a transforaminal approach:A prospective randomized controlled study with 2-year follow up. Spine (Phila Pa 1976) 41 Suppl 19:B30-B37, 2016
 
15) Bai J, Zhang W, Wang Y et al:Application of transiliac approach to intervertebral endoscopic discectomy in L5/S1 intervertebral disc herniation. Eur J Med Res 22(1):14, 2017
PubMed
16) Choi KC, Park CK:Percutaneous endoscopic lumbar discectomy for L5-S1 disc herniation:Consideration of the relation between the iliac crest and L5-S1 disc. Pain Physician 19(2):E301-E308, 2016
 
P.227 掲載の参考文献
17) Fang G, Ding Z, Song Z:Comparison of the effects of epidural anesthesia and local anesthesia in lumbar transforaminal endoscopic surgery. Pain Physician 19(7):E1001-E1004, 2016
 
18) Zhu Y, Zhao Y, Fan G et al:Comparison of the effects of local anesthesia and epidural anesthesia for percutaneous transforaminal endoscopic discectomy in elderly patients over 65 years old. Int J Surg 48:260-263, 2017
 
19) Kim SK, Lee SC, Park SW:Transsacral epiduroscopic laser decompression versus the microscopic open interlaminar approach for L5-S1 disc herniation. J Spinal Cord Med, 2018 (doi:10.1080/10790268.2018.1442285)
 
P.228 掲載の参考文献
1) Laouissat F, Sebaaly A, Gehrchen M et al:Classification of normal sagittal spine alignment:refounding the Roussouly classification. Eur Spine J 27(8):2002-2011, 2018
PubMed
P.229 掲載の参考文献
2) Sebaaly A, Grobost P, Mallam L et al:Description of the sagittal alignment of the degenerative human spine. Eur Spine J 27(2):489-496, 2018
PubMed
3) Pizones J, Martin MB, Perez-Grueso FJS et al:Impact of adult scoliosis on roussouly sagittal shape classification. Spine (Phila Pa 1976) 44(4):270-279, 2019
PubMed
P.230 掲載の参考文献
4) Asai Y, Tsutsui S, Oka H et al:Sagittal spino-pelvic alignment in adults:The Wakayama Spine Study. PLoS One 12(6):e0178697, 2017
 
5) Uehara M, Takahashi J, Ikegami S et al:Sagittal spinal alignment deviation in the general elderly population:a Japanese cohort survey randomly sampled from a basic resident registry. Spine J 19(2):349-356, 2019
 
6) Scheer JK, Lafage R, Schwab FJ et al:Under correction of sagittal deformities based on age-adjusted alignment thresholds leads to worse health-related quality of life whereas over correction provides no additional benefit. Spine (Phila Pa 1976) 43(6):388-393, 2018
PubMed
7) Lafage R, Schwab F, Challier V et al:Defining spino-pelvic alignment thresholds:Should operative goals in adult spinal deformity surgery account for age? Spine (Phila Pa 1976) 41(1):62-68, 2016
PubMed
P.231 掲載の参考文献
8) Gille O, Bouloussa H, Mazas S et al:A new classification system for degenerative spondylolisthesis of the lumbar spine. Eur Spine J 26(12):3096-3105, 2017
PubMed
9) Salem KMI, Eranki AP, Paquette S et al:Do intraoperative radiographs predict final lumbar sagittal alignment following single-level transforaminal lumbar interbody fusion? J Neurosurg Spine 28(5):486-491, 2018
PubMed
10) Tempel ZJ, Gandhoke GS, Bolinger BD et al:The influence of pelvic incidence and lumbar lordosis mismatch on development of symptomatic adjacent level disease following single-level transforaminal lumbar interbody fusion. Neurosurgery 80(6):880-886, 2017
PubMed
11) Phan K, Nazareth A, Hussain AK et al:Relationship between sagittal balance and adjacent segment disease in surgical treatment of degenerative lumbar spine disease:meta-analysis and implications for choice of fusion technique. Eur Spine J 27(8):1981-1991, 2018
PubMed
P.232 掲載の参考文献
12) Ogura Y, Shinozaki Y, Kobayashi Y et al:Impact of sagittal spinopelvic alignment on clinical outcomes and health-related quality of life after decompression surgery without fusion for lumbar spinal stenosis. J Neurosurg Spine, 2019 (doi:10.3171/2018.10.SPINE181094)
 
P.233 掲載の参考文献
13) McDowell MM, Tempel ZJ, Gandhoke GS et al:Evolution of sagittal imbalance following corrective surgery for sagittal plane deformity. Neurosurgery 81(1):129-134, 2017
PubMed
14) Inami S, Moridaira H, Takeuchi D et al:Optimum pelvic incidence minus lumbar lordosis value can be determined by individual pelvic incidence. Eur Spine J 25(11):3638-3643, 2016
PubMed
15) Le Huec JC, Hasegawa K:Normative values for the spine shape parameters using 3D standing analysis from a database of 268 asymptomatic Caucasian and Japanese subjects. Eur Spine J 25(11):3630-3637, 2016
PubMed
16) Ames C, Gammal I, Matsumoto M et al:Geographic and ethnic variations in radiographic disability thresholds:Analysis of North American and Japanese operative adult spinal deformity populations. Neurosurgery 78(6):793-801, 2016
PubMed
P.234 掲載の参考文献
17) Takemoto M, Boissiere L, Vital JM et al:Are sagittal spinopelvic radiographic parameters significantly associated with quality of life of adult spinal deformity patients? Multivariate linear regression analyses for pre-operative and short-term post-operative health-related quality of life. Eur Spine J 26(8):2176-2186, 2017
PubMed
18) Yeh KT, Lee RP, Chen IH et al:Correlation of functional outcomes and sagittal alignment after long instrumented fusion for degenerative thoracolumbar spinal disease. Spine (Phila Pa 1976) 43(19):1355-1362, 2018
 
19) Lafage R, Schwab F, Glassman S et al:Age-adjusted alignment goals have the potential to reduce PJK. Spine (Phila Pa 1976) 42(17):1275-1282, 2017
PubMed
P.235 掲載の参考文献
20) Yilgor C, Sogunmez N, Boissiere L et al:Global Alignment and Proportion (GAP) Score:Development and validation of a new method of analyzing spinopelvic alignment to predict mechanical complications after adult spinal deformity surgery. J Bone Joint Surg Am 99(19):1661-1672, 2017
 
21) Lee HD, Jeon CH, Chung NS et al:Comparative analysis of three imaging modalities for evaluation of cervical sagittal alignment parameters:A validity and reliability study. Spine (Phila Pa 1976) 42(24):1901-1907, 2017
PubMed
22) Kim SW, Kim TH, Bok DH et al:Analysis of cervical spine alignment in currently asymptomatic individuals:prevalence of kyphotic posture and its relationship with other spinopelvic parameters. Spine J 18(5):797-810, 2018
PubMed
23) Yoshida G, Alzakri A, Pointillart V et al:Global spinal alignment in patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976) 43(3):E154-E162, 2018
PubMed
P.236 掲載の参考文献
24) Mizutani J, Strom R, Abumi K et al:How cervical reconstruction surgery affects global spinal alignment. Neurosurgery 84(4):898-907, 2019
PubMed
P.237 掲載の参考文献
1) Takai K:Spinal arteriovenous shunts:Angioarchitecture and historical changes in classification. Neurol Med Chir (Tokyo) 57(7):356-365, 2017
PubMed
P.238 掲載の参考文献
2) Sato K, Endo T, Niizuma K et al:Concurrent dural and perimedullary arteriovenous fistulas at the craniocervical junction:case series with special reference to angioarchitecture. J Neurosurg 118(2):451-459, 2013
PubMed
3) Hiramatsu M, Sugiu K, Ishiguro T et al:Angioarchitecture of arteriovenous fistulas at the craniocervical junction:a multicenter cohort study of 54 patients. J Neurosurg 128(6):1839-1849, 2018
PubMed
4) Clarke MJ, Patrick TA, White JB et al:Spinal extradural arteriovenous malformations with parenchymal drainage:venous drainage variability and implications in clinical manifestations. Neurosurg Focus 26(1):E5, 2009
 
5) Kiyosue H, Matsumaru Y, Niimi Y et al:Angiographic and clinical characteristics of thoracolumbar spinal epidural and dural arteriovenous fistulas. Stroke 48(12):3215-3222, 2017
PubMed
6) Takai K, Shojima M, Imai H et al:Microsurgical and endovascular treatments of spinal extradural arteriovenous fistulas with or without intradural venous drainage. World Neurosurg 111:e819-e829, 2018
PubMed
7) Hunt R, Roberts RM, Mortimer AM:Spinal dural arteriovenous fistula:delay to radiological diagnosis and sources of radiological error. Clin Radiol 73(9):835.e11-835.e16, 2018
 
P.239 掲載の参考文献
8) Barreras P, Heck D, Greenberg B et al:Analysis of 30 spinal angiograms falsely reported as normal in 18 patients with subsequently documented spinal vascular malformations. AJNR Am J Neuroradiol 38(9):1814-1819, 2017
PubMed
9) Brinjikji W, Nasr DM, Morris JM et al:Clinical outcomes of patients with delayed diagnosis of spinal dural arteriovenous fistulas. AJNR Am J Neuroradiol 37(2):380-386, 2016
PubMed
10) Nasr DM, Brinjikji W, Rabinstein AA et al:Clinical outcomes following corticosteroid administration in patients with delayed diagnosis of spinal arteriovenous fistulas. J Neurointerv Surg 9(6):607-610, 2017
PubMed
11) Mathur S, Symons SP, Huynh TJ et al:First-pass contrast-enhanced MRA for pretherapeutic diagnosis of spinal epidural arteriovenous fistulas with intradural venous reflux. AJNR Am J Neuroradiol 38(1):195-199, 2017
PubMed
12) Orru' E, Sorte DE, Wolinsky JP et al:Intraoperative spinal digital subtraction angiography:indications, technique, safety, and clinical impact. J Neurointerv Surg 9(6):601-607, 2017
PubMed
P.240 掲載の参考文献
13) Nakanishi K, Tanaka N, Fujimoto Y et al:Electrophysiological assessment and classification of motor pathway function in patients with spinal dural arteriovenous fistula. J Clin Neurophysiol 36(1):45-51, 2019
PubMed
14) Steinmetz MP, Chow MM, Krishnaney AA et al:Outcome after the treatment of spinal dural arteriovenous fistulae:a contemporary single-institution series and meta-analysis. Neurosurgery 55(1):77-87, 2004
PubMed
15) Bakker NA, Uyttenboogaart M, Luijckx GJ et al:Recurrence rates after surgical or endovascular treatment of spinal dural arteriovenous fistulas:A meta-analysis. Neurosurgery 77(1):137-144, 2015
PubMed
16) Niimi Y, Matsukawa H, Uchiyama N et al:The preventive effect of endovascular treatment for recurrent hemorrhage in patients with spinal cord arteriovenous malformations. AJNR Am J Neuroradiol 36(9):1763-1768, 2015
PubMed
P.241 掲載の参考文献
17) Jung SC, Song Y, Cho SH et al:Endovascular management of aneurysms associated with spinal arteriovenous malformations. J Neurointerv Surg 10(2):198-203, 2018
PubMed
18) Consoli A, Smajda S, Trenkler J et al:Intradural spinal cord arteriovenous shunts in the pediatric population:natural history, endovascular management, and follow-up. Childs Nerv Syst, 2019 (doi:10.1007/s00381-019-04108-0)
 
19) Takai K, Kurita H, Hara T et al:Influence of indocyanine green angiography on microsurgical treatment of spinal perimedullary arteriovenous fistulas. Neurosurg Focus 40(3):E10, 2016
 
20) Ye ZP, Yang XY, Li WS et al:Microsurgical resection of cervical spinal cord arteriovenous malformations:Report of 6 cases. World Neurosurg 96:362-369, 2016
PubMed
21) Velat GJ, Chang SW, Abla AA et al:Microsurgical management of glomus spinal arteriovenous malformations:pial resection technique:Clinical article. J Neurosurg Spine 16(6):523-531, 2012
PubMed
22) Zhan PL, Jahromi BS, Kruser TJ et al:Stereotactic radiosurgery and fractionated radiotherapy for spinal arteriovenous malformations-A systematic review of the literature. J Clin Neurosci 62:83-87, 2019
PubMed
P.242 掲載の参考文献
23) Byun JS, Tsang ACO, Hilditch CA et al:Presentation and outcomes of patients with thoracic and lumbosacral spinal epidural arteriovenous fistulas:a systematic review and meta-analysis. J Neurointerv Surg 11(1):95-98, 2019
PubMed
P.243 掲載の参考文献
1) Dalamagkas K, Tsintou M, Seifalian A et al:Translational regenerative therapies for chronic spinal cord injury. Int J Mol Sci 19(6):E1776, 2018
 
2) Lane MA, Lepore AC, Fischer I:Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury. Expert Rev Neurother 17(5):433-440, 2017
PubMed
3) NeuralStem Inc:Neuralstem reports third quarter 2015 financial results-Nov 09, 2015
 
P.244 掲載の参考文献
4) Theodore N, Hlubek R, Danielson J et al:First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury:A clinical pilot study for safety and feasibility. Neurosurgery 79(2):E305-E312, 2016
 
5) Li L, Adnan H, Xu B et al:Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury:a systematic review and meta-analysis. Eur Spine J 24(5):919-930, 2015
PubMed
6) Bunge MB, Wood PM:Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury. Handb Clin Neurol 109:523-540, 2012
PubMed
7) Bunge MB, Monje PV, Khan A et al:From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials. Prog Brain Res 231:107-133, 2017
PubMed
8) Zhu H, Poon W, Liu Y et al:Phase I-II Clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant 25(11):1925-1943, 2016
PubMed
P.245 掲載の参考文献
9) Cizkova D, Cubinkova V, Smolek T et al:Localized intrathecal delivery of mesenchymal stromal cells conditioned medium improves functional recovery in a rat model of spinal cord injury. Int J Mol Sci 19(3):E870, 2018
 
10) Bansal H, Verma P, Agrawal A et al:Autologous bone marrow-derived stem cells in spinal cord injury. J Stem Cells 11(1):51-61, 2016
PubMed
11) Nagoshi N, Okano H:iPSC-derived neural precursor cells:potential for cell transplantation therapy in spinal cord injury. Cell Mol Life Sci 75(6):989-1000, 2018
PubMed
12) Doulames VM, Plant GW:Induced pluripotent stem cell therapies for cervical spinal cord injury. Int J Mol Sci 17(4):530, 2016
PubMed
13) Nori S, Nakamura M, Okano H:Plasticity and regeneration in the injured spinal cord after cell transplantation therapy. Prog Brain Res 231:33-56, 2017
PubMed
14) Nagoshi N, Okano H:Applications of induced pluripotent stem cell technologies in spinal cord injury. J Neurochem 141(6):848-860, 2017
PubMed
15) Iwatsuki K, Tajima F, Ohnishi Y et al:A pilot clinical study of olfactory mucosa autograft for chronic complete spinal cord injury. Neurol Med Chir (Tokyo) 56(6):285-292, 2016
PubMed
16) Wang S, Lu J, Li YA et al:Autologous olfactory lamina propria transplantation for chronic spinal cord injury:Three-year follow-up outcomes from a prospective double-blinded clinical trial. Cell Transplant 25(1):141-157, 2016
 
P.246 掲載の参考文献
1) Keric N, Eum DJ, Afghanyar F et al:Evaluation of surgical strategy of conventional vs. percutaneous robot-assisted spinal trans-pedicular instrumentation in spondylodiscitis. J Robot Surg 11(1):17-25, 2017
PubMed
2) Macke JJ, Woo R, Varich L:Accuracy of robot-assisted pedicle screw placement for adolescent idiopathic scoliosis in the pediatric population. J Robot Surg 10(2):145-150, 2016
PubMed
3) Tsai TH, Wu DS, Su YF et al:A retrospective study to validate an intraoperative robotic classification system for assessing the accuracy of kirschner wire (K-wire) placements with postoperative computed tomography classification system for assessing the accuracy of pedicle screw placements. Medicine (Baltimore) 95(38):e4834, 2016
 
4) Lonjon N, Chan-Seng E, Costalat V et al:Robot-assisted spine surgery:feasibility study through a prospective case-matched analysis. Eur Spine J 25(3):947-955, 2016
PubMed
P.247 掲載の参考文献
5) Pacchiarotti G, Wang MY, Kolcun JPG et al:Robotic paravertebral schwannoma resection at extreme locations of the thoracic cavity. Neurosurg Focus 42(5):E17, 2017
 
6) Togawa D, Kayanja MM, Reinhardt MK et al:Bone-mounted miniature robotic guidance for pedicle screw and translaminar facet screw placement:part 2--Evaluation of system accuracy. Neurosurgery 60(2 Suppl 1):129-139, 2007
 
7) Lefranc M, Peltier J:Evaluation of the ROSA(TM) Spine robot for minimally invasive surgical procedures. Expert Rev Med Devices 13(10):899-906, 2016
 
8) Hyun SJ, Kim KJ, Jahng TA et al:Minimally invasive robotic versus open fluoroscopic-guided spinal instrumented fusions:A randomized controlled trial. Spine (Phila Pa 1976) 42(6):353-358, 2017
PubMed
P.248 掲載の参考文献
9) Kim HJ, Jung WI, Chang BS et al:A prospective, randomized, controlled trial of robot-assisted vs freehand pedicle screw fixation in spine surgery. Int J Med Robot 13(3), 2017 (doi:10.1002/rcs.1779)
 
10) Keric N, Eum DJ, Afghanyar F et al:Evaluation of surgical strategy of conventional vs. percutaneous robot-assisted spinal trans-pedicular instrumentation in spondylodiscitis. J Robot Surg 11(1):17-25, 2017
PubMed
11) Lonjon N, Chan-Seng E, Costalat V et al:Robot-assisted spine surgery:feasibility study through a prospective case-matched analysis. Eur Spine J 25(3):947-955, 2016
PubMed
12) Kuo KL, Su YF, Wu CH et al:Assessing the intraoperative accuracy of pedicle screw placement by using a bone-mounted miniature robot system through secondary registration. PLoS One 11(4):e0153235, 2016
 
13) Macke JJ, Woo R, Varich L:Accuracy of robot-assisted pedicle screw placement for adolescent idiopathic scoliosis in the pediatric population. J Robot Surg 10(2):145-150, 2016
PubMed
P.249 掲載の参考文献
14) Yang CF, Sun Z, Speicher PJ et al:Use and outcomes of minimally invasive lobectomy for Stage I non-small cell lung cancer in the National Cancer Data Base. Ann Thorac Surg 101(3):1037-1042, 2016
 
15) Pacchiarotti G, Wang MY, Kolcun JPG et al:Robotic paravertebral schwannoma resection at extreme locations of the thoracic cavity. Neurosurg Focus 42(5):E17, 2017
 
16) Jun C, Sukumaran M, Wolinsky JP:Robot-assisted resection of pre-sacral schwannoma. Neurosurg Focus 45(Video-Suppl1):V1, 2018
 

VII. 水頭症

P.253 掲載の参考文献
1) Louveau A, Plog BA, Antila S et al:Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 127(9):3210-3219, 2017
PubMed
2) Ringstad G, Vatnehol SAS, Eide PK:Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 140(10):2691-2705, 2017
PubMed
3) Hasan-Olive MM, Enger R, Hansson HA et al:Loss of perivascular aquaporin-4 in idiopathic normal pressure hydrocephalus. Glia 67(1):91-100, 2019
PubMed
4) Eide PK, Hansson HA:Astrogliosis and impaired aquaporin-4 and dystrophin systems in idiopathic normal pressure hydrocephalus. Neuropathol Appl Neurobiol 44(5):474-490, 2018
PubMed
5) Raper D, Louveau A, Kipnis J:How do meningeal lymphatic vessels drain the CNS? Trends Neurosci 39(9):581-586, 2016
PubMed
P.254 掲載の参考文献
6) Naganawa S, Taoka T, Kawai H et al:Appearance of the organum vasculosum of the lamina terminalis on contrast-enhanced MR imaging. Magn Reson Med Sci 17(2):132-137, 2018
PubMed
7) Wostyn P, De Deyn PP:Optic nerve sheath distention as a protective mechanism against the visual impairment and intracranial pressure syndrome in astronauts. Invest Ophthalmol Vis Sci 58(11):4601-4602, 2017
PubMed
8) Wostyn P, De Deyn PP:Intracranial pressure-induced optic nerve sheath response as a predictive biomarker for optic disc edema in astronauts. Biomark Med 11(11):1003-1008, 2017
PubMed
9) Roberts DR, Albrecht MH, Collins HR et al:Effects of spaceflight on astronaut brain structure as indicated on MRI. N Engl J Med 377(18):1746-1753, 2017
PubMed
10) Yamada S, Ishikawa M, Yamamoto K:Comparison of CSF distribution between idiopathic normal pressure hydrocephalus and Alzheimer disease. AJNR Am J Neuroradiol 37(7):1249-1255, 2016
PubMed
P.255 掲載の参考文献
11) Ishikawa M, Oowaki H, Takezawa M et al:Disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal-pressure hydrocephalus and its implication in pathogenesis. Acta Neurochir Suppl 122:287-290, 2016
PubMed
12) Jaraj D, Rabiei K, Marlow T et al:Estimated ventricle size using Evans index:reference values from a population-based sample. Eur J Neurol 24(3):468-474, 2017
PubMed
13) Brix MK, Westman E, Simmons A et al:The Evans' Index revisited:New cut-off levels for use in radiological assessment of ventricular enlargement in the elderly. Eur J Radiol 95:28-32, 2017
PubMed
14) Espay AJ, Da Prat GA, Dwivedi AK et al:Deconstructing normal pressure hydrocephalus:Ventriculomegaly as early sign of neurodegeneration. Ann Neurol 82(4):503-513, 2017
PubMed
P.256 掲載の参考文献
15) Kuriyama N, Miyajima M, Nakajima M et al:Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan:Epidemiological and clinical characteristics. Brain Behav 7(3):e00635, 2017
 
16) Jang H, Park SB, Kim Y et al:Prognostic value of amyloid PET scan in normal pressure hydrocephalus. J Neurol 265(1):63-73, 2018
PubMed
17) Leinonen V, Rauramaa T, Johansson J et al:S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies. J Alzheimers Dis 64(1):171-179, 2018
 
18) Allali G, Garibotto V, Mainta IC et al:Dopaminergic imaging separates normal pressure hydrocephalus from its mimics. J Neurol 265(10):2434-2441, 2018
PubMed
P.257 掲載の参考文献
19) Yamada S, Kimura T, Jingami N et al:Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus:post hoc analysis of SINPHONI-2. J Neurosurg 126(6):2002-2009, 2017
PubMed
20) Mihalj M, Dolic K, Kolic K et al:CSF tap test - Obsolete or appropriate test for predicting shunt responsiveness? A systemic review. J Neurol Sci 362:78-84, 2016
PubMed
21) Yamada S, Ishikawa M, Miyajima M et al:Disease duration:the key to accurate CSF tap test in iNPH. Acta Neurol Scand 135(2):189-196, 2017
PubMed
22) Schniepp R, Trabold R, Romagna A et al:Walking assessment after lumbar puncture in normal-pressure hydrocephalus:a delayed improvement over 3 days. J Neurosurg 126(1):148-157, 2017
 
23) Matsuoka T, Akakabe M, Iida JI et al:Changes in cognitive function scores after cerebrospinal fluid tap testing in patients with suspected idiopathic normal-pressure hydrocephalus. Cogn Behav Neurol 31(4):201-206, 2018
PubMed
24) Nakajima M, Miyajima M, Ogino I et al:Preoperative phosphorylated tau concentration in the cerebrospinal fluid can predict cognitive function three years after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 66(1):319-331, 2018
PubMed
25) Nagata Y, Bundo M, Sugiura S et al:PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus. Mol Med Rep 16(3):3034-3040, 2017
PubMed
P.258 掲載の参考文献
26) Murakami Y, Matsumoto Y, Hoshi K et al:Rapid increase of 'brain-type' transferrin in cerebrospinal fluid after shunt surgery for idiopathic normal pressure hydrocephalus:a prognosis marker for cognitive recovery. J Biochem 164(3):205-213, 2018
 
27) Nakajima M, Miyajima M, Akiba C et al:Lumboperitoneal shunts for the treatment of idiopathic normal pressure hydrocephalus:A comparison of small-lumen abdominal catheters to gravitational add-on valves in a single center. Oper Neurosurg (Hagerstown) 15(6):634-642, 2018
 
28) Kameda M, Yamada S, Atsuchi M et al:Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials. Acta Neurochir (Wien) 159(6):995-1003, 2017
PubMed
29) Tullberg M, Persson J, Petersen J et al:Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective-a cost utility analysis. Acta Neurochir (Wien) 160(3):509-518, 2018
PubMed
P.260 掲載の参考文献
1) Whitehead WE, Riva-Cambrin J, Kulkarni AV et al:Ventricular catheter entry site and not catheter tip location predicts shunt survival:a secondary analysis of 3 large pediatric hydrocephalus studies. J Neurosurg Pediatr 19(2):157-167, 2017
 
P.261 掲載の参考文献
2) Stovell MG, Zakaria R, Ellenbogen JR et al:Long-term follow-up of endoscopic third ventriculostomy performed in the pediatric population. J Neurosurg Pediatr 17(6):734-738, 2016
PubMed
3) Kulkarni AV, Riva-Cambrin J, Holubkov R et al:Endoscopic third ventriculostomy in children:prospective, multicenter results from the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 18(4):423-429, 2016
PubMed
4) Weil AG, Westwick H, Wang S et al:Efficacy and safety of endoscopic third ventriculostomy and choroid plexus cauterization for infantile hydrocephalus:a systematic review and meta-analysis. Childs Nerv Syst 32(11):2119-2131, 2016
PubMed
P.262 掲載の参考文献
5) Fallah A, Weil AG, Juraschka K et al:The importance of extent of choroid plexus cauterization in addition to endoscopic third ventriculostomy for infantile hydrocephalus:a retrospective North American observational study using propensity score-adjusted analysis. J Neurosurg Pediatr 20(6):503-510, 2017
PubMed
6) Kulkarni AV, Riva-Cambrin J, Rozzelle CJ et al:Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus:a prospective study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 21(3):214-223, 2018
PubMed
P.263 掲載の参考文献
7) Kulkarni AV, Sgouros S, Constantini S et al:International Infant Hydrocephalus Study:initial results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus. Childs Nerv Syst 32(6):1039-1048, 2016
PubMed
8) Kulkarni AV, Sgouros S, Leitner Y et al:International Infant Hydrocephalus Study (IIHS):5-year health outcome results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus. Childs Nerv Syst 34(12):2391-2397, 2018
PubMed
9) Kulkarni AV, Sgouros S, Constantini S et al:Outcome of treatment after failed endoscopic third ventriculostomy (ETV) in infants with aqueductal stenosis:results from the International Infant Hydrocephalus Study (IIHS). Childs Nerv Syst 33(5):747-752, 2017
PubMed
P.264 掲載の参考文献
10) Elbabaa SK, Gildehaus AM, Pierson MJ et al:First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era:hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt). Childs Nerv Syst 33(7):1157-1168, 2017
 
11) Pan IW, Harris DA, Luerssen TG et al:Comparative effectiveness of surgical treatments for pediatric hydrocephalus. Neurosurgery 83(3):480-487, 2018
PubMed
12) Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E et al:Endoscopic treatment versus shunting for infant hydrocephalus in Uganda. N Engl J Med 377(25):2456-2464, 2017
PubMed

VIII. 神経科学

P.266 掲載の参考文献
1) https://clinicaltrials.gov/ct2/home
 
2) Barker RA, Parmar M, Studer L et al:Human trials of stem cell-derived dopamine neurons for Parkinson's disease:Dawn of a new era. Cell Stem Cell 21(5):569-573, 2017
PubMed
3) https://clinicaltrials.gov/ct2/show/NCT02452723?term=stem+cell&cond=Parkinson+Disease&rank=13
 
P.267 掲載の参考文献
4) Gonzalez R, Garitaonandia I, Poustovoitov M et al:Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson's disease. Cell Transplant 25(11):1945-1966, 2016
 
5) Garitaonandia I, Gonzalez R, Christiansen-Weber T et al:Neural stem cell tumorigenicity and biodistribution assessment for phase I clinical trial in Parkinson's disease. Sci Rep 6:34478, 2016
 
6) Garitaonandia I, Gonzalez R, Sherman G et al:Novel approach to stem cell therapy in Parkinson's disease. Stem Cells Dev 27(14):951-957, 2018
PubMed
7) https://clinicaltrials.gov/ct2/show/NCT03119636?term=stem+cell&cond=Parkinson+Disease&rank=14
 
P.268 掲載の参考文献
8) Gu Q, Wang J, Wang L et al:Accreditation of biosafe clinical-grade human embryonic stem cells according to Chinese regulations. Stem Cell Reports 9(1):366-380, 2017
 
9) Wang YK, Zhu WW, Wu MH et al:Human clinical-grade parthenogenetic escderived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson's disease. Stem Cell Reports 11(1):171-182, 2018
PubMed
10) https://www.umin.ac.jp/ctr/index-j.htm
 
11) https://dbcentre3.jmacct.med.or.jp/jmactr/
 
12) https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000038278
 
13) https://dbcentre3.jmacct.med.or.jp/JMACTR/App/JMACTRE02_04/JMACTRE02_04.aspx?kbn=3&seqno=8542
 
14) Kikuchi T, Morizane A, Doi D et al:Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature 548(7669):592-596, 2017
 
P.269 掲載の参考文献
15) Morizane A, Kikuchi T, Hayashi T et al:MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun 8(1):385, 2017
PubMed
16) https://clinicaltrials.gov/ct2/show/NCT03482050?term=embryonic+stem+cell&cond=ALS&rank=1
 
17) Serio A, Patani R:Concise review:The cellular conspiracy of amyotrophic lateral sclerosis. Stem Cells 36(3):293-303, 2018
PubMed
18) Izrael M, Slutsky SG, Admoni T et al:Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models. Stem Cell Res Ther 9(1):152, 2018
PubMed
P.270 掲載の参考文献
19) Baker EW, Platt SR, Lau VW et al:Induced pluripotent stem cell-derived neural stem cell therapy enhances recovery in an ischemic stroke pig model. Sci Rep 7(1):10075, 2017
 
20) Kokaia Z, Tornero D, Lindvall O:Transplantation of reprogrammed neurons for improved recovery after stroke. Prog Brain Res 231:245-263, 2017
PubMed
21) Kalladka D, Sinden J, Pollock K et al:Human neural stem cells in patients with chronic ischaemic stroke (PISCES):a phase 1, first-in-man study. Lancet 388(10046):787-796, 2016
PubMed
22) https://clinicaltrials.gov/ct2/show/NCT02117635?term=stem+cell+PISCES&cond=stroke&rank=3
 
23) https://clinicaltrials.gov/ct2/show/NCT03629275
 
P.271 掲載の参考文献
24) Xu H, Wang B, Ono M et al:Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24(4):566-578.e7, 2019
 
P.272 掲載の参考文献
1) Muir KW:Clinical trial design for stem cell therapies in stroke:What have we learned? Neurochem Int 106:108-113, 2017
PubMed
P.273 掲載の参考文献
2) Hess DC, Wechsler LR, Clark WM et al:Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS):a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 16(5):360-368, 2017
 
3) Steinberg GK, Kondziolka D, Wechsler LR et al:Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke:A phase 1/2a study. Stroke 47(7):1817-1824, 2016
PubMed
P.274 掲載の参考文献
4) Kalladka D, Sinden J, Pollock K et al:Human neural stem cells in patients with chronic ischaemic stroke (PISCES):a phase 1, first-in-man study. Lancet 388(10046):787-796, 2016
PubMed
5) Honmou O, Houkin K, Matsunaga T et al:Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6):1790-1807, 2011
 
6) Nakazaki M, Sasaki M, Kataoka-Sasaki Y et al:Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. J Neurosurg 127(4):917-926, 2017
PubMed
7) Sarmah D, Agrawal V, Rane P et al:Mesenchymal stem cell therapy in ischemic stroke:A meta-analysis of preclinical studies. Clin Pharmacol Ther 103(6):990-998, 2018
PubMed
8) Namioka T, Namioka A, Sasaki M et al:Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction. J Neurosurg, 2018 (doi:10.3171/2018.5.JNS18140)
 
P.275 掲載の参考文献
9) Sasaki Y, Sasaki M, Kataoka-Sasaki Y et al:Synergic effects of rehabilitation and intravenous infusion of mesenchymal stem cells after stroke in rats. Phys Ther 96(11):1791-1798, 2016
PubMed
P.276 掲載の参考文献
10) Fisher M, Feuerstein G, Howells DW et al:Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40(6):2244-2250, 2009
PubMed
11) Namioka A, Namioka T, Sasaki M et al:Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS173121)
 
12) Hachinski V, World Stroke Organization:Stroke and potentially preventable dementias proclamation:Updated World Stroke Day Proclamation. Stroke 46(11):3039-3040, 2015
PubMed
13) Sweeney MD, Sagare AP, Zlokovic BV:Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133-150, 2018
PubMed
14) Nakazaki M, Sasaki M, Kataoka-Sasaki Y et al:Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model. Neuroscience 408:361-377, 2019
 
P.277 掲載の参考文献
15) Sakai T, Sasaki M, Kataoka-Sasaki Y et al:Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxiaischemia. J Neurosurg Pediatr 22(5):513-522, 2018
 
16) Nagahama H, Nakazaki M, Sasaki M et al:Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction. Brain Res 1695:37-44, 2018
 
17) Nakamura H, Sasaki Y, Sasaki M et al:Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats. J Neurosurg Sci 63(1):42-49, 2019 (Epub 2017 Feb 8)
 
P.278 掲載の参考文献
1) Ohgaki H, Kleihues P:Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170(5):1445-1453, 2007
PubMed
P.279 掲載の参考文献
2) Parsons DW, Jones S, Zhang X et al:An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812, 2008
 
3) Yan H, Parsons DW, Jin G et al:IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765-773, 2009
PubMed
4) Suzuki H, Aoki K, Chiba K et al:Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47(5):458-468, 2015
PubMed
P.280 掲載の参考文献
5) Louis DN, Perry A, Reifenberger G et al:The 2016 World Health Organization Classification of Tumors of the Central Nervous System:a summary. Acta Neuropathol 131(6):803-820, 2016
PubMed
6) Toyota M, Ahuja N, Ohe-Toyota M et al:CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96(15):8681-8686, 1999
PubMed
7) Noushmehr H, Weisenberger DJ, Diefes K et al:Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5):510-522, 2010
PubMed
8) Schwartzentruber J, Korshunov A, Liu XY et al:Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226-231, 2012
PubMed
9) Bender S, Tang Y, Lindroth AM et al:Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660-672, 2013
PubMed
10) Lewis PW, Muller MM, Koletsky MS et al:Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857-861, 2013
PubMed
P.281 掲載の参考文献
11) Sturm D, Bender S, Jones DT et al:Paediatric and adult glioblastoma:multiform (epi) genomic culprits emerge. Nat Rev Cancer 14(2):92-107, 2014
PubMed
12) Brennan CW, Verhaak RG, McKenna A et al:The somatic genomic landscape of glioblastoma. Cell 155(2):462-477, 2013
PubMed
13) Sturm D, Witt H, Hovestadt V et al:Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425-437, 2012
PubMed
P.282 掲載の参考文献
14) Dang L, White DW, Gross S et al:Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274):739-744, 2009
PubMed
15) Ward PS, Patel J, Wise DR et al:The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3):225-234, 2010
PubMed
16) Figueroa ME, Abdel-Wahab O, Lu C et al:Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18(6):553-567, 2010
 
17) Turcan S, Rohle D, Goenka A et al:IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483(7390):479-483, 2012
PubMed
18) Lu C, Ward PS, Kapoor GS et al:IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483(7390):474-478, 2012
 
19) Wise DR, Ward PS, Shay JE et al:Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108(49):19611-19616, 2011
 
20) Hirata M, Sasaki M, Cairns RA et al:Mutant IDH is sufficient to initiate enchondromatosis in mice. Proc Natl Acad Sci U S A 112(9):2829-2834, 2015
PubMed
P.283 掲載の参考文献
21) Rohle D, Popovici-Muller J, Palaskas N et al:An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340(6132):626-630, 2013
PubMed
P.284 掲載の参考文献
22) DiNardo CD, Stein EM, de Botton S et al:Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N Engl J Med 378(25):2386-2398, 2018
PubMed
23) van den Bent MJ, Wefel JS, Schiff D et al:Response assessment in neuro-oncology (a report of the RANO group):assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12(6):583-593, 2011
PubMed
P.287 掲載の参考文献
1) Schwartz TH, Morgenstern PF, Anand VK:Lessons learned in the evolution of endoscopic skull base surgery. J Neurosurg 130(2):337-346, 2019
PubMed
P.288 掲載の参考文献
2) Almeida JP, Ruiz-Trevino AS, Liang B et al:Reoperation for growth hormone-secreting pituitary adenomas:report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 129(2):404-416, 2018
 
3) Pomeraniec IJ, Kano H, Xu Z et al:Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas:a multicenter matched-cohort study. J Neurosurg 129(3):648-657, 2018
PubMed
4) Ishikawa T, Takeuchi K, Nagata Y et al:Three types of dural suturing for closure of CSF leak after endoscopic transsphenoidal surgery. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS18366)
 
5) Ordonez-Rubiano EG, Forbes JA, Morgenstern PF et al:Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas. J Neurosurg, 2018 (doi:10.3171/2018.6.JNS18901)
PubMed
P.289 掲載の参考文献
6) Elshazly K, Kshettry VR, Farrell CJ et al:Clinical outcome after endoscopic endonasal resection of tuberculum sella meningiomas. Oper Neurosurg (Hagerstown) 14(5):494-502, 2018
PubMed
7) Jones SH, Iannone AF, Patel KS et al:The impact of age on long-term quality of life after endonasal endoscopic resection of skull base meningiomas. Neurosurgery 79(5):736-745, 2016
PubMed
8) Asemota AO, Ishii M, Brem H et al:Comparison of complications, trends, and costs in endoscopic vs microscopic pituitary surgery:Analysis from a US Health Claims Database. Neurosurgery 81(3):458-472, 2017
PubMed
9) Zagzoog N, Attar A, Reddy K:The 50 most cited publications in endoscopic third ventriculostomy:a bibliometric analysis. J Neurosurg Pediatr 23(2):145-152, 2018
PubMed
P.290 掲載の参考文献
10) Hong S, Hirokawa D, Usami K et al:The long-term outcomes of endoscopic third ventriculostomy in pediatric hydrocephalus, with an emphasis on future intellectual development and shunt dependency. J Neurosurg Pediatr 23(1):104-108, 2018
 
11) Grand W, Leonardo J, Chamczuk AJ et al:Endoscopic third ventriculostomy in 250 adults with hydrocephalus:Patient selection, outcomes, and complications. Neurosurgery 78(1):109-119, 2016
PubMed
12) Torres-Corzo JG, Rangel-Castilla L, Islas-Aguilar MA et al:A novel approach of navigation-assisted flexible neuroendoscopy. Oper Neurosurg (Hagerstown) 14(3):E33-E37, 2018
 
13) Oertel J, Linsler S, Csokonay A et al:Management of severe intraoperative hemorrhage during intraventricular neuroendoscopic procedures:the dry field technique. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS172537)
 
P.291 掲載の参考文献
14) Kolcun JPG, Brusko GD, Basil GW et al:Endoscopic transforaminal lumbar interbody fusion without general anesthesia:operative and clinical outcomes in 100 consecutive patients with a minimum 1-year follow-up. Neurosurg Focus 46(4):E14, 2019
 
15) McGrath Jr.LB, White-Dzuro GA, Hofstetter CP:Comparison of clinical outcomes following minimally invasive or lumbar endoscopic unilateral laminotomy for bilateral decompression. J Neurosurg Spine, 2019 (doi:10.3171/2018.9.SPINE18689)
 
16) Roland JL, Smyth MD:Recent advances in the neurosurgical treatment of pediatric epilepsy:JNSPG 75th Anniversary Invited Review Article. J Neurosurg Pediatr 23(4):411-421, 2019
PubMed
17) Flanders TM, Blue R, Roberts S et al:Fully endoscopic microvascular decompression for hemifacial spasm. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS172631)
 
18) Fernandez-Miranda JC, Zwagerman NT, Abhinav K et al:Cavernous sinus compartments from the endoscopic endonasal approach:anatomical considerations and surgical relevance to adenoma surgery. J Neurosurg 129(2):430-441, 2018
PubMed
19) Truong HQ, Sun X, Celtikci E et al:Endoscopic anterior transmaxillary "transalisphenoid" approach to Meckel's cave and the middle cranial fossa:an anatomical study and clinical application. J Neurosurg 130(1):227-237, 2018
 
20) Wang WH, Lieber S, Mathias RN et al:The foramen lacerum:surgical anatomy and relevance for endoscopic endonasal approaches. J Neurosurg, 2018 (doi:10.3171/2018.6.JNS181117)
 
P.292 掲載の参考文献
21) Jeon C, Hong CK, Woo KI et al:Endoscopic transorbital surgery for Meckel's cave and middle cranial fossa tumors:surgical technique and early results. J Neurosurg, 2018 (doi:10.3171/2018.6.JNS181099)
 
22) Oertel JM, Burkhardt BW:Vitom-3D for exoscopic neurosurgery:Initial experience in cranial and spinal procedures. World Neurosurg 105:153-162, 2017
PubMed
23) Ricciardi L, Chaichana KL, Cardia A et al:The exoscope in neurosurgery:an innovative "point of view". A systematic review of the technical, surgical and educational aspects. World Neurosurg 124:136-144, 2019
PubMed
24) Toyooka T, Otani N, Wada K et al:Headup display may facilitate safe keyhole surgery for cerebral aneurysm clipping. J Neurosurg 129(4):883-889, 2018
PubMed
25) Rosseau G, Bailes J, del Maestro R et al:The development of a virtual simulator for training neurosurgeons to perform and perfect endoscopic endonasal transsphenoidal surgery. Neurosurgery 73 Suppl 1:85-93, 2013
 
P.293 掲載の参考文献
1) Telkes I, Ince NF, Onaran I et al:Spatio-spectral characterization of local field potentials in the subthalamic nucleus via multitrack microelectrode recordings. Conf Proc IEEE Eng Med Biol Soc 2015:5561-5564, 2015
 
P.294 掲載の参考文献
2) Mueller K, Jech R, Ruzicka F et al:Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease. Neuroimage Clin 19:1025-1035, 2018
 
3) Hell F, Plate A, Mehrkens JH et al:Subthalamic oscillatory activity and connectivity during gait in Parkinson's disease. Neuroimage Clin 19:396-405, 2018
 
4) Bichsel O, Gassert R, Stieglitz L et al:Functionally separated networks for self-paced and externally-cued motor execution in Parkinson's disease:Evidence from deep brain recordings in humans. Neuroimage 177:20-29, 2018
PubMed
5) Fukuma R, Yanagisawa T, Tanaka M et al:Real-time neurofeedback to modulate β-band power in the subthalamic nucleus in Parkinson's disease Patients. eNeuro 5(6):ENEURO.0246-18.2018
 
P.295 掲載の参考文献
6) Fasano A, Laganiere SE, Lam S et al:Lesions causing freezing of gait localize to a cerebellar functional network. Ann Neurol 81(1):129-141, 2017
PubMed
7) Rothkirch I, Granert O, Knutzen A et al:Dynamic causal modeling revealed dysfunctional effective connectivity in both, the cortico-basal-ganglia and the cerebello-cortical motor network in writers' cramp. Neuroimage Clin 18:149-159, 2018
PubMed
8) van der Salm SMA, van der Meer JN, Cath DC et al:Distinctive tics suppression network in Gilles de la Tourette syndrome distinguished from suppression of natural urges using multimodal imaging. Neuroimage Clin 20:783-792, 2018
PubMed
9) Alagapan S, Lustenberger C, Hadar E et al:Low-frequency direct cortical stimulation of left superior frontal gyrus enhances working memory performance. Neuroimage 184:697-706, 2019
PubMed
P.296 掲載の参考文献
10) Nakai Y, Nagashima A, Hayakawa A et al:Four-dimensional map of the human early visual system. Clin Neurophysiol 129(1):188-197, 2018
PubMed
11) Nakai Y, Jeong JW, Brown EC et al:Three- and four-dimensional mapping of speech and language in patients with epilepsy. Brain 140(5):1351-1370, 2017
PubMed
12) Caruana F, Gerbella M, Avanzini P et al:Motor and emotional behaviours elicited by electrical stimulation of the human cingulate cortex. Brain 141(10):3035-3051, 2018
PubMed
P.297 掲載の参考文献
13) Mazzola L, Mauguiere F, Isnard J:Electrical Stimulations of the Human Insula:Their Contribution to the Ictal Semiology of Insular Seizures. J Clin Neurophysiol 34(4):307-314, 2017
 
14) Mazzola L, Royet JP, Catenoix H et al:Gustatory and olfactory responses to stimulation of the human insula. Ann Neurol 82(3):360-370, 2017
PubMed
15) Rech F, Herbet G, Gaudeau Y et al:A probabilistic map of negative motor areas of the upper limb and face:a brain stimulation study. Brain 142(4):952-965, 2019
 
16) Trimmel K, van Graan AL, Caciagli L et al:Left temporal lobe language network connectivity in temporal lobe epilepsy. Brain 141(8):2406-2418, 2018
PubMed
17) Geranmayeh F, Chau TW, Wise RJS et al:Domain-general subregions of the medial prefrontal cortex contribute to recovery of language after stroke. Brain 140(7):1947-1958, 2017
PubMed
P.298 掲載の参考文献
18) Shahid H, Sebastian R, Schnur TT et al:Important considerations in lesion-symptom mapping:Illustrations from studies of word comprehension. Hum Brain Mapp 38(6):2990-3000, 2017
PubMed
19) Kitamura T, Ogawa SK, Roy DS et al:Engrams and circuits crucial for systems consolidation of a memory. Science 356(6333):73-78, 2017
PubMed
20) Tennant KA, Taylor SL, White ER et al:Optogenetic rewiring of thalamocortical circuits to restore function in the stroke injured brain. Nat Commun 8:15879, 2017
PubMed
P.299 掲載の参考文献
1) Rainov NG:A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11(17):2389-2401, 2000
PubMed
2) Wheeler LA, Manzanera AG, Bell SD et al:Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma. Neuro Oncol 18(8):1137-1145, 2016
PubMed
3) Desjardins A, Gromeier M, Herndon JE 2nd et al:Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med 379(2):150-161, 2018
PubMed
P.300 掲載の参考文献
4) Adams D, Gonzalez-Duarte A, O'Riordan WD et al:Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11-21, 2018
PubMed
5) Kim SS, Rait A, Kim E et al:A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano 8(6):5494-5514, 2014
 
6) Lee TJ, Yoo JY, Shu D et al:RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21. Mol Ther 25(7):1544-1555, 2017
PubMed
7) Bae Y, Green ES, Kim GY et al:Dipeptide-functionalized polyamidoamine dendrimer-mediated apoptin gene delivery facilitates apoptosis of human primary glioma cells. Int J Pharm 515(1-2):186-200, 2016
 
8) Gao S, Li J, Jiang C et al:Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Drug Des Devel Ther 10:1-11, 2016
PubMed
9) Kodama Y, Kuramoto H, Mieda Y et al:Application of biodegradable dendrigraft poly-l-lysine to a small interfering RNA delivery system. J Drug Target 25(1):49-57, 2017
 
10) Mastorakos P, Song E, Zhang C et al:Biodegradable DNA nanoparticles that provide widespread gene delivery in the brain. Small 12(5):678-685, 2016
PubMed
P.301 掲載の参考文献
11) Sokolov ME, Bashirov FV, Markosyan VA et al:Triple-gene therapy for stroke:A proof-of-concept in vivo study in rats. Front Pharmacol 9:111, 2018
PubMed
12) Christine CW, Bankiewicz KS, Van Laar AD et al:Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease. Ann Neurol, 2019 (doi:10.1002/ana.25450)
 
13) Kantor B, Tagliafierro L, Gu J et al:Downregulation of SNCA expression by targeted editing of DNA methylation:A potential strategy for precision therapy in PD. Mol Ther 26(11):2638-2649, 2018
PubMed
14) Niethammer M, Tang CC, LeWitt PA et al:Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. JCI Insight 2(7):e90133, 2017
 
15) Palfi S, Gurruchaga JM, Lepetit H et al:Long-term follow-up of a phase I/II study of ProSavin, a Lentiviral vector gene therapy for Parkinson's disease. Hum Gene Ther Clin Dev 29(3):148-155, 2018
PubMed
P.302 掲載の参考文献
16) Snowball A, Chabrol E, Wykes RC et al:Epilepsy gene therapy using an engineered potassium channel. J Neurosci, 2019 (doi:10.1523/JNEURO-SCI.1143-18.2019)
 
17) Shimazaki K, Kobari T, Oguro K et al:Hippocampal GAD67 transduction using rAAV8 regulates epileptogenesis in EL Mice. Mol Ther Methods Clin Dev 13:180-186, 2019
PubMed
18) Lieb A, Qiu Y, Dixon CL et al:Biochemical autoregulatory gene therapy for focal epilepsy. Nat Med 24(9):1324-1329, 2018
PubMed
19) Drew L:Gene therapy targets epilepsy. Nature 564(7735):S10-S11, 2018
PubMed
20) Nguyen LH, Gao M, Lin J et al:Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment. Sci Rep 7:42212, 2017
PubMed
21) Eggers R, de Winter F, Hoyng SA et al:Timed GDNF gene therapy using an immune-evasive gene switch promotes long distance axon regeneration. Brain 142(2):295-311, 2019
PubMed

IX. 手術・手技

P.304 掲載の参考文献
1) Li A, Liu W, Cao P et al:Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary adenoma:A systematic review and meta-analysis. World Neurosurg 101:236-246, 2017
PubMed
2) Phan K, Xu J, Reddy R et al:Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas-systematic review and meta-analysis. World Neurosurg 97:398-406, 2017
PubMed
P.305 掲載の参考文献
3) Jethwa PR, Patel TD, Hajart AF et al:Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States. World Neurosurg 87:65-76, 2016
PubMed
4) Liu JK, Sevak IA, Carmel PW et al:Microscopic versus endoscopic approaches for craniopharyngiomas:choosing the optimal surgical corridor for maximizing extent of resection and complication avoidance using a personalized, tailored approach. Neurosurg Focus 41(6):E5, 2016
 
5) Fomichev D, Kalinin P, Kutin M et al:Extended transsphenoidal endoscopic endonasal surgery of suprasellar craniopharyngiomas. World Neurosurg 94:181-187, 2016
PubMed
6) Gui S, Zong X, Wang X et al:Classification and surgical approaches for transnasal endoscopic skull base chordoma resection:a 6-year experience with 161 cases. Neurosurg Rev 39(2):321-332, 2016
PubMed
P.306 掲載の参考文献
7) Dhandapani S, Singh H, Negm HM et al:Cavernous sinus invasion in pituitary adenomas:Systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery. World Neurosurg 96:36-46, 2016
PubMed
8) Borg A, Kirkman MA, Choi D:Endoscopic endonasal anterior skull base surgery:A systematic review of complications during the past 65 years. World Neurosurg 95:383-391, 2016
PubMed
9) Magro E, Graillon T, Lassave J et al:Complications related to the endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary macroadenomas in 300 consecutive patients. World Neurosurg 89:442-453, 2016
 
10) Cote DJ, Alzarea A, Acosta MA et al:Predictors and rates of delayed symptomatic hyponatremia after transsphenoidal surgery:A systematic review. World Neurosurg 88:1-6, 2016
 
P.307 掲載の参考文献
11) Tomita Y, Kurozumi K, Inagaki K et al:Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma. Acta Neurochir (Wien) 161(4):707-715, 2019
PubMed
12) Dolati P, Eichberg D, Golby A et al:Multimodal navigation in endoscopic transsphenoidal resection of pituitary tumors using image-based vascular and cranial nerve segmentation:A prospective validation study. World Neurosurg 95:406-413, 2016
PubMed
13) Sefcik RK, Rasouli J, Bederson JB et al:Three-Dimensional, computer simulated navigation in endoscopic neurosurgery. Interdiscip Neurosurg 8:17-22, 2017
PubMed
14) Amr AN, Conrad J, Kantelhardt S et al:Autostereoscopic three-dimensional neuronavigation to the sella:Technical note. World Neurosurg 105:386-393, 2017
 
15) Kurozumi K, Kameda M, Ishida J et al:Simultaneous combination of electromagnetic navigation with visual evoked potential in endoscopic transsphenoidal surgery:clinical experience and technical considerations. Acta Neurochir (Wien) 159(6):1043-1048, 2017
PubMed
16) Ratre S, Yadav YR, Parihar VS et al:Microendoscopic removal of deep-seated brain tumors using tubular retraction system. J Neurol Surg A Cent Eur Neurosurg 77(4):312-320, 2016
PubMed
P.308 掲載の参考文献
17) Matsumoto Y, Kurozumi K, Shimazu Y et al:Endoscope-assisted resection of cavernous angioma at the foramen of Monro:a case report. Springerplus 5(1):1820, 2016
PubMed
18) Otani Y, Kurozumi K, Ishida J et al:Combination of the tubular retractor and brain spatulas provides an adequate operative field in surgery for deep-seated lesions:Case series and technical note. Surg Neurol Int 9:220, 2018
 
19) Pennacchietti V, Garzaro M, Grottoli S et al:Three-dimensional endoscopic endonasal approach and outcomes in sellar lesions:A single-center experience of 104 cases. World Neurosurg 89:121-125, 2016
PubMed
20) Rigante M, La Rocca G, Lauretti L et al:Preliminary experience with 4K ultra-high definition endoscope:analysis of pros and cons in skull base surgery. Acta Otorhinolaryngol Ital 37(3):237-241, 2017
PubMed
P.309 掲載の参考文献
21) Yamashita H, Aoki H, Tanioka K et al:Ultra-high definition (8K UHD) endoscope:our first clinical success. Springerplus 5(1):1445, 2016
PubMed
22) Yamashita H, Tanioka K, Miyake G et al:8K ultra-high-definition microscopic camera for ophthalmic surgery. Clin Ophthalmol 12:1823-1828, 2018
PubMed
23) Duek I, Amit M, Sviri GE et al:Combined endoscopic transcervical-transoral robotic approach for resection of parapharyngeal space tumors. Head Neck 39(4):786-790, 2017
PubMed
24) Duek I, Sviri GE, Billan S et al:Minimally invasive surgery for resection of parapharyngeal space tumors. J Neurol Surg B Skull Base 79(3):250-256, 2018
PubMed
25) Eroglu U, Meco C, Caglar S et al:Pure robotic surgery for odontoid tumor:First case. World Neurosurg 116:299-304, 2018
PubMed
26) Davis MC, Can DD, Pindrik J et al:Virtual interactive presence in global surgical education:International collaboration through augmented reality. World Neurosurg 86:103-111, 2016
PubMed
P.310 掲載の参考文献
1) Yamamoto M, Serizawa T, Shuto T et al:Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi-institutional prospective observational study. Lancet Oncol 15(4):387-395, 2014
 
2) Yamamoto M, Serizawa T, Higuchi Y et al:A multi-institutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901 Study Update):Irradiation-related complications and long-term maintenance of Mini-Mental State Examination Scores. Int J Radiat Oncol Biol Phys 99(1):31-40, 2017
PubMed
3) Sahgal A, Ruschin M, Ma L et al:Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. Neuro Oncol 19(suppl_2):ii2-ii15, 2017
 
P.311 掲載の参考文献
4) Kayama T, Sato S, Sakurada K et al:Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504):A phase III, noninferiority, randomized controlled trial. J Clin Oncol:JCO2018786186, 2018
PubMed
5) Minniti G, Scaringi C, Paolini S et al:Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (> 2 cm) brain metastases:A comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95(4):1142-1148, 2016
 
6) Colaco RJ, Martin P, Kluger HM et al:Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? J Neurosurg 125(1):17-23, 2016
PubMed
7) Furuta H, Yoshida T, Natsume A et al:Inflammation flare and radiation necrosis around a stereotactic radiotherapy-pretreated brain metastasis site after nivolumab treatment. J Thorac Oncol 13(12):1975-1978, 2018
PubMed
8) Chen L, Douglass J, Kleinberg L et al:Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100(4):916-925, 2018
PubMed
P.312 掲載の参考文献
9) Fang P, Jiang W, Allen P et al:Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma. J Neurooncol 133(3):595-602, 2017
PubMed
10) Milano MT, Grimm J, Soltys SG et al:Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol Biol Phys:S0360-3016(18)30125-1, 2018
 
11) Astradsson A, Munck Af Rosenschold P, Feldt-Rasmussen U et al:Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults:findings in a prospective cohort. Acta Oncol 56(3):415-421, 2017
 
P.313 掲載の参考文献
12) Watanabe S, Yamamoto M, Kawabe T et al:Stereotactic radiosurgery for vestibular schwannomas:average 10-year follow-up results focusing on long-term hearing preservation. J Neurosurg 125(Suppl 1):64-72, 2016
 
13) Santa Maria PL, Shi Y, Gurgel RK et al:Long-term hearing outcomes following stereotactic radiosurgery in vestibular schwannoma patients-A retrospective cohort study. Neurosurgery, 2018 (doi:10.1093/neuros/nyy407)
 
14) Kruyt IJ, Verheul JB, Hanssens PEJ et al:Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2:a matched cohort study with sporadic vestibular schwannomas. J Neurosurg 128(1):49-59, 2018
PubMed
P.314 掲載の参考文献
15) Combs SE, Farzin M, Boehmer J et al:Clinical outcome after high-precision radiotherapy for skull base meningiomas:Pooled data from three large German centers for radiation oncology. Radiother Oncol 127(2):274-279, 2018
PubMed
16) Pollock BE, Link MJ, Stafford SL et al:The risk of radiation-induced tumors or malignant transformation after single-fraction intracranial radiosurgery:Results based on a 25-year experience. Int J Radiat Oncol Biol Phys 97(5):919-923, 2017
 
17) Ding D, Starke RM, Kano H et al:Radiosurgery for cerebral arteriovenous malformations in a randomized trial of unruptured brain arteriovenous malformations (ARUBA) -eligible patients:A multicenter study. Stroke 47(2):342-349, 2016
 
P.315 掲載の参考文献
18) Karlsson B, Jokura H, Yang HC et al:The NASSAU (New ASSessment of cerebral Arteriovenous Malformations yet Unruptured) analysis:Are the results from the ARUBA trial also applicable to unruptured arteriovenous malformations deemed suitable for Gamma Knife surgery? Neurosurgery, 2018 (doi:10.1093/neuros/nyy391)
 
19) Park SH, Park KS, Kang DH et al:Stereotactic radiosurgery for intracranial dural arteriovenous fistulas:its clinical and angiographic perspectives. Acta Neurochir (Wien) 159(6):1093-1103, 2017
PubMed
P.316 掲載の参考文献
1) Belykh EG, Zhao X, Cavallo C et al:Laboratory evaluation of a robotic operative microscope-visualization platform for neurosurgery. Cureus 10(7):e3072, 2018
 
P.317 掲載の参考文献
2) Belykh E, George L, Zhao X et al:Microvascular anastomosis under 3D exoscope or endoscope magnification:A proof-of-concept study. Surg Neurol Int 9:115, 2018
PubMed
3) Nossek E, Schneider JR, Kwan K et al:Technical aspects and operative nuances using a high-definition 3-dimensional exoscope for cerebral bypass surgery. Oper Neurosurg (Hagerstown), 2018 (doi:10.1093/ons/opy342)
 
4) Kwan K, Schneider JR, Du V et al:Lessons learned using a high-definition 3-dimensional exoscope for spinal surgery. Oper Neurosurg (Hagerstown) 16(5):619-625, 2019 (Epub 2018 Aug 14)
 
5) Rossini Z, Cardia A, Milani D et al:VITOM 3D:Preliminary experience in cranial surgery. World Neurosurg 107:663-668, 2017
PubMed
6) Angileri FF, Esposito F, Scibilia A et al:Exoscope-guided (VITOM 3D) single-stage removal of supratentorial cavernous angioma and hemangioblastoma:3-dimensional operative video. Oper Neurosurg (Hagerstown):opz010, 2019
PubMed
P.318 掲載の参考文献
7) Garneau JC, Laitman BM, Cosetti MK et al:The use of the exoscope in lateral skull base surgery:Advantages and limitations. Otol Neurotol 40(2):236-240, 2019
PubMed
8) Gildenberg PL, Ledoux R, Cosman E et al:The exoscope--a frame-based video/graphics system for intraoperative guidance of surgical resection. Stereotact Funct Neurosurg 63(1-4):23-25, 1994
 
9) Ricciardi L, Chaichana KL, Cardia A et al:The exoscope in neurosurgery:an innovative "point of view". A systematic review of the technical, surgical and educational aspects. World Neurosurg:S1878-8750(19)30080-4, 2019
 
10) Murai Y, Sato S, Yui K et al:Preliminary clinical microneurosurgical experience with the 4K3-dimensional microvideoscope (ORBEYE) system for microneurological surgery:Observation study. Oper Neurosurg (Hagerstown), 2018 (doi:10.1093/ons/opy277)
 
11) Takahashi S, Toda M, Nishimoto M et al:Pros and cons of using ORBEYE(TM) for microneurosurgery. Clin Neurol Neurosurg 174:57-62, 2018
PubMed
12) Moisi MD, Hoang K, Tubbs RS et al:Advancement of surgical visualization methods:Comparison study between traditional microscopic surgery and a novel robotic optoelectronic visualization tool for spinal surgery. World Neurosurg 98:273-277, 2017
 
P.319 掲載の参考文献
13) Beez T, Munoz-Bendix C, Beseoglu K et al:First clinical applications of a high-definition three-dimensional exoscope in pediatric neurosurgery. Cureus 10(1):e2108, 2018
 
14) Oertel JM, Burkhardt BW:Vitom-3D for exoscopic neurosurgery:Initial experience in cranial and spinal procedures. World Neurosurg 105:153-162, 2017
PubMed
15) Gonen L, Chakravarthi SS, Monroy-Sosa A et al:Initial experience with a robotically operated video optical telescopic-microscope in cranial neurosurgery:feasibility, safety, and clinical applications. Neurosurg Focus 42(5):E9, 2017
 
16) Bohl MA, Oppenlander ME, Spetzler R:A prospective cohort evaluation of a robotic, auto-navigating operating microscope. Cureus 8(6):e662, 2016
 
P.320 掲載の参考文献
1) Riva M, Amin-Hanjani S, Giussani C et al:Indocyanine green videoangiography in aneurysm surgery:Systematic review and meta-analysis. Neurosurgery 83(2):166-180, 2018
PubMed
P.321 掲載の参考文献
2) Catapano G, Sgulo F, Laleva L et al:Multimodal use of indocyanine green endoscopy in neurosurgery:a single-center experience and review of the literature. Neurosurg Rev 41(4):985-998, 2018
PubMed
3) Kubota H, Sanada Y, Nagatsuka K et al:Safe and accurate sylvian dissection with the use of indocyanine green videoangiography. Surg Neurol Int 7(Suppl 14):S427-S429, 2016
 
4) Yokoyama J, Ishibashi K, Shiramizu H et al:Impact of endoscopic indocyanine green fluorescence imaging on superselective intra-arterial chemotherapy for recurrent cancer of the skull base. Anticancer Res 36(7):3419-3424, 2016
PubMed
5) Fischer G, Rediker J, Oertel J:Endoscope-versus microscope-integrated near-infrared indocyanine green videoangiography in aneurysm surgery. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS172650)
 
6) Murai Y, Sato S, Yui K et al:Preliminary clinical microneurosurgical experience with the 4K3-dimensional microvideoscope (ORBEYE) system for microneurological surgery:Observation study. Oper Neurosurg (Hagerstown), 2018 (doi:10.1093/ons/opy277)
 
P.322 掲載の参考文献
7) Suero Molina E, Schipmann S, Stummer W:Maximizing safe resections:the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature. Neurosurg Rev 42(2):197-208, 2019 (Epub 2017 Sep 18)
 
8) Coburger J, Wirtz CR:Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma:a systematic review. J Neurooncol 141(3):533-546, 2019
PubMed
9) Eljamel MS, Mahboob SO:The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection;a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI. Photodiagnosis Photodyn Ther 16:35-43, 2016
PubMed
10) Yano H, Nakayama N, Ohe N et al:Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium. J Neurooncol 133(2):389-397, 2017
PubMed
11) Suero Molina E, Wolfer J, Ewelt C et al:Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas:technical note. J Neurosurg 128(2):399-405, 2018
PubMed
P.323 掲載の参考文献
12) Saito K, Hirai T, Takeshima H et al:Genetic factors affecting intraoperative 5-aminolevulinic acid-induced fluorescence of diffuse gliomas. Radiol Oncol 51(2):142-150, 2017
PubMed
13) Foster N, Eljamel S:ALA-induced fluorescence image guided surgery of meningiomas:A meta-analyses. Photodiagnosis Photodyn Ther 15:73-78, 2016
PubMed
14) Dijkstra BM, Jeltema HJR, Kruijff S et al:The application of fluorescence techniques in meningioma surgery-a review. Neurosurg Rev, 2018 (doi:10.1007/s10143-018-01062-4)
 
P.324 掲載の参考文献
15) Roberts DW, Olson JD, Evans LT et al:Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection. J Neurosurg 128(6):1690-1697, 2018
PubMed
16) Yoneda T, Nonoguchi N, Ikeda N et al:Spectral radiance of protoporphyrin IX fluorescence and its histopathological implications in 5-aminolevulinic acid-guided surgery for glioblastoma. Photomed Laser Surg 36(5):266-272, 2018
PubMed
17) Morshed RA, Han SJ, Lau D et al:Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma:technical note. J Neurosurg 128(5):1448-1453, 2018
PubMed
P.325 掲載の参考文献
1) Dammann P, Jagersberg M, Kulcsar Z et al:Clipping of ruptured intracranial aneurysms in a hybrid room environmenta case-control study. Acta Neurochir (Wien) 159(7):1291-1298, 2017
 
2) Gruter BE, Strange F, Burn F et al:Hybrid operating room settings for treatment of complex dural arteriovenous fistulas. World Neurosurg 120:e932-e939, 2018
PubMed
P.326 掲載の参考文献
3) Mori R, Yuki I, Kajiwara I et al:Hybrid operating room for combined neuroendovascular and endoscopic treatment of ruptured cerebral aneurysms with intraventricular hemorrhage. World Neurosurg 89:727.e9-e727.e12, 2016
 
4) Tang CL, Liao CH, Chen WH et al:Endoscope-assisted transsphenoidal puncture of the cavernous sinus for embolization of carotid-cavernous fistula in a neurosurgical hybrid operating suite. J Neurosurg 127(2):327-331, 2017
 
5) Fomekong E, Safi SE, Raftopoulos C:Spine navigation based on 3-dimensional robotic fluoroscopy for accurate percutaneous pedicle screw placement:A prospective study of 66 consecutive cases. World Neurosurg 108:76-83, 2017
PubMed
6) Pireau N, Cordemans V, Banse X et al:Radiation dose reduction in thoracic and lumbar spine instrumentation using navigation based on an intraoperative cone beam CT imaging system:a prospective randomized clinical trial. Eur Spine J 26(11):2818-2827, 2017
 
7) Carver D, Kirkpatrick AW, D'Amours S et al:A prospective evaluation of the utility of a hybrid operating suite for severely injured patients:Overstated or underutilized? Ann Surg, 2018 (doi:10.1097/SLA.0000000000003175)
PubMed
8) Coburger J, Nabavi A, Konig R et al:Contemporary use of intraoperative imaging in glioma surgery:A survey among EANS members. Clin Neurol Neurosurg 163:133-141, 2017
PubMed
9) Eljamel MS, Mahboob SO:The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection;a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI. Photodiagnosis Photodyn Ther 16:35-43, 2016
PubMed
P.327 掲載の参考文献
10) Coburger J, Merkel A, Scherer M et al:Low-grade glioma surgery in intraoperative magnetic resonance imaging:Results of a multicenter retrospective assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery 78(6):775-786, 2016
 
11) Scherer M, Jungk C, Younsi A et al:Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI:analysis from a prospective single-center registry of supratentorial gliomas. Neurosurg Focus 40(3):E4, 2016
 
12) Ahmadi R, Campos B, Haux D et al:Assessing perioperative complications associated with use of intraoperative magnetic resonance imaging during glioma surgery-a single centre experience with 516 cases. Br J Neurosurg 30(4):397-400, 2016
PubMed
13) Hauser SB, Kockro RA, Actor B et al:Combining 5-aminolevulinic acid fluorescence and intraoperative magnetic resonance imaging in glioblastoma surgery:A histology-based evaluation. Neurosurgery 78(4):475-483, 2016
PubMed
P.328 掲載の参考文献
14) Tandon V, Raheja A, Suri A et al:Randomized trial for superiority of high field strength intra-operative magnetic resonance imaging guided resection in pituitary surgery. J Clin Neurosci 37:96-103, 2017
PubMed
15) Fujii Y, Muragaki Y, Maruyama T et al:Threshold of the extent of resection for WHO Grade III gliomas:retrospective volumetric analysis of 122 cases using intraoperative MRI. J Neurosurg 129(1):1-9, 2018
PubMed
16) Li YM, Suki D, Hess K et al:The influence of maximum safe resection of glioblastoma on survival in 1229 patients:Can we do better than gross-total resection? J Neurosurg 124(4):977-988, 2016
PubMed
P.329 掲載の参考文献
17) Jenkinson MD, Barone DG, Bryant A et al:Intraoperative imaging technology to maximise extent of resection for glioma. Cochrane Database Syst Rev 1:CD012788, 2018
PubMed
P.330 掲載の参考文献
1) Sicking J, Voss KM, Spille DC et al:The evolution of cranial meningioma surgery-a single-center 25-year experience. Acta Neurochir (Wien) 160(9):1801-1812, 2018
PubMed
2) Narayan V, Bir SC, Mohammed N et al:Surgical management of giant intracranial meningioma:Operative nuances, challenges, and outcome. World Neurosurg 110:e32-e41, 2018
PubMed
P.331 掲載の参考文献
3) Li H, Wang L, Hao S et al:Identification of the facial nerve in relation to vestibular schwannoma using preoperative diffusion tensor tractography and intraoperative tractography-integrated neuronavigation system. World Neurosurg 107:669-677, 2017
 
4) Li Z, Wang M, Zhang L et al:Neuronavigation-guided corticospinal tract mapping in brainstem tumor surgery:Better preservation of motor function. World Neurosurg 116:e291-e297, 2018
 
5) Lu CY, Chen XL, Chen XL et al:Clinical application of 3.0 T intraoperative magnetic resonance combined with multimodal neuronavigation in resection of cerebral eloquent area glioma. Medicine (Baltimore) 97(34):e11702, 2018
 
6) Grech-Sollars M, Vaqas B, Thompson G et al:An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems. J Neurosurg, 2017 (doi:10.3171/2016.7.JNS16106.test)
 
7) Pesce A, Frati A, D'Andrea G et al:The real impact of an intraoperative magnetic resonance imaging-equipped operative theatre in neurovascular surgery:The Sapienza University experience. World Neurosurg 120:190-199, 2018
PubMed
8) Fredrickson VL, Russin JJ, Strickland BA et al:Intraoperative imaging for vascular lesions. Neurosurg Clin N Am 28(4):603-613, 2017
PubMed
9) Chartrain AG, Kellner CP, Fargen KM et al:A review and comparison of three neuronavigation systems for minimally invasive intracerebral hemorrhage evacuation. J Neurointerv Surg 10(1):66-74, 2018
PubMed
10) Wu R, Qin H, Cai Z et al:The clinical efficacy of electromagnetic navigation-guided hematoma puncture drainage in patients with hypertensive basal ganglia hemorrhage. World Neurosurg 118:e115-e122, 2018
PubMed
P.332 掲載の参考文献
11) Bilhar RPO, de Lima DA, Leite JAD et al:Accuracy of pedicle screw insertion:A comparison between fluoroscopic guidance and navigation techniques. Acta Ortop Bras 26(6):397-400, 2018
PubMed
12) Fichtner J, Hofmann N, Rienmuller A et al:Revision rate of misplaced pedicle screws of the thoracolumbar spine-comparison of three-dimensional fluoroscopy navigation with freehand placement:A systematic analysis and review of the literature. World Neurosurg 109:e24-e32, 2018
PubMed
13) Kouyoumdjian P, Gras-Combe G, Grelat M et al:Surgeon's and patient's radiation exposure during percutaneous thoracolumbar pedicle screw fixation:A prospective multicenter study of 100 cases. Orthop Traumatol Surg Res 104(5):597-602, 2018
 
14) Zhang C, Wu J, Xu C et al:Minimally invasive full-endoscopic posterior cervical foraminotomy assisted by O-Arm-Based Navigation. Pain Physician 21(3):E215-E223, 2018
 
P.333 掲載の参考文献
15) Sefcik RK, Rasouli J, Bederson JB et al:Three-dimensional, computer simulated navigation in endoscopic neurosurgery. Interdiscip Neurosurg 8:17-22, 2017
PubMed
16) Wang X, Li L, Wang Y et al:Clinical application of multimodal neuronavigation system in neuroendoscope-assisted skull base chordoma resection. J Craniofac Surg 28(6):e554-e557, 2017
 
17) Cinalli G, Imperato A, Mirone G et al:Initial experience with endoscopic ultrasonic aspirator in purely neuroendoscopic removal of intraventricular tumors. J Neurosurg Pediatr 19(3):325-332, 2017
 
P.334 掲載の参考文献
18) Gerard IJ, Kersten-Oertel M, Petrecca K et al:Brain shift in neuronavigation of brain tumors:A review. Med Image Anal 35:403-420, 2017
PubMed
19) Iversen DH, Wein W, Lindseth F et al:Automatic intraoperative correction of brain shift for accurate neuronavigation. World Neurosurg 120:e1071-e1078, 2018
PubMed
20) Fan X, Roberts DW, Schaewe TJ et al:Intraoperative image updating for brain shift following dural opening. J Neurosurg 126(6):1924-1933, 2017
PubMed
P.335 掲載の参考文献
1) Abboud T, Schwarz C, Westphal M et al:A comparison between threshold criterion and amplitude criterion in transcranial motor evoked potentials during surgery for supratentorial lesions. J Neurosurg, 2018 (doi:10.3171/2018.4.JNS172468)
 
P.336 掲載の参考文献
2) Moiyadi A, Velayutham P, Shetty P et al:Combined motor evoked potential monitoring and subcortical dynamic mapping in motor eloquent tumors allows safer and extended resections. World Neurosurg 120:e259-e268, 2018
PubMed
3) Li Z, Wang M, Zhang L et al:Neuronavigation-guided corticospinal tract mapping in brainstem tumor surgery:Better preservation of motor function. World Neurosurg 116:e291-e297, 2018
 
P.337 掲載の参考文献
4) Motomura K, Sumita K, Chalise L et al:Characterization of intraoperative motor evoked potential monitoring for surgery of the pediatric population with brain tumors. World Neurosurg 119:e1052-e1059, 2018
PubMed
5) Umemura T, Nishizawa S, Nakano Y et al:Intraoperative monitoring of motor-evoked potential for parenchymal brain tumor removal:An analysis of false-negative cases. J Clin Neurosci 57:105-110, 2018
 
6) Silverstein JW, Rosenthal A, Ellis JA:Direct cortical motor evoked potentials versus transcranial motor evoked potentials for the detection of cortical ischemia during supratentorial craniotomy:Case report. Cureus 10(12):e3771, 2018
 
P.338 掲載の参考文献
7) Do HJ, Seo HG, Oh BM et al:Limitation of intraoperative transcranial electrical stimulation-motor evoked potential monitoring during brain tumor resection adjacent to the primary motor cortex. Ann Rehabil Med 42(5):767-772, 2018
 
8) Della Puppa A, Rossetto M, Volpin F et al:Microsurgical clipping of intracranial aneurysms assisted by neurophysiological monitoring, microvascular flow probe, and ICG-VA:Outcomes and intraoperative data on a multimodal strategy. World Neurosurg 113:e336-e344, 2018
PubMed
9) Yata S, Ida M, Shimotsuji H et al:Bite injuries caused by transcranial electrical stimulation motor-evoked potentials' monitoring:incidence, associated factors, and clinical course. J Anesth 32(6):844-849, 2018
PubMed
P.339 掲載の参考文献
10) Nishimura F, Wajima D, Park YS et al:Efficacy of the visual evoked potential monitoring in endoscopic transnasal transsphenoidal surgery as a real-time visual function. Neurol India 66(4):1075-1080, 2018
PubMed
11) Toyama K, Wanibuchi M, Honma T et al:Effectiveness of intraoperative visual evoked potential in avoiding visual deterioration during endonasal transsphenoidal surgery for pituitary tumors. Neurosurg Rev, 2018 (doi:10.1007/s10143-018-1024-3)
 
12) Gutzwiller EM, Cabrilo I, Radovanovic I et al:Intraoperative monitoring with visual evoked potentials for brain surgeries. J Neurosurg 130(2):654-660, 2018
PubMed
P.340 掲載の参考文献
13) Metwali H, Kniese K, Fahlbusch R:Intraoperative monitoring of the integrity of the anterior visual pathways:A methodologic review and meta-analysis. World Neurosurg 110:217-225, 2018
PubMed
14) Yoshino M, Hara T:Light axis adjustment with a sterilised photostimulation device for visually evoked potential monitoring. Br J Neurosurg 32(3):283-285, 2018
PubMed
15) Shahar T, Korn A, Barkay G et al:Elaborate mapping of the posterior visual pathway in awake craniotomy. J Neurosurg 128(5):1503-1511, 2018
PubMed
P.341 掲載の参考文献
16) Dalvandi M, Rafie AN, Kamali A et al:Evaluation of the prognostic value of multimodal intraoperative monitoring in posterior fossa surgery patients with cerebellopontine angle tumors. Eur J Transl Myol 28(1):7260, 2018
PubMed
17) Seidel K, Biner MS, Zubak I et al:Continuous dynamic mapping to avoid accidental injury of the facial nerve during surgery for large vestibular schwannomas. Neurosurg Rev, 2018 (doi:10.1007/s10143-018-1044-z)
 
18) Cornelius JF, Schipper J, Tortora A et al:Continuous and dynamic facial nerve mapping during surgery of cerebellopontine angle tumors:Clinical pilot series. World Neurosurg 119:e855-e863, 2018
PubMed
P.342 掲載の参考文献
19) Yoshimoto T, Maruichi K, Itoh Y et al:Monitoring corticocortical evoked potentials during intracranial vascular surgery. World Neurosurg 122:e947-e954, 2019
PubMed
20) Suzuki Y, Enatsu R, Kanno A et al:The influence of anesthesia on corticocortical evoked potential monitoring network between frontal and temporoparietal cortices. World Neurosurg 123:e685-e692, 2019
PubMed
21) Ares WJ, Grandhi RM, Panczykowski DM et al:Diagnostic accuracy of somatosensory evoked potential monitoring in evaluating neurological complications during endovascular aneurysm treatment. Oper Neurosurg (Hagerstown) 14(2):151-157, 2018
PubMed
P.343 掲載の参考文献
22) Lee S, Kim DY, Kim SB et al:Predictive value of neurophysiologic monitoring during neurovascular intervention for postoperative new neurologic deficits. Neuroradiology 61(2):207-215, 2019
 
23) Domenick Sridharan N, Thirumala P, Chaer R et al:Predictors of cross-clamp-induced intraoperative monitoring changes during carotid endarterectomy using both electroencephalography and somatosensory evoked potentials. J Vasc Surg 67(1):191-198, 2018
PubMed
P.344 掲載の参考文献
24) Sakata K, Suematsu K, Takeshige N et al:Novel method of intraoperative ocular movement monitoring using a piezoelectric device:experimental study of ocular motor nerve activating piezoelectric potentials (OMNAPP) and clinical application for skull base surgeries. Neurosurg Rev 2018 (doi:10.1007/s10143-018-1028-z)
 
25) Dias S, Sarnthein J, Jehli E et al:Safeness and utility of concomitant intraoperative monitoring with intraoperative magnetic resonance imaging in children:A pilot study. World Neurosurg 115:e637-e644, 2018
PubMed
26) Park SK, Joo BE, Lee S et al:The critical warning sign of real-time brainstem auditory evoked potentials during microvascular decompression for hemifacial spasm. Clin Neurophysiol 129(5):1097-1102, 2018
PubMed
27) Kim SY, Im HW, Choi YD et al:Intraoperative monitoring of hypoglossal nerve using hypoglossal motor evoked potential in infratentorial tumor surgery:A report of two cases. Ann Rehabil Med 42(2):352-357, 2018
PubMed

X. 画像診断

P.346 掲載の参考文献
1) Hale AT, Stonko DP, Wang L et al:Machine learning analyses can differentiate meningioma grade by features on magnetic resonance imaging. Neurosurg Focus 45(5):E4, 2018
 
2) Kamnitsas K, Ledig C, Newcombe VFJ et al:Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal 36:61-78, 2017
PubMed
3) Liu Y, Stojadinovic S, Hrycushko B et al:A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery. PLoS One 12(10):e0185844, 2017
 
4) Charron O, Lallement A, Jarnet D et al:Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network. Comput Biol Med 95:43-54, 2018
PubMed
P.347 掲載の参考文献
5) Akkus Z, Ali I, Sedlar J et al:Predicting Deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J Digit Imaging 30(4):469-476, 2017
PubMed
6) Chang K, Bai HX, Zhou H et al:Residual convolutional neural network for the determination of IDH status in low- and high-grade gliomas from MR imaging. Clin Cancer Res 24(5):1073-1081, 2018
PubMed
7) Korfiatis P, Kline TL, Lachance DH et al:Residual deep convolutional neural network predicts MGMT methylation status. J Digit Imaging 30(5):622-628, 2017
PubMed
8) Liu J, Chen F, Pan C et al:A cascaded deep convolutional neural network for joint segmentation and genotype prediction of brainstem gliomas. IEEE Trans Biomed Eng 65(9):1943-1952, 2018
 
9) Chang P, Grinband J, Weinberg BD et al:Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. AJNR Am J Neuroradiol 39(7):1201-1207, 2018
PubMed
P.348 掲載の参考文献
10) Chen L, Bentley P, Rueckert D:Fully automatic acute ischemic lesion segmentation in DWI using convolutional neural networks. Neuroimage Clin 15:633-643, 2017
PubMed
11) Titano JJ, Badgeley M, Schefflein J et al:Automated deep-neural-network surveillance of cranial images for acute neurologic events. Nat Med 24(9):1337-1341, 2018
PubMed
12) Prevedello LM, Erdal BS, Ryu JL et al:Automated critical test findings identification and online notification system using artificial intelligence in imaging. Radiology 285(3):923-931, 2017
PubMed
13) Chilamkurthy S, Ghosh R, Tanamala S et al:Deep learning algorithms for detection of critical findings in head CT scans:a retrospective study. Lancet 392(10162):2388-2396, 2018
PubMed
P.349 掲載の参考文献
14) Hale AT, Stonko DP, Lim J et al:Using an artificial neural network to predict traumatic brain injury. J Neurosurg Pediatr 23(2):219-226, 2018
PubMed
15) Liu J, Chen Y, Lan L et al:Prediction of rupture risk in anterior communicating artery aneurysms with a feed-forward artificial neural network. Eur Radiol 28(8):3268-3275, 2018
 
16) Chen H, Zhang Y, Zhang W et al:Low-dose CT via convolutional neural network. Biomed Opt Express 8(2):679-694, 2017
 
P.350 掲載の参考文献
17) Yang Q, Yan P, Zhang Y et al:Low-dose CT image denoising using a generative adversarial network with Wasserstein distance and perceptual loss. IEEE Trans Med Imaging 37(6):1348-1357, 2018
PubMed
18) Zhu B, Liu JZ, Cauley SF et al:Image reconstruction by domain-transform manifold learning. Nature 555(7697):487-492, 2018
PubMed
P.351 掲載の参考文献
1) Ma D, Gulani V, Seiberlich N et al:Magnetic resonance fingerprinting. Nature 495(7440):187-192, 2013
PubMed
2) Panda A, Mehta BB, Coppo S et al:Magnetic resonance fingerprinting-An overview. Curr Opin Biomed Eng 3:56-66, 2017
PubMed
P.352 掲載の参考文献
3) Badve C, Yu A, Dastmalchian S et al:MR fingerprinting of adult brain tumors:Initial experience. AJNR Am J Neuroradiol 38(3):492-499, 2017
PubMed
4) Liao C, Wang K, Cao X et al:Detection of lesions in mesial temporal lobe epilepsy by using MR fingerprinting. Radiology 288(3):804-812, 2018
PubMed
5) Ma D, Jiang Y, Chen Y et al:Fast 3D magnetic resonance fingerprinting for a whole-brain coverage. Magn Reson Med 79(4):2190-2197, 2018
 
6) Liao C, Bilgic B, Manhard MK et al:3D MR fingerprinting with accelerated stack-of-spirals and hybrid sliding-window and GRAPPA reconstruction. Neuroimage 162:13-22, 2017
PubMed
7) Gillies RJ, Kinahan PE, Hricak H:Radiomics:Images are more than pictures, they are data. Radiology 278(2):563-577, 2016
PubMed
8) Hu LS, Ning S, Eschbacher JM et al:Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Neuro Oncol 19(1):128-137, 2017
 
9) Arita H, Kinoshita M, Kawaguchi A et al:Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas. Sci Rep 8(1):11773, 2018
PubMed
P.353 掲載の参考文献
10) Kinoshita M, Sakai M, Arita H et al:Introduction of high throughput magnetic resonance T2-weighted image texture analysis for WHO grade 2 and 3 gliomas. PLoS One 11(10):e0164268, 2016
 
11) Li Y, Jiang J, Shen T et al:Radiomics features as predictors to distinguish fast and slow progression of Mild Cognitive Impairment to Alzheimer's disease. Conf Proc IEEE Eng Med Biol Soc 2018:127-130, 2018
 
12) Cui Y, Ren S, Tha KK et al:Volume of high-risk intratumoral subregions at multiparametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 27(9):3583-3592, 2017
PubMed
13) Sakai K, Yamada K, Akazawa K et al:Can we shorten the q-space imaging to make it clinically feasible? Jpn J Radiol 35(1):16-24, 2017
 
P.354 掲載の参考文献
14) Spampinato MV, Chan C, Jensen JH et al:Diffusional kurtosis imaging and motor outcome in acute ischemic stroke. AJNR Am J Neuroradiol 38(7):1328-1334, 2017
PubMed
15) Zhang H, Schneider T, Wheeler-Kingshott CA et al:NODDI:practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61(4):1000-1016, 2012
PubMed
16) Kadota Y, Hirai T, Azuma M et al:Differentiation between glioblastoma and solitary brain metastasis using neurite orientation dispersion and density imaging. J Neuroradiol:S0150-9861(18)30218-9, 2018
 
17) Hara S, Hori M, Ueda R et al:Unraveling specific brain microstructural damage in moyamoya disease using diffusion magnetic resonance imaging and positron emission tomography. J Stroke Cerebrovasc Dis 28(4):1113-1125, 2019
PubMed
18) https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm580154.htm
 
19) http://www.jsmrm.jp/modules/other/index.php?content_id=1
 
20) Barry RL, Vannesjo SJ, By S et al:Spinal cord MRI at 7T. Neuroimage 168:437-451, 2018
PubMed
21) Oh BH, Moon HC, Baek HM et al:Comparison of 7T and 3T MRI in patients with moyamoya disease. Magn Reson Imaging 37:134-138, 2017
PubMed
P.355 掲載の参考文献
22) Kurabe S, Okamoto K, Suzuki K et al:The posterior limb of the internal capsule as the subcortical transitional zone of the anterior and posterior circulations:Insights from human 7T MRI. Cerebrovasc Dis 41(5-6):256-264, 2016
 
23) Lyu M, Barth M, Xie VB et al:Robust SENSE reconstruction of simultaneous multislice EPI with low-rank enhanced coil sensitivity calibration and slice-dependent 2D Nyquist ghost correction. Magn Reson Med 80(4):1376-1390, 2018
PubMed
24) Liu Y, Lyu M, Barth M et al:PECGRAPPA reconstruction of simultaneous multislice EPI with slice-dependent 2D Nyquist ghost correction. Magn Reson Med 81(3):1924-1934, 2019
PubMed
25) Lustig M, Donoho D, Pauly JM:Sparse MRI:The application of compressed sensing for rapid MR imaging. Magn Reson Med 58(6):1182-1195, 2007
PubMed
26) Lu SS, Qi M, Zhang X et al:Clinical evaluation of highly accelerated compressed sensing time-of-flight mr angiography for intracranial arterial stenosis. AJNR Am J Neuroradiol 39(10):1833-1838, 2018
PubMed
27) Sartoretti T, Reischauer C, Sartoretti E et al:Common artefacts encountered on images acquired with combined compressed sensing and SENSE. Insights Imaging 9(6):1107-1115, 2018
PubMed
28) Zhu C, Tian B, Chen L et al:Accelerated whole brain intracranial vessel wall imaging using black blood fast spin echo with compressed sensing (CS-SPACE). MAGMA 31(3):457-467, 2018
PubMed
P.356 掲載の参考文献
29) Hatay GH, Yildirim M, Ozturk-Isik E:Considerations in applying compressed sensing to in vivo phosphorus MR spectroscopic imaging of human brain at 3T. Med Biol Eng Comput 55(8):1303-1315, 2017
 
P.357 掲載の参考文献
1) Haller S, Zaharchuk G, Thomas DL et al:Arterial spin labeling perfusion of the brain:Emerging clinical applications. Radiology 281(2):337-356, 2016
PubMed
P.358 掲載の参考文献
2) Okazaki S, Yamagami H, Yoshimoto T et al:Cerebral hyperperfusion on arterial spin labeling MRI after reperfusion therapy is related to hemorrhagic transformation. J Cereb Blood Flow Metab 37(9):3087-3090, 2017
PubMed
3) Hara S, Tanaka Y, Ueda Y et al:Noninvasive evaluation of CBF and perfusion delay of moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays:Comparison with 15O-Gas PET and DSC-MRI. AJNR Am J Neuroradiol 38(4):696-702, 2017
 
4) Lee S, Yun TJ, Yoo RE et al:Monitoring cerebral perfusion changes after revascularization in patients with moyamoya disease by using arterial spin-labeling MR imaging. Radiology 288(2):565-572, 2018
 
P.359 掲載の参考文献
5) Amukotuwa SA, Heit JJ, Marks MP et al:Detection of cortical venous drainage and determination of the Borden Type of dural arteriovenous fistula by means of 3D pseudocontinuous arterial spin-labeling MRI. AJR Am J Roentgenol 207(1):163-169, 2016
PubMed
6) Hodel J, Leclerc X, Kalsoum E et al:Intracranial arteriovenous shunting:Detection with arterial spin-labeling and susceptibility-weighted imaging combined. AJNR Am J Neuroradiol 38(1):71-76, 2017
PubMed
7) Yoo RE, Yun TJ, Yoon BW et al:Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings. PLoS One 12(3):e0173538, 2017
 
8) Shimogawa T, Morioka T, Sayama T et al:The initial use of arterial spin labeling perfusion and diffusion-weighted magnetic resonance images in the diagnosis of nonconvulsive partial status epileptics. Epilepsy Res 129:162-173, 2017
PubMed
P.360 掲載の参考文献
9) Lin T, Lai Z, Zuo Z et al:ASL perfusion features and type of circle of Willis as imaging markers for cerebral hyperperfusion after carotid revascularization:a preliminary study. Eur Radiol 29(5):2651-2658, 2019 (Epub 2018 Nov 15)
 
10) Yamashita K, Hiwatashi A, Togao O et al:MR imaging-based analysis of glioblastoma multiforme:Estimation of IDH1 mutation status. AJNR Am J Neuroradiol 37(1):58-65, 2016
PubMed
11) Ye J, Bhagat SK, Li H et al:Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imaging. Exp Ther Med 11(6):2432-2436, 2016
PubMed
P.361 掲載の参考文献
12) Yamada S, Kelly E:Cerebrospinal fluid dynamics and the pathophysiology of hydrocephalus:New concepts. Semin Ultrasound CT MR 37(2):84-91, 2016
PubMed
13) Ohtonari T, Nishihara N, Ota S et al:Novel assessment of cerebrospinal fluid dynamics by time-spatial labeling inversion pulse magnetic resonance imaging in patients with Chiari malformation type I. World Neurosurg 112:e165-e171, 2018
PubMed
14) Horie T, Kajihara N, Matsumae M et al:Magnetic resonance imaging technique for visualization of irregular cerebrospinal fluid motion in the ventricular system and subarachnoid space. World Neurosurg 97:523-531, 2017
PubMed
P.362 掲載の参考文献
1) Matsumoto Y, Oikawa K, Nomura JI et al:Optimal brain 99mTc-ethyl cysteinate dimer SPECT imaging and analysis to detect misery perfusion on 15O PET imaging in patients with chronic occlusive disease of unilateral major cerebral artery. Clin Nucl Med 42(7):499-505, 2017
PubMed
P.363 掲載の参考文献
2) Ohta T, Nakahara I, Matsumoto S et al:Prediction of cerebral hyperperfusion after carotid artery stenting by cerebral angiography and single-photon emission computed tomography without acetazolamide challenge. Neurosurgery 81(3):512-519, 2017
PubMed
3) Kojima D, Komoribayashi N, Omama S et al:Crossed cerebellar tracer uptake on acute-stage 123I-Iomazenil SPECT imaging predicts 3-month functional outcome in patients with nonfatal hypertensive putaminal or thalamic hemorrhage. Clin Nucl Med 43(6):396-401, 2018
PubMed
4) Nakagawa M, Mutoh T, Takenaka S et al:Asymptomatic mild hyperperfusion for the prediction of clinical outcome in postoperative patients after subarachnoid hemorrhage. Med Sci Monit 23:285-291, 2017
PubMed
P.364 掲載の参考文献
5) Mutoh T, Totsune T, Takenaka S et al:Reduced CBF recovery detected by longitudinal 3D-SSP SPECT analyses predicts outcome of postoperative patients after subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 45(2):127-132, 2018
PubMed
6) Setta K, Kojima D, Shimada Y et al:Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease. Ann Nucl Med 32(9):611-619, 2018
PubMed
7) Sato S, Kojima D, Shimada Y et al:Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease. J Cereb Blood Flow Metab 38(6):1021-1031, 2018
PubMed
P.365 掲載の参考文献
8) Nakamizo A, Amano T, Michiwaki Y et al:Long-term neurocognitive outcomes in patients with adult moyamoya disease. World Neurosurg 119:e441-e448, 2018
PubMed
9) Miyoshi K, Chida K, Kobayashi M et al:Two-year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion:A prospective cohort study. Neurosurgery, 2018 (doi:10.1093/neuros/nyy234)
 
10) Chiba T, Setta K, Shimada Y et al:Comparison of effects between clopidogrel and cilostazol on cerebral perfusion in nonsurgical adult patients with symptomatically ischemic moyamoya disease:Subanalysis of a prospective cohort. J Stroke Cerebrovasc Dis 27(11):3373-3379, 2018
PubMed
P.366 掲載の参考文献
11) Derdeyn CP, Zipfel GJ, Zazulia AR et al:Baseline hemodynamic impairment and future stroke risk in adult idiopathic moyamoya phenomenon:Results of a prospective natural history Study. Stroke 48(4):894-899, 2017
PubMed
12) Yanagihara W, Chida K, Kobayashi M et al:Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg, 2018 (doi:10.3171/2018.7.JNS18149)
 
13) Kazumata K, Tha KK, Uchino H et al:Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease. J Neurosurg 127(2):260-269, 2017
PubMed
P.368 掲載の参考文献
1) Ideguchi M, Nishizaki T, Ikeda N et al:A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement. J Neurooncol 138(3):537-548, 2018
PubMed
2) Sato M, Tateishi K, Murata H et al:Three-dimensional multimodality fusion imaging as an educational and planning tool for deep-seated meningiomas. Br J Neurosurg 32(5):509-515, 2018
PubMed
3) Fujimoto S, Takai K, Nakatomi H et al:Three-dimensional angioarchitecture and microsurgical treatment of arteriovenous fistulas at the craniocervical junction. J Clin Neurosci 53:140-146, 2018
PubMed
4) Won TB, Hwang P, Lim JH et al:Early experience with a patient-specific virtual surgical simulation for rehearsal of endoscopic skull-base surgery. Int Forum Allergy Rhinol 8(1):54-63, 2018
PubMed
P.369 掲載の参考文献
5) Rotariu DI, Ziyad F, Budu A et al:The role of OsiriX based virtual endoscopy in planning endoscopic transsphenoidal surgery for pituitary adenoma. Turk Neurosurg 27(3):339-345, 2017
PubMed
6) Goertz L, Kabbasch C, Borggrefe J et al:Preoperative three-dimensional angiography may reduce ischemic complications during clipping of ruptured intracranial aneurysms. World Neurosurg 120:e1163-e1170, 2018
PubMed
7) Yao S, Zhang J, Zhao Y et al:Multimodal image-based virtual reality presurgical simulation and evaluation for trigeminal neuralgia and hemifacial spasm. World Neurosurg 113:e499-e507, 2018
PubMed
8) Nowell M, Rodionov R, Zombori G et al:A pipeline for 3D multimodality image integration and computer-assisted planning in epilepsy surgery. J Vis Exp (111):e53450, 2016
 
9) Ohtani K, Mashiko T, Oguro K et al:Preoperative three-dimensional diagnosis of neurovascular relationships at the root exit zones during microvascular decompression for hemifacial spasm. World Neurosurg 92:171-178, 2016
PubMed
10) Shono N, Kin T, Nomura S et al:Microsurgery simulator of cerebral aneurysm clipping with interactive cerebral deformation featuring a virtual arachnoid. Oper Neurosurg (Hagerstown) 14(5):579-589, 2018
PubMed
11) Yoshino M, Nakatomi H, Kin T et al:Usefulness of high-resolution 3D multifusion medical imaging for preoperative planning in patients with posterior fossa hemangioblastoma:technical note. J Neurosurg 127(1):139-147, 2017
PubMed
12) Yoshino M, Kin T, Hara T:Usefulness of high-resolution three-dimensional multifusion medical imaging for preoperative planning in patients with cerebral arteriovenous malformation. World Neurosurg:S1878-8750 (19)30100-7, 2019
 
13) Fernandes de Oliveira Santos B, Silva da Costa MD, Centeno RS et al:Clinical application of an open-source 3D volume rendering software to neurosurgical approaches. World Neurosurg 110:e864-e872, 2018
PubMed
P.370 掲載の参考文献
14) Li Y, Zhao Y, Zhang J et al:Low-cost interactive image-based virtual endoscopy for the diagnosis and surgical planning of suprasellar arachnoid cysts. World Neurosurg 88:76-82, 2016
 
15) Govsa F, Ozer MA, Biceroglu H et al:Creation of 3-dimensional life size:patient-specific C1 fracture models for screw fixation. World Neurosurg 114:e173-e181, 2018
PubMed
16) Wang L, Ye X, Hao Q et al:Three-dimensional intracranial middle cerebral artery aneurysm models for aneurysm surgery and training. J Clin Neurosci 50:77-82, 2018
 
17) Ghizoni E, de Souza JPSAS, Raposo-Amaral CE et al:3D-printed craniosynostosis model:New simulation surgical tool. World Neurosurg 109:356-361, 2018
PubMed
18) Wang L, Ye X, Hao Q et al:Comparison of two three-dimensional printed models of complex intracranial aneurysms for surgical simulation. World Neurosurg 103:671-679, 2017
 
19) Andereggen L, Gralla J, Andres RH et al:Stereolithographic models in the interdisciplinary planning of treatment for complex intracranial aneurysms. Acta Neurochir (Wien) 158(9):1711-1720, 2016
PubMed
20) Goel A, Jankharia B, Shah A et al:Three-dimensional models:an emerging investigational revolution for craniovertebral junction surgery. J Neurosurg Spine 25(6):740-744, 2016
PubMed
21) Archavlis E, Schwandt E, Kosterhon M et al:A modified microsurgical endoscopic-assisted transpedicular corpectomy of the thoracic spine based on virtual 3-dimensional planning. World Neurosurg 91:424-433, 2016
PubMed
22) Eastwood KW, Bodani VP, Drake JM:Three-dimensional simulation of collision-free paths for combined endoscopic third ventriculostomy and pineal region tumor biopsy:Implications for the design specifications of future flexible endoscopic instruments. Oper Neurosurg (Hagerstown) 12(3):231-238, 2016
PubMed
23) Li X, Zhu W, He J et al:Application of computer assisted three-dimensional simulation operation and biomechanics analysis in the treatment of sagittal craniosynostosis. J Clin Neurosci 44:323-329, 2017
 

書評

最近チェックした商品履歴

Loading...